Department of Neurology

Quick Links

* (Neurology Faculty Profile)

Robert Hauser

Robert Hauser, MD, MBA

Director, Parkinson's Disease & Movement Disorder Center

Contact Info

Education

  • MBA, Business Administration, University of South Florida, 2000
  • MD, Medicine, Temple University, 1982

Interdisciplinary and Emerging Signature Programs

  • Neuroscience

Research Interests

  • Dr. Hauser has authored or co-authored more than 400 peer-reviewed publications and is one of the world's most cited Parkinson's Disease and Movement Disorders investigators. He is Past Chairman of the Interventional Neurology Section of the American Academy of Neurology, has served on the executive committee of the Parkinson Study Group, and was a member of the steering committee for the NIH-sponsored Neuroprotective Exploratory Trials in Parkinson's Disease program (NET-PD). Dr. Hauser lectures frequently at scientific meetings and served as Chairman of the 2009 World Federation of Neurology International Congress on Parkinson's Disease and Related Disorders. Dr. Hauser's primary research interest is the development of new medical and surgical treatments for Parkinson's disease and other movement disorders. He has extensive expertise in clinical trial design and execution. The outcome measures he developed have become the gold standard for use in clinical trials. He provides expert clinical care for patients with Parkinson's disease and botulinum toxin injections for cervical dystonia, blepharospasm, and hemifacial spasm.

Awards/Honors

  • America'a Top Doctors (Top 1%) (Castle Connolly - 2013)
  • Board Certification (American Society of Neuroimaging (MRI - Magnetic Resonance Imaging) - 2012)
  • Board Certification (American Board of Psychiatry & Neurology - 2012)
  • America'a Top Doctors (Top 1%) (Castle Connolly - 2012)
  • America's Top Doctors (Castle Connolly - 2011)
  • America's Top Doctors (Castle Connolly - 2010)
  • America's Top Doctors (Castle Connolly - 2009)
  • America's Top Doctors (Castle Connolly - 2008)
  • America's Top Doctors (Castle Connolly - 2008)
  • America's Top Doctors (Castle Connolly - 2007)
  • America's Top Doctors (Castle Connolly - 2006)
  • MIllion Dollar Researcher (University of South Florida - 2006)
  • America's Top Doctors (Castle Connolly - 2005)
  • Center of Excellence (National Parkinson Foundation - 2005)
  • America's Top Doctors (Castle Connolly - 2004)
  • America's Top Doctors (Castle Connolly - 2003)

Memberships

  • Fellow (American Academy of Neurology, 2004 - Present)
  • Member (Movement Disorders Society, 1988 - Present)
  • Member (American Academy of Neurology, 1988 - Present)

Recent Publications

  • Olanow, C. Warren|Hauser, Robert A.|Burdick, Daniel J.|Dhall, Rohit|de Marcaida, Joy Antonelle|Gil, Ramon A.|Kreitzman, David L.|Elmer, Lawrence W.|McGarry, Andrew|Kieburtz, Karl A Randomized Phase 3 Study Comparing P2B001 to its Components (Low‐Dose Extended‐Release Rasagiline and Pramipexole) and to Optimized Doses of Marketed Extended‐Release Pramipexole in Early Parkinson's Disease Movement Disorders [08853185]. 39(2) , 2024.
  • Fung, Victor S.C.|Aldred, Jason|Arroyo, Martha P.|Bergquist, Filip|Boon, Agnita J.W.|Bouchard, Manon|Bray, Sarah|Dhanani, Sara|Facheris, Maurizio F.|Fisseha, Nahome|Freire-Alvarez, Eric|Hauser, Robert A.|Jeong, Anna|Jia, Jia|Kukreja, Pavnit|Soileau, Michael J.|Spiegel, Amy M.|Talapala, Saritha|Tarakad, Arjun|Urrea-Mendoza, Enrique|Zamudio, Jorge|Pahwa, Rajesh Continuous subcutaneous foslevodopa/foscarbidopa infusion for the treatment of motor fluctuations in Parkinson’s disease: Considerations for initiation and maintenance Clinical Parkinsonism & Related Disorders [25901125]. 10, 2024.
  • LeWitt, Peter|Lohmann, Ebba|Manzanares, Lydia Lopez|Malaty, Irene|Massey, Janice|Mcallister, Peter|Moore, Peter|Moro, Elena|Ondo, William|Mora, Javier Pagonabarraga|Paus, Sebastian|Peckham, Elizabeth|Pillai, Rekha|Rudzinska, Monika|Schwartz, Harvey|Singer, Carlos|Slawek, Jaroslaw|Sycha, Thomas|Szabela, Dariusz|Tate, Jessica|Thakur, Nicklesh|Torres, Diego|Trejo, Jose Maria|Truong, Daniel|Tse, Winona|Tutaj, Andrzej|Vasquez, Alberto|Vysata, Oldrich|Woznicova, Ivana|Yegiaian, Sharon|Albrecht, Philipp|Barbano, Richard|Bettle, Norman|Bösch, Sylvia|Bouhour, Francoise|Boyd, James|Castelnovo, Giovanni|Chand, Pratap|Cooper, Christine|Criswell, Susan|Dashtipour, Khashayar|Deik, Andres|Ellenbogen, Aaron|Evidente, Virgilio|Feigenbaum, Danielle|Fox, Susan|Frei, Karen|Gitt, Jeffrey|Goudreau, John|Habibi, Behzad|Harrower, Timothy|Haslinger, Bernhard|Hedera, Peter|Heitzman, Daragh|Hermanowicz, Neal|Hernandez-Vara, Jorge|Isaacs, David|Isaacson, Stuart|Jech, Robert|Jinnah, Hyder|Kobylecki, Christopher|Kollewe, Katja|Kompoliti, Aikaterini|Koziorowski, Dariusz|Kreisler, Alexandre|Kumar, Rajeev|Kupsch, Andreas|LeDoux, Mark|Comella, Cynthia L.|Jankovic, Joseph|Hauser, Robert A.|Patel, Atul T.|Banach, Marta D.|Ehler, Edvard|Vitarella, Domenico|Rubio, Roman G.|Gross, Todd M. Efficacy and Safety of DaxibotulinumtoxinA for Injection in Cervical Dystonia: ASPEN-1 Phase 3 Randomized Controlled Trial Neurology [00283878]. 102(4) , 2024.
  • Fernandez, Hubert H.|Macklin, Eric A.|Hauser, Robert A.|Chou, Kelvin L.|Cakmak, Yusuf O.|Ozsoy, Burak|Fahn, Stanley Intrinsic auricular muscle zone stimulation for Parkinson disease: The EARSTIM-PD Phase II multi-center pilot study results Parkinsonism and Related Disorders [13538020]. 121, 2024.
  • Hauser, Robert A.|Videnovic, Aleksandar|Soares-da-Silva, Patrício|Liang, Grace S.|Olson, Kurt|Jen, Eric|Rocha, José-Francisco|Klepitskaya, Olga OFF-times before, during, and after nighttime sleep periods in Parkinson's disease patients with motor fluctuations and the effects of opicapone: A post hoc analysis of diary data from BIPARK-1 and -2 Parkinsonism and Related Disorders [13538020]. 123, 2024.
  • Espay, Alberto J.|Hauser, Robert A.|Dhall, Rohit|Thakkar, Sandeep|Cloud, Leslie|Zeitlin, Leonid|Banisadr, Ghazal|Fisher, Stanley|Visser, Hester Safety and Efficacy of IPX203 in Parkinson's Disease: The RISE‐PD Open‐Label Extension Study Movement Disorders [08853185]. 39(2) , 2024.
  • Frank, Samuel|Anderson, Karen E.|Fernandez, Hubert H.|Hauser, Robert A.|Claassen, Daniel O.|Stamler, David|Factor, Stewart A.|Jimenez-Shahed, Joohi|Barkay, Hadas|Wilhelm, Amanda|Alexander, Jessica K.|Chaijale, Nayla|Barash, Steve|Savola, Juha-Matti|Gordon, Mark Forrest|Chen, Maria Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia and Chorea Associated with Huntington Disease Neurology and Therapy [21938253]. , 2024.
  • Trosch, Richard M.|Comella, Cynthia L.|Caroff, Stanley N.|Ondo, William G.|Shillington, Alicia C.|LaChappelle, Brandon J.|Hauser, Robert A.|Correll, Christoph U.|Friedman, Joseph H. The Clinician’s Tardive Inventory (CTI): A New Clinical Tool for Documenting and Rating Tardive Dyskinesia The Journal of Clinical Psychiatry [01606689]. 85(1) , 2024.
  • Hauser, R.A.|Factor, S.A.|Ondo, W.G.|Zhang, I.|Navia, B.|Pappert, E. Antiemetics may not be necessary for titration of apomorphine sublingual film for the treatment of "OFF" episodes in Parkinson's disease Parkinsonism and Related Disorders [13538020]. 113, 2023.
  • Isaacson, Stuart H.|Hauser, Robert A.|Pahwa, Rajesh|Gray, David|Duvvuri, Sridhar Dopamine agonists in Parkinson’s disease: Impact of D1-like or D2-like dopamine receptor subtype selectivity and avenues for future treatment Clinical Parkinsonism & Related Disorders [25901125]. 9, 2023.
  • Pappert, Eric|Zhang, Yi|Bowling, Alyssa|Navia, Bradford|Ondo, William G.|Hauser, Robert A.|Isaacson, Stuart H. Dose Optimization of Apomorphine Sublingual Film for OFF Episodes in Parkinson’s Disease: Is the Prophylactic Use of an Antiemetic Necessary? Journal of Parkinson's Disease [18777171]. 13(3) , 2023.
  • Comella, C.|Hauser, R.|Isaacson, S.|Truong, D.|Oguh, O.|Hui, J.|Molho, E.|Brodsky, M.|Furr-Stimming, E.|Comes, G.|Hast, M.|Charles, D. IncobotulinumtoxinA injections at intervals <10 weeks are effective and safe for cervical dystonia patients with inadequate benefit from standard intervals Parkinsonism and Related Disorders [13538020]. 113, 2023.
  • Comella, Cynthia|Hauser, Robert|Isaacson, Stuart|Truong, Daniel|Oguh, Odinachi|Hui, Jennifer|Molho, Eric|Brodsky, Matthew|Furr-Stimming, Erin|Comes, Georg|Hast, Michael|Charles, David Injections of incobotulinumtoxina at intervals less than 10 weeks are effective and safe for cervical dystonia patients with inadequate benefit from standard injection intervals Journal of the Neurological Sciences [0022510X]. 455, 2023.
  • Hauser, Robert A.|Espay, Alberto J.|Ellenbogen, Aaron L.|Fernandez, Hubert H.|Isaacson, Stuart H.|LeWitt, Peter A.|Ondo, William G.|Pahwa, Rajesh|Schwarz, Johannes|Stocchi, Fabrizio|Zeitlin, Leonid|Banisadr, Ghazal|Fisher, Stanley|Visser, Hester|D’Souza, Richard IPX203 vs Immediate-Release Carbidopa-Levodopa for the Treatment of Motor Fluctuations in Parkinson Disease: The RISE-PD Randomized Clinical Trial Archives of Neurology [00039942]. 80(10) , 2023.
  • Vaswani, Pavan A.|Morley, James F.|Jennings, Danna|Siderowf, Andrew|Marek, Kenneth|Seibyl, John|Stern, Matthew|Russell, David|Sethi, Kapil|Frank, Samuel|Simuni, Tanya|Hauser, Robert|Ravina, Bernard|Richards, Irene|Liang, Grace|Adler, Charles|Saunders-Pullman, Rachel|Evatt, Marian L.|Lai, Eugene|Subramanian, Indu|Hogarth, Penelope|Chung, Kathryn Predictive value of abbreviated olfactory tests in prodromal Parkinson disease npj Parkinson's Disease [23738057]. 9(1) , 2023.
  • Trosch, Richard M.|Comella, Cynthia L.|Caroff, Stanley N.|Ondo, William G.|Shillington, Alicia C.|LaChappelle, Brandon J.|Hauser, Robert A.|Correll, Christof U.|Friedman, Joseph H. Reliability of the Clinician’s Tardive Inventory (CTI) CNS Spectrums [10928529]. 28(2) , 2023.
  • Martino, Davide|Karnik, Vikram|Bhidayasiri, Roongroj|Hall, Deborah A.|Hauser, Robert A.|Macerollo, Antonella|Pringsheim, Tamara M.|Truong, Daniel|Factor, Stewart A.|Skorvanek, Matej|Schrag, Anette Scales for Antipsychotic‐Associated Movement Disorders: Systematic Review, Critique, and Recommendations Movement Disorders [08853185]. 38(6) , 2023.
  • Grosset, Donald G.|Blank, Burkhard|Waters, Cheryl H.|LeWitt, Peter A.|Hauser, Robert A. The Clinical Development of Levodopa Inhalation Powder Clinical Neuropharmacology [03625664]. 46(2) , 2023.
  • Comella, C.|Isaacson, S.|Charles, D.|Truong, D.|Oguh, O.|Hui, J.|Molho, E.|Brodsky, M.|Furr-Stimming, E.|Comes, G.|Hast, M.|Hauser, R. Treatment of cervical dystonia using shorter incobotulinumtoxinA injection intervals improves patient-reported outcomes in those with inadequate benefits from standard intervals Parkinsonism and Related Disorders [13538020]. 113, 2023.
  • Isaacson, Stuart|Charles, David|Comella, Cynthia|Truong, Daniel|Oguh, Odinachi|Hui, Jennifer|Molho, Eric|Brodsky, Matthew|Furr-Stimming, Erin|Comes, Georg|Hast, Michael|Hauser, Robert Treatment of cervical dystonia using shorter incobotulinumtoxina injection intervals improves patient-reported outcomes in those with inadequate benefits from standard intervals Journal of the Neurological Sciences [0022510X]. 455, 2023.
  • Morinan, Gareth|Hauser, Robert A.|Schrag, Anette|Tang, Jingxuan|O’Keeffe, Jonathan|MDS-NMS Scale Development Study Group Abbreviated MDS-UPDRS for Remote Monitoring in PD Identified Using Exhaustive Computational Search Parkinson's Disease [20908083]. 2022, 2022.
  • Hauser, Robert A.|Lytle, Judy|Formella, Andrea E.|Tanner, Caroline M. Amantadine delayed release/extended release capsules significantly reduce OFF time in Parkinson’s disease npj Parkinson's Disease [23738057]. 8(1) , 2022.
  • Pahwa, Rajesh|Fox, Susan|Hauser, Robert A.|Isaacson, Stuart|Lytle, Judy|Johnson, Reed|Llorens, Lily|Formella, Andrea E.|Tanner, Caroline M. Clinically important change on the Unified Dyskinesia Rating Scale among patients with Parkinson's disease experiencing dyskinesia Frontiers in Neurology [16642295]. 13, 2022.
  • Hauser, Robert A.|Meyer, Jonathan M.|Factor, Stewart A.|Comella, Cynthia L.|Tanner, Caroline M.|Xavier, Rose Mary|Caroff, Stanley N.|Lundt, Leslie Differentiating tardive dyskinesia: a video-based review of antipsychotic-induced movement disorders in clinical practice CNS Spectrums [10928529]. 27(2) , 2022.
  • Hauser, Robert A.|Favit, Antonella|Hewitt, L. Arthur|Lindsten, Annika|Gorny, Stephen|Kymes, Steven|Isaacson, Stuart H. Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment Neurology and Therapy [21938253]. 11(1) , 2022.
  • Hauser, Robert A.|Barkay, Hadas|Fernandez, Hubert H.|Factor, Stewart A.|Jimenez-Shahed, Joohi|Gross, Nicholas|Marinelli, Leslie|Wilhelm, Amanda|Gordon, Mark Forrest|Savola, Juha-Matti|Anderson, Karen E. Effects of Long-Term Deutetrabenazine Treatment in Patients with Tardive Dyskinesia and Underlying Psychiatric or Mood Disorders CNS Spectrums [10928529]. 27(2) , 2022.
  • Comella, Cynthia|Hauser, Robert A.|Isaacson, Stuart H.|Truong, Daniel|Oguh, Odinachi|Hui, Jennifer|Molho, Eric S.|Brodsky, Matthew|Furr-Stimming, Erin|Comes, Georg|Hast, Michael A.|Charles, David Efficacy and safety of two incobotulinumtoxinA injection intervals in cervical dystonia patients with inadequate benefit from standard injection intervals of botulinum toxin: Phase 4, open-label, randomized, noninferiority study Clinical Parkinsonism & Related Disorders [25901125]. 6, 2022.
  • Taylor, Kirsten|Grachev, Igor|Avbersek, Andreja|Muglia, Pierandrea|Merchant, Kaplana|Tauscher, Johannes|Tai, Yen|Politis, Marios|Smejdir, Debra|Rees, Linda|Williams, Karen|Kausar, Farah|Williams, Karen|Richardson, Whitney|Willeke, Diana|Peacock, Shawnees|Sommerfeld, Barbara|Freed, Alison|Wakeman, Katrina|Blair, Courtney|Guthrie, Stephanie|Harrell, Leigh|Hunter, Christine|Thomas, Cathi-Ann|James, Raymond|Zimmerman, Grace|Brown, Victoria|Mule, Jennifer|Hilt, Ella|Ribb, Kori|Ainscough, Susan|Wethington, Misty|Ranola, Madelaine|Santana, Helen Mejia|Moreno, Juliana|Raymond, Deborah|Speketer, Krista|Carvajal, Lisbeth|Carvalo, Stephanie|Croitoru, Ioana|Garrido, Alicia|Payne, Laura Marie|Viswanth, Veena|Severt, Lawrence|Facheris, Maurizio|Soares, Holly|Mintun, Mark A.|Cedarbaum, Jesse|Taylor, Peggy|Biglan, Kevin|Vandenbroucke, Emily|Sheikh, Zulfiqar Haider|Bingol, Baris|Fischer, Tanya|Sardi, Pablo|Forrat, Remi|Reith, Alastair|Egebjerg, Jan|Hillert, Gabrielle Ahlberg|Saba, Barbara|Min, Chris|Umek, Robert|Mather, Joe|De Santi, Susan|Post, Anke|Boess, Frank|Simuni, Tanya|Merchant, Kalpana|Brumm, Michael C.|Cho, Hyunkeun|Caspell-Garcia, Chelsea|Coffey, Christopher S.|Chahine, Lana M.|Alcalay, Roy N.|Nudelman, Kelly|Foroud, Tatiana|Mollenhauer, Brit|Siderowf, Andrew|Tanner, Caroline|Iwaki, Hirotaka|Sherer, Todd|Marek, Kenneth|Siderowf, Andrew|Seibyl, John|Coffey, Christopher|Tosun-Turgut, Duygu|Shaw, Leslie M.|Trojanowski, John Q.|Singleton, Andrew|Kieburtz, Karl|Toga, Arthur|Mollenhauer, Brit|Galasko, Douglas|Poewe, Werner|Foroud, Tatiana|Poston, Kathleen|Bressman, Susan|Reimer, Alyssa|Arnedo, Vanessa|Clark, Adrienne|Frasier, Mark|Kopil, Catherine|Chowdhury, Sohini|Casaceli, Cynthia|Dorsey, Ray|Wilson, Renee|Mahes, Sugi|Seibyl, John|Salerno, Christina|Ahrens, Monica|Brumm, Michael|Cho, Hyunkeun Ryan|Fedler, Janel|LaFontant, David-Erick|Kurth, Ryan|Crawford, Karen|Casalin, Paola|Malferrari, Giulia|Weisz, Mali Gani|Orr-Urtreger, Avi|Trojanowski, John|Shaw, Leslie|Montine, Thomas|Baglieri, Chris|Christini, Amanda|Russell, David|Dahodwala, Nabila|Giladi, Nir|Factor, Stewart|Hogarth, Penelope|Standaert, David|Hauser, Robert|Jankovic, Joseph|Saint-Hilaire, Marie|Richard, Irene|Shprecher, David|Fernandez, Hubert|Brockmann, Katrina|Rosenthal, Liana|Barone, Paolo|Espayc, Alberto|Rowe, Dominic|Marder, Karen|Santiago, Anthony|Bressman, Susan|Hu, Shu-Ching|Isaacson, Stuart|Corvol, Jean-Christophe|Martinez, Javiar Ruiz|Tolosa, Eduardo Longitudinal clinical and biomarker characteristics of non-manifesting LRRK2 G2019S carriers in the PPMI cohort npj Parkinson's Disease [23738057]. 8(1) , 2022.
  • Hauser, Robert A.|Barkay, Hadas|Fernandez, Hubert H.|Factor, Stewart A.|Jimenez-Shahed, Joohi|Gross, Nicholas|Marinelli, Leslie|Wilhelm, Amanda|Alexander, Jessica|Gordon, Mark Forrest|Savola, Juha-Matti|Anderson, Karen E. Long-Term Deutetrabenazine Treatment for Tardive Dyskinesia Is Associated With Sustained Benefits and Safety: A 3-Year, Open-Label Extension Study Frontiers in Neurology [16642295]. 13, 2022.
  • Hauser, Robert A.|Barkay, Hadas|Fernandez, Hubert H.|Factor, Stewart A.|Jimenez-Shahed, Joohi|Gross, Nicholas|Marinelli, Leslie|Wilhelm, Amanda|Gordon, Mark Forrest|Savola, Juha-Matti|Anderson, Karen E. Long-Term Efficacy and Safety of Deutetrabenazine in Patients with Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonist Use CNS Spectrums [10928529]. 27(2) , 2022.
  • Hauser, Robert A.|Barkay, Hadas|Wilhelm, Amanda|Wieman, Maria|Savola, Juha-Matti|Gordon, Mark Forrest Minimal clinically important change in Abnormal Involuntary Movement Scale score in tardive dyskinesia as assessed in pivotal trials of deutetrabenazine Parkinsonism and Related Disorders [13538020]. 97, 2022.
  • Camilleri, Michael|Subramanian, Thyagarajan|Pagan, Fernando|Isaacson, Stuart|Gil, Ramon|Hauser, Robert A.|Feldman, Mary|Goldstein, Mark|Kumar, Rajeev|Truong, Daniel|Chhabria, Nisha|Walter, Benjamin L.|Eskenazi, Jonathan|Riesenberg, Robert|Burdick, Daniel|Tse, Winona|Molho, Eric|Robottom, Bradley|Bhatia, Perminder|Kadimi, Srinath|Klos, Kevin|Shprecher, David|Marquez-Mendoza, Otto|Hidalgo, Gonzalo|Grill, Stephen|Li, George|Mandell, Howard|Hughes, Mary|Stephenson, Sharisse|Vandersluis, Joel|Pfeffer, Michael|Duker, Andrew|Shivkumar, Vikram|Kinney, William|MacDougall, James|Zasloff, Michael|Barbut, Denise Oral ENT-01 Targets Enteric Neurons to Treat Constipation in Parkinson Disease: A Randomized Controlled Trial Annals of Internal Medicine [00034819]. 175(12) , 2022.
  • Hauser, Robert A.|Giladi, Nir|Poewe, Werner|Brotchie, Jonathan|Friedman, Hadas|Oren, Sheila|Litman, Pninit P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson’s Disease Advances in Therapy [0741238X]. 39(5) , 2022.
  • Hauser, Robert A.|Goud, Santosh|Formella, Andrea E. Potential Utility of Amantadine DR/ER in Persons with Parkinson’s Disease Meeting 5-2-1 Criteria for Device Aided Therapy Clinical Parkinsonism & Related Disorders [25901125]. 6, 2022.
  • Soileau, Michael J|Aldred, Jason|Budur, Kumar|Fisseha, Nahome|Fung, Victor SC|Jeong, Anna|Kimber, Thomas E|Klos, Kevin|Litvan, Irene|O'Neill, Daniel|Robieson, Weining Z|Spindler, Meredith A|Standaert, David G|Talapala, Saritha|Vaou, Eleni Okeanis|Zheng, Hui|Facheris, Maurizio F|Hauser, Robert A Safety and efficacy of continuous subcutaneous foslevodopa-foscarbidopa in patients with advanced Parkinson's disease: a randomised, double-blind, active-controlled, phase 3 trial Lancet Neurology [14744422]. 21(12) , 2022.
  • Dukart, Juergen|D’Urso, Giulia|Finch, Rebecca|Zanigni, Stefano|Monnet, Annabelle|Pross, Nathalie|Hahn, Andrea|Svoboda, Hanno|Britschgi, Markus|Lipsmeier, Florian|Volkova-Volkmar, Ekaterina|Lindemann, Michael|Dziadek, Sebastian|Holiga, Štefan|Rukina, Daria|Kustermann, Thomas|Kerchner, Geoffrey A.|Fontoura, Paulo|Umbricht, Daniel|Doody, Rachelle|Nikolcheva, Tania|Bonni, Azad|Pagano, Gennaro|Taylor, Kirsten I.|Anzures-Cabrera, Judith|Marchesi, Maddalena|Simuni, Tanya|Marek, Kenneth|Postuma, Ronald B.|Pavese, Nicola|Stocchi, Fabrizio|Azulay, Jean-Philippe|Mollenhauer, Brit|López-Manzanares, Lydia|Russell, David S.|Boyd, James T.|Nicholas, Anthony P.|Luquin, María R.|Hauser, Robert A.|Gasser, Thomas|Poewe, Werner|Ricci, Benedicte|Boulay, Anne|Vogt, Annamarie|Boess, Frank G. Trial of Prasinezumab in Early-Stage Parkinson’s Disease New England Journal of Medicine [00284793]. 387(5) , 2022.
  • Rupprechter, Samuel|Morinan, Gareth|Peng, Yuwei|Foltynie, Thomas|Sibley, Krista|Weil, Rimona S.|Leyland, Louise-Ann|Baig, Fahd|Morgante, Francesca|Gilron, Ro’ee|Wilt, Robert|Starr, Philip|Hauser, Robert A.|O’Keeffe, Jonathan A Clinically Interpretable Computer-Vision Based Method for Quantifying Gait in Parkinson’s Disease Sensors [14248220]. 21(16) , 2021.
  • Jankovic, Joseph|Comella, Cynthia|Hauser, Robert A.|Patel, Atul T.|Gross, Todd M.|Rubio, Roman G.|Vitarella, Domenico A phase 3 trial evaluating the efficacy, duration of effect, and safety of daxibotulinumtoxinA for injection in the treatment of cervical dystonia Toxicon [00410101]. 190, 2021.
  • Lew, Mark F.|Hauser, Robert A.|Isaacson, Stuart H.|Truong, Daniel|Patel, Atul T.|Brashear, Allison|Ondo, William|Maisonobe, Pascal|Dashtipour, Khashayar|Bahroo, Laxman|Wietek, Stefan AbobotulinumtoxinA provides flexibility for the treatment of cervical dystonia with 500 U/1 mL and 500 U/2 mL dilutions Clinical Parkinsonism & Related Disorders [25901125]. 5, 2021.
  • Esquenazi, Alberto|Delgado, Mauricio R.|Hauser, Robert A.|Lysandropoulos, Andreas|Gracies, Jean-Michel AbobotulinumtoxinA: Evidence for long duration of response from 5 patient populations Toxicon [00410101]. 190, 2021.
  • Hauser, Robert A.|Walsh, Ryan R.|Pahwa, Rajesh|Chernick, Dustin|Formella, Andrea E. Amantadine ER (Gocovri®) Significantly Increases ON Time Without Any Dyskinesia: Pooled Analyses From Pivotal Trials in Parkinson's Disease Frontiers in Neurology [16642295]. 12, 2021.
  • Patel, Atul T.|Lew, Mark F.|Dashtipour, Khashayar|Isaacson, Stuart|Hauser, Robert A.|Ondo, William|Maisonobe, Pascal|Wietek, Stefan|Rubin, Bruce|Brashear, Allison Correction: Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study PLoS ONE [19326203]. 16(4) , 2021.
  • Pringsheim, Tamara|Day, Gregory S.|Smith, DonB.|Rae-Grant, Alex|Licking, Nicole|Armstrong, Melissa J.|de Bie, Rob M. A.|Roze, Emmanuel|Miyasaki, Janis M.|A.Hauser, Robert|Espay, Alberto J.|Martello, Justin P.|Gurwell, Julie|Billinghurst, Lori|Sullivan, Kelly|Fitts, Michael S.|Cothros, Nicholas|Hall, Deborah A.|Rafferty, Miriam|Hagerbrant, Lynn|Hastings, Tara|O’Brien, Mary Dolan|Silsbee, Heather|Gronseth, Gary|Lang, Anthony E.|Lang, Anthony E.|Pringsheim, Tamara|Day, Gregory S.|Smith, Don B.|Rae-Grant, Alex|Licking, Nicole|Armstrong, Melissa J.|de Bie, Rob M.A.|Roze, Emmanuel|Miyasaki, Janis M.|Hauser, Robert A.|Espay, Alberto J.|Martello, Justin P.|Gurwell, Julie A.|Billinghurst, Lori|Sullivan, Kelly|Fitts, Michael S.|Cothros, Nicholas|Hall, Deborah A.|Rafferty, Miriam|Hagerbrant, Lynn|Hastings, Tara|O'Brien, Mary Dolan|Silsbee, Heather|Gronseth, Gary Dopaminergic Therapy for Motor Symptoms in Early Parkinson Disease Practice Guideline Summary: A Report of the AAN Guideline Subcommittee Neurology [00283878]. 97(20) , 2021.
  • Hauser, Robert A.|Zeitlin, Leonid|Fisher, Stanley|D'Souza, Richard Duration of benefit per Dose: Carbidopa-Levodopa immediate release vs. extended release capsules (Rytary®) Parkinsonism and Related Disorders [13538020]. 82, 2021.
  • Jimenez-Shahed, Joohi|Barkay, Hadas|Anderson, Karen E.|Fernandez, Hubert H.|Factor, Stewart A.|Hauser, Robert A.|Wieman, Maria|Gordon, Mark Forrest|Savola, Juha-Matti Effect of Deutetrabenazine on Metabolic Parameters in the Treatment of Tardive Dyskinesia CNS Spectrums [10928529]. 26(2) , 2021.
  • Ahmed, Anwar|Mari, Zoltan|Waters, Cheryl|Ratel, Amber Servi|Saint-Hilaire, Marie|Waikar, Sushrut S.|Curhan, Gary C.|McMahon, Gearoid Michael|Friedman, Joseph Harold|James, Raymond|McGraw, Martha|Zhang, Lin|Bluett, Brent|Togasaki, Daniel M.|Mihaila, Dragos|Evatt, Marian|Rezak, Michael|Jain, Samay|Stover, Natividad|Soileau, Michael|Goetz, Christopher|Kumar, Rajeev|LaFaver, Kathrin|Simuni, Tanya|Poon, Cynthia|Laroche, Ashley|Thomas, Karen|Fitzgerald, Rebecca|Houghton, David J.|Macklin, Eric A.|Goudreau, John|Russell, Doozie|Hinson, Vanessa|Blindauer, Karen|Schwarzschild, Michael A.|Callahan, Katherine F.|Crotty, Grace F.|Klements, David|Pothier, Lindsay|Hung, Albert|Bwala, Grace|Videnovic, Aleksandar|Rosenthal, Liana|Beck, Christopher A.|Deik, Andres F.|Shah, Binit B.|Serrano, Carmen|Criswell, Susan R.|Schiess, Mya C.|Fang, John Y.|Cloud, Leslie|Espay, Alberto J.|Leehey, Maureen|Chou, Kelvin|Pahwa, Rajesh|Langhammer, April|Christine, Chadwick|Daley, Aaron|Litvan, Irene|Dewey, Richard B.|Gerald, Ashley|LeDoux, Mark S.|Bhatti, Danish|Peterson, Carolyn|Reich, Stephen|Park, Ariane|Casaceli, Cindy|Kamp, Cornelia|Oakes, David|Rudolph, Alice|Schneider, Ruth B.|Bolger, Patrick|Kostrzebski, Melissa|Mozaffarian, Dariush|Mestre, Tiago|Suski, Valerie|Mosovsky, Sherri|Hauser, Robert A.|Lang, Anthony|Houston, Emily|Shoulson, Ira|Ascherio, Alberto|Marek, Kenneth|Bixby, Melissa|Ciccarello, Jill|Zauber, Sarah Elizabeth|LeWitt, Peter A.|Kaminski, Patricia|Gauger, Lisa|Scott, Burton|Durphy, Jennifer|Simon, David K.|de Marcaida, J. Antonelle|Bodis-Wollner, Ivan|Henchcliffe, Claire|Gunzler, Steven A.|Boyd, James T.|Mehta, Shyamal H.|Brodsky, Matthew|Keith, Kellie|Jimenez-Shahed, Joohi|Aldred, Jason|Lungu, Codrin|Rabin, Marcie|Kurlan, Roger|Ainslie, Melissa|Hunter, Christine|Morgan, John C.|Shill, Holly A.|Shprecher, David Effect of Urate-Elevating Inosine on Early Parkinson Disease Progression: The SURE-PD3 Randomized Clinical Trial Journal of the American Medical Association [00987484]. 326(10) , 2021.
  • Mehta, Shyamal H.|Pahwa, Rajesh|Tanner, Caroline M.|Hauser, Robert A.|Johnson, Reed Effects of Gocovri (Amantadine) Extended Release Capsules on Non-Motor Symptoms in Patients with Parkinson’s Disease and Dyskinesia Neurology and Therapy [21938253]. 10(1) , 2021.
  • Hauser, Robert A.|Mehta, Shyamal H.|Kremens, Daniel|Chernick, Dustin|Formella, Andrea E. Effects of Gocovri (Amantadine) Extended-Release Capsules on Motor Aspects of Experiences of Daily Living in People with Parkinson’s Disease and Dyskinesia Neurology and Therapy [21938253]. 10(2) , 2021.
  • Hauser, Robert A.|Hattori, Nobutaka|Fernandez, Hubert|Isaacson, Stuart H.|Mochizuki, Hideki|Rascol, Olivier|Stocchi, Fabrizio|Li, June|Mori, Akihisa|Nakajima, Yu|Ristuccia, Robert|LeWitt, Peter Efficacy of Istradefylline, an Adenosine A2A Receptor Antagonist, as Adjunctive Therapy to Levodopa in Parkinson’s Disease: A Pooled Analysis of 8 Phase 2b/3 Trials Journal of Parkinson's Disease [18777171]. 11(4) , 2021.
  • Venuto, Charles|Baker, Liana|Kostrzebski, Melissa|Matthews, Helen|Wyse, Richard K.|Fiske, Brian|Brundin, Patrik|Ward, Tina|Simuni, Tanya|Dawson, Ted M.|Merchant, Kalpana|Schwarzschild, Michael|Coffey, Christopher S.|Klingner, Elizabeth|Caspell-Garcia, Chelsea|Lafontant, David-Erick|Adams, Jamie|Augustine, Erika|Baker, Deborah|Brocht, Alicia|Casaceli, Cindy|Eaton, Ken|Henderson, Sue|McMullen, Nichole|Muneath, Phounsavath|Trusso, Laura|Field, Carlinda|Brahmachari, Saurav|Rosenthal, Liana|Carman, Emily|Kamp, Cornelia|Bolger, Patrick|Wegel, Claire|Reynolds, Holly|Levy, Oren|Servi, Amber|Chou, Kelvin|Stovall, Angela S|Pal, Gian|Keith, Kellie|Chung, Kathryn|Shahed, Joohi|Hunter, Christine|Shah, Binit|Sullivan, Katie|Hung, Albert Y.|Bwala, Grace|Spindler, Meredith|Oliver, Alexandria|Hauser, Robert A.|Rocha, Claudia|Molho, Eric|Evans, Sharon|Shill, Holly A.|Ismail, Farah|Stover, Natividad|Cromer, Candace|Blair, Courtney|Zhang, Lin|Kishchenko, Olga|Swan, Matthew|Ramirez, Laura|Frank, Samuel|Burrows, Stephanie|Duker, Andrew|Gruenwald, Christina|Blindauer, Karen|Wheeler, Lynn|Seeberger, Lauren|Simpson, Abigail|Scott, Burton L.|Gauger, Lisa|Ahmed, Anwar|Pitchford, Yvette|Mule, Jennifer|Ramirez-Zamora, Adolfo|Ridgeway, Derek B.|Slevin, John Slevin|Wagner, Renee Wagner|Hinson, Vanessa|Jenkins, Shonna|Goudreau, John L.|Russell, Doozie|Mari, Zoltan|Dumitrescu, Lilliana|Aldred, Jason|Bixby, Melissa|LeDoux, Mark|Rafaloff, Gary|Adams, Jamie|Weiner, David|Simon, David K. Efficacy of Nilotinib in Patients With Moderately Advanced Parkinson Disease: A Randomized Clinical Trial Archives of Neurology [00039942]. 78(3) , 2021.
  • Naito, Anna|Wills, Anne-Marie|Tropea, Thomas F.|Ramirez-Zamora, Adolfo|Hauser, Robert A.|Martino, Davide|Turner, Travis H.|Rafferty, Miriam R.|Afshari, Mitra|Williams, Karen L.|Vaou, Okeanis|McKeown, Martin J.|Ginsburg, Letty|Ezra, Adi|Iansek, Robert|Wallock, Kristin|Evers, Christiana|Schroeder, Karlin|DeLeon, Rebeca|Yarab, Nicole|Alcalay, Roy N.|Beck, James C. Expediting telehealth use in clinical research studies: recommendations for overcoming barriers in North America npj Parkinson's Disease [23738057]. 7(1) , 2021.
  • Jenner, Peter|Mori, Akihisa|Aradi, Stephen D.|Hauser, Robert A. Istradefylline – a first generation adenosine A 2A antagonist for the treatment of Parkinson’s disease Expert Review of Neurotherapeutics [14737175]. 21(3) , 2021.
  • Hauser, Robert A.|Barkay, Hadas|Fernandez, Hubert H.|Factor, Stewart A.|Jimenez-Shahed, Joohi|Gross, Nicholas|Marinelli, Leslie|Wilhelm, Amanda|Gordon, Mark Forrest|Savola, Juha-Matti|Anderson, Karen E. Long-Term Deutetrabenazine Treatment Is Associated With Continued Improvement in Tardive Dyskinesia in the Completed 3-Year Open-Label Extension Study CNS Spectrums [10928529]. 26(2) , 2021.
  • Barkay, Hadas|Hauser, Robert A.|Wilhelm, Amanda|Wieman, Maria|Gordon, Mark Forrest|Savola, Juha-Matti Minimal Clinically Important Difference in AIMS Score Based on CGIC and PGIC in Patients With Tardive Dyskinesia Treated With Deutetrabenazine CNS Spectrums [10928529]. 26(2) , 2021.
  • LeWitt, Peter A.|Comella, Cynthia L.|Hauser, Robert A. On demand therapy for Parkinson’s disease patients: Opportunities and choices Postgraduate Medicine [00325481]. 133(7) , 2021.
  • Roberts, Angela C.|Rafferty, Miriam R.|Wu, Samuel S.|Miao, Guanhuong|Cubillos, Fernando|Simuni, Tanya|Marras, Connie|Davis, Tom|Dahodwala, Nabila|Neault, Marilyn|Ramirez-Zamora, Adolfo|Rafferty, Miriam|Malaty, Irene|Parashos, Sotirios|Kraakevik, Jeff|Simuni, Tanya|Dahodwala, Nabila|Jankovic, Joseph|Simon, David|Pahwa, Rajesh|Mills, Kelly|Way, Christopher|Morgan, John|Pagan, Fernando|Hauser, Robert|Davis, Thomas|Salins, Naomi|Gurevich, Tanya|Bloem, Bastiaan|Marras, Connie|Singer, Carlos|Lafontaine, Anne Louise|Feigin, Andrew|Miyasaki, Janis|Litvan, Irene Patterns and predictors of referrals to allied health services for individuals with Parkinson's disease: A Parkinson's foundation (PF) QII study Parkinsonism and Related Disorders [13538020]. 83, 2021.
  • Dashtipour, Khashayar|Gupta, Fiona|Hauser, Robert A.|Karunapuzha, Cherian A.|Morgan, John C. Pimavanserin Treatment for Parkinson’s Disease Psychosis in Clinical Practice Parkinson's Disease [20908083]. 2021, 2021.
  • Hauser, Robert A.|Banisadr, Ghazal|Vuong, Kara|Freilich, David|Fisher, Stanley|D’Souza, Richard Real-World Experience with Carbidopa-Levodopa Extended-Release Capsules (Rytary®): Results of a Nationwide Dose Conversion Survey Parkinson's Disease [20908083]. 2021, 2021.
  • Videnovic, Aleksandar|Amara, Amy W.|Comella, Cynthia|Schweitzer, Paula K.|Emsellem, Helene|Liu, Kris|Sterkel, Amanda L.|Gottwald, Mildred D.|Steinerman, Joshua R.|Jochelson, Philip|Zomorodi, Katie|Hauser, Robert A. Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial Movement Disorders [08853185]. 36(10) , 2021.
  • Patel, Atul T.|Lew, Mark F.|Dashtipour, Khashayar|Isaacson, Stuart|Hauser, Robert A.|Ondo, William|Maisonobe, Pascal|Wietek, Stefan|Rubin, Bruce|Brashear, Allison Sustained functional benefits after a single set of injections with abobotulinumtoxinA using a 2-mL injection volume in adults with cervical dystonia: 12-week results from a randomized, double-blind, placebo-controlled phase 3b study PLoS ONE [19326203]. 16(2) , 2021.
  • Hauser, Robert A.|Barkay, Hadas|Fernandez, Hubert H.|Factor, Stewart A.|Jimenez-Shahed, Joohi|Gross, Nicholas|Marinelli, Leslie|Forrest Gordon, Mark|Savola, Juha-Matti|Anderson, Karen E. 134 Long-Term Deutetrabenazine Treatment Is Associated with Sustained Treatment Response in Tardive Dyskinesia: Results from an Open-Label Extension Study CNS Spectrums [10928529]. 25(2) , 2020.
  • Fernandez, Hubert H.|Barkay, Hadas|Hauser, Robert A.|Factor, Stewart A.|Jimenez-Shahed, Joohi|Gross, Nicholas|Marinelli, Leslie|Gordon, Mark Forrest|Savola, Juha-Matti|Anderson, Karen E. 151 Confirmed Safety of Deutet.rabenazine for Tardive Dyskinesia in a 3-Year Open-Label Extension Study CNS Spectrums [10928529]. 25(2) , 2020.
  • Farbman, Eric S.|Waters, Cheryl H.|LeWitt, Peter A.|Rudzińska, Monika|Klingler, Michael|Lee, Angela|Qian, Jenny|Oh, Charles|Hauser, Robert A. A 12-month, dose-level blinded safety and efficacy study of levodopa inhalation powder (CVT-301, Inbrija) in patients with Parkinson's disease Parkinsonism and Related Disorders [13538020]. 81, 2020.
  • Olanow, C Warren|Factor, Stewart A|Espay, Alberto J|Hauser, Robert A|Shill, Holly A|Isaacson, Stuart|Pahwa, Rajesh|Leinonen, Mika|Bhargava, Parul|Sciarappa, Ken|Navia, Bradford|Blum, David|xx, xx Apomorphine sublingual film for off episodes in Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 study Lancet Neurology [14744422]. 19(2) , 2020.
  • Hauser, Robert A.|Zeitlin, Leonid|Fisher, Stanley|D’Souza, Richard Carbidopa and Levodopa Extended Release Capsules in Patients with and without Troublesome and Non-Troublesome Dyskinesia Journal of Parkinson's Disease [18777171]. 10(3) , 2020.
  • Simuni, Tanya|Uribe, Liz|Cho, Hyunkeun Ryan|Caspell-Garcia, Chelsea|Coffey, Christopher S|Siderowf, Andrew|Trojanowski, John Q|Shaw, Leslie M|Seibyl, John|Singleton, Andrew|Toga, Arthur W|Galasko, Doug|Foroud, Tatiana|Tosun, Duygu|Poston, Kathleen|Weintraub, Daniel|Mollenhauer, Brit|Tanner, Caroline M|Kieburtz, Karl|Chahine, Lana M|Reimer, Alyssa|Hutten, Samantha J|Bressman, Susan|Marek, Kenneth|Arnedo, Vanessa|Clark, Adrienne|Fraiser, Mark|Kopil, Catherine|Chowdhury, Sohini|Sherer, Todd|Daegele, Nichole|Casaceli, Cynthia|Dorsey, Ray|Wilson, Renee|Mahes, Sugi|Salerno, Christina|Crawford, Karen|Casalin, Paola|Malferrari, Giulia|Weisz, Mali Gani|Orr-Urtreger, Avi|Montine, Thomas|Baglieri, Chris|Christini, Amanda|Russell, David|Dahodwala, Nabila|Giladi, Nir|Factor, Stewart|Hogarth, Penelope|Standaert, David|Hauser, Robert|Jankovic, Joseph|Saint-Hilaire, Marie|Richard, Irene|Shprecher, David|Fernandez, Hubert|Brockmann, Katrina|Rosenthal, Liana|Barone, Paolo|Espay, Alberto|Rowe, Dominic|Marder, Karen|Santiago, Anthony|Hu, Shu-Ching|Isaacson, Stuart|Corvol, Jean-Christophe|Ruiz Martinez, Javiar|Tolosa, Eduardo|Tai, Yen|Politis, Marios|Smejdir, Debra|Rees, Linda|Williams, Karen|Kausar, Farah|Williams, Karen|Richardson, Whitney|Willeke, Diana|Peacock, Shawnees|Sommerfeld, Barbara|Freed, Alison|Wakeman, Katrina|Blair, Courtney|Guthrie, Stephanie|Harrell, Leigh|Hunter, Christine|Thomas, Cathi-Ann|James, Raymond|Zimmerman, Grace|Brown, Victoria|Mule, Jennifer|Hilt, Ella|Ribb, Kori|Ainscough, Susan|Wethington, Misty|Ranola, Madelaine|Mejia Santana, Helen|Moreno, Juliana|Raymond, Deborah|Speketer, Krista|Carvajal, Lisbeth|Carvalo, Stephanie|Croitoru, Ioana|Garrido, Alicia|Payne, Laura Marie|Viswanth, Veena|Severt, Lawrence|Facheris, Maurizio|Soares, Holly|Mintun, Mark A.|Cedarbaum, Jesse|Taylor, Peggy|Biglan, Kevin|Vandenbroucke, Emily|Haider Sheikh, Zulfiqar|Bingol, Baris|Fischer, Tanya|Sardi, Pablo|Forrat, Remi|Reith, Alastair|Egebjerg, Jan|Ahlberg Hillert, Gabrielle|Saba, Barbara|Min, Chris|Umek, Robert|Mather, Joe|De Santi, Susan|Post, Anke|Boess, Frank|Taylor, Kirsten|Grachev, Igor|Avbersek, Andreja|Muglia, Pierandrea|Merchant, Kaplana|Tauscher, Johannes Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study Lancet Neurology [14744422]. 19(1) , 2020.
  • Eberly, Shirley|Oakes, David|Siderowf, Andrew|Stern, Matthew|Jennings, Danna|Seibyl, John|Marek, Kenneth Clinical and Imaging Progression in the PARS Cohort: Long‐Term Follow‐up Movement Disorders [08853185]. 35(9) , 2020.
  • Mills, Kelly A.|Schneider, Ruth B.|Saint-Hilaire, Marie|Ross, G. Webster|Hauser, Robert A.|Lang, Anthony E.|Halverson, Matthew J.|Oakes, David|Eberly, Shirley|Litvan, Irene|Blindauer, Karen|Aquino, Camila|Simuni, Tanya|Marras, Connie Cognitive impairment in Parkinson's disease: Associations between subjective and objective cognitive decline in a large longitudinal study Parkinsonism and Related Disorders [13538020]. 80, 2020.
  • Esquenazi, Alberto|Delgado, Mauricio R.|Hauser, Robert A.|Picaut, Philippe|Foster, Keith|Lysandropoulos, Andreas|Gracies, Jean-Michel Duration of Symptom Relief Between Injections for AbobotulinumtoxinA (Dysport®) in Spastic Paresis and Cervical Dystonia: Comparison of Evidence From Clinical Studies Frontiers in Neurology [16642295]. 11, 2020.
  • Hauser, Robert A.|Eidelberg, David|Riggare, Sara|Pahwa, Rajesh|Cenci, M. Angela Dyskinesia matters Movement Disorders [08853185]. 35(3) , 2020.
  • Tanner, Caroline M.|Pahwa, Rajesh|Hauser, Robert A.|Oertel, Wolfgang H.|Isaacson, Stuart H.|Jankovic, Joseph|Johnson, Reed|Chernick, Dustin|Hubble, Jean EASE LID 2: A 2-Year Open-Label Trial of Gocovri (Amantadine) Extended Release for Dyskinesia in Parkinson’s Disease Journal of Parkinson's Disease [18777171]. 10(2) , 2020.
  • Lew, M.F.|Hauser, R.A.|Isaacson, S.|Ferreira, J.J.|Serbin, M.|Farahmand, K.|Olson, K.|Klepitskaya, O.|Rocha, F.|Soares-da-Silva, P.|Liang, G.S. Efficacy of opicapone in Parkinson's patients with motor fluctuations and ON Hoehn & Yahr ≤2.5: post hoc analysis of BIPARK-1 Parkinsonism and Related Disorders [13538020]. 79, 2020.
  • Bhidayasiri, Roongroj|Kane, John M.|Frei, Karen P.|Caroff, Stanley N.|Correll, Christoph U.|Fahn, Stanley|Jankovic, Joseph|Hauser, Robert A.|Truong, Daniel D. Expanding phenomenologic heterogeneity of tardive syndromes: Time for an updated assessment tool Parkinsonism and Related Disorders [13538020]. 77, 2020.
  • Simuni, Tanya|Merchant, Kalpana|Gan‐Or, Ziv|Levy, Oren|Alcalay, Roy N.|Chahine, Lana M.|Scherzer, Clemens|Foroud, Tatiana|Nudelman, Kelly|Blauwendraat, Cornelis|Chiang, Ming Sum Ruby|Sardi, Sergio Pablo|Hutten, Samantha J.|Wolf, Pavlina|Helesicova, Karolina|Zhang, Xiaokui Kate|Caspell‐Garcia, Chelsea|Zheng, Dandi|Li, Gen Longitudinal Measurements of Glucocerebrosidase activity in Parkinson’s patients Annals of Clinical and Translational Neurology [23289503]. 7(10) , 2020.
  • Aradi, Stephen D.|Hauser, Robert A. Medical Management and Prevention of Motor Complications in Parkinson's Disease Neurotherapeutics [19337213]. 17(4) , 2020.
  • Hauser, R.A.|Lew, M.F.|Comella, C.L.|Poewe, W.|Rascol, O.|Ferreira, J.J.|Olson, K.|Farahmand, K.|Shah, C.|Rocha, J.-F.|Soares-da-Silva, P.|Klepitskaya, O. Nighttime and morning OFF improvements with opicapone in patients with Parkinson's Disease and motor fluctuations: BIPARK-1 and BIPARK-2 pooled subanalyses Parkinsonism and Related Disorders [13538020]. 79, 2020.
  • LeWitt, Peter A|Kymes, Steve|Hauser, Robert A Parkinson Disease and Orthostatic Hypotension in the Elderly: Recognition and Management of Risk Factors for Falls Aging and Disease [21525250]. 11(3) , 2020.
  • Hauser, R.|Mehta, S.|Maulis, M.|Bhargava, P.|Navia, B.|Blum, D.|Pappert, E. Patient-reported motor responses to apomorphine sublingual film based on home dosing and response diaries Parkinsonism and Related Disorders [13538020]. 79, 2020.
  • Wohlgemuth, William K.|Factor, Stewart A.|Wittine, Lara|Amara, Amy W.|Wallace, Douglas M.|Malaty, Irene A.|Trotti, Lynn Marie|Hauser, Robert A.|Nallu, Sagarika Practical Evaluation and Management of Insomnia in Parkinson's Disease: A Review Movement Disorders Clinical Practice [23301619]. 7(3) , 2020.
  • Hauser, Robert A.|Eidelberg, David|Pahwa, Rajesh|Riggare, Sara|Cenci, M. Angela Reply to: Letter to Editor by Chaudhuri, Jenner, Antonini Movement Disorders [08853185]. 35(5) , 2020.
  • LeWitt, Peter A.|Aradi, Stephen D.|Hauser, Robert A.|Rascol, Olivier The challenge of developing adenosine A2A antagonists for Parkinson disease: Istradefylline, preladenant, and tozadenant Parkinsonism and Related Disorders [13538020]. 80, 2020.
  • Espay, Alberto J.|Hauser, Robert A.|Armstrong, Melissa J. The Narrowing Path for Nilotinib and Other Potential Disease-Modifying Therapies for Parkinson Disease Archives of Neurology [00039942]. 77(3) , 2020.
  • Hauser, R.A.|Klingler, M.|Abeynayake, I.|Roberts, H. UPDRS motor-score improvement after CVT-301 treatment is associated with improved scores in Parkinson's Disease Questionnaire (PDQ-39) activities of daily living Parkinsonism and Related Disorders [13538020]. 79, 2020.
  • Anderson, Karen E.|Stamler, David|Davis, Mat D.|Hauser, Robert A.|Jarskog, L. Fredrik|Jimenez-Shahed, Joohi|Kumar, Rajeev|Ochudlo, Stanislaw|McEvoy, Joseph|Fernandez, Hubert H. 34 Long-Term Deutetrabenazine Treatment Response in Tardive Dyskinesia by Concomitant Dopamine-Receptor Antagonists and Baseline Comorbidities CNS Spectrums [10928529]. 24(1) , 2019.
  • Anderson, Karen E.|Stamler, David|Davis, Mat D.|Gross, Nicholas|Hauser, Robert A.|Jarskog, L. Fredrik|Jimenez-Shahed, Joohi|Kumar, Rajeev|Ochudlo, Stanislaw|McEvoy, Joseph|Fernandez, Hubert H. 35 Long-term Improvements in Site-Rated Outcomes with Deutetrabenazine Treatment in Patients with Tardive Dyskinesia CNS Spectrums [10928529]. 24(1) , 2019.
  • Hauser, Robert A.|Fernandez, Hubert H.|Stamler, David|Davis, Mat D.|Factor, Stewart A.|Jimenez-Shahed, Joohi|Ondo, William G.|Jarskog, L. Fredrik|Woods, Scott W.|LeDoux, Mark S.|Shprecher, David R.|Anderson, Karen E. 45 Long-term Treatment with Deutetrabenazine Is Associated with Continued Improvement in Tardive Dyskinesia: Results from an Open-label Extension Study CNS Spectrums [10928529]. 24(1) , 2019.
  • Fernandez, Hubert H.|Stamler, David|Davis, Mat D.|Factor, Stewart A.|Hauser, Robert A.|Jimenez-Shahed, Joohi|Ondo, William G.|Jarskog, L. Fredrik|Woods, Scott W.|LeDoux, Mark S.|Shprecher, David R.|Anderson, Karen E. 46 Confirmed Safety of Deutetrabenazine for Tardive Dyskinesia in a 2-Year Open-label Extension Study CNS Spectrums [10928529]. 24(1) , 2019.
  • Prakash, Neha|Caspell-Garcia, Chelsea|Coffey, Christopher|Siderowf, Andrew|Tanner, Caroline M.|Kieburtz, Karl|Mollenhauer, Brit|Galasko, Douglas|Merchant, Kalpana|Foroud, Tatiana|Chahine, Lana M.|Weintraub, Daniel|Casaceli, Cindy|Dorsey, Ray|Wilson, Renee|Herzog, Margaret|Daegele, Nichole|Arnedo, Vanessa|Frasier, Mark|Sherer, Todd|Marek, Ken|Frank, Samuel|Jennings, Danna|Simuni, Tanya|Marek, Kenneth|Siderowf, Andrew|Seibyl, John|Coffey, Christopher|Tanner, Caroline|Tosun-Turgut, Duygu|Simuni, Tanya|Shaw, Leslie|Trojanowski, John|Singleton, Andrew|Kieburtz, Karl|Toga, Arthur|Mollenhauer, Brit|Galasko, Douglas|Poewe, Werner|Foroud, Tatiana|Poston, Kathleen|Sherer, Todd|Chowdhury, Sohini|Frasier, Mark|Kopil, Catherine|Arnedo, Vanessa|Marek, Kenneth|Daegele, Nichole|Casaceli, Cynthia|Dorsey, Ray|Wilson, Renee|Mahes, Sugi|Seibyl, John|Salerno, Christina|Coffey, Christopher|Caspell-Garcia, Chelsea|Toga, Arthur|Crawford, Karen|Foroud, Tatiana|Casalin, Paola|Malferrari, Giulia|Weisz, Mali Gani|Orr-Urtreger, Avi|Trojanowski, John|Shaw, Leslie|Singleton, Andrew|Foroud, Tatiana|Foroud, Tatiana|Montine, Thomas|Foroud, Tatiana|Russell, David|Tanner, Caroline|Simuni, Tanya|Dahodwala, Nabila|Mollenhauer, Brit|Galasko, Douglas|Poewe, Werner|Giladi, Nir|Factor, Stewart|Hogarth, Penelope|Standaert, David|Hauser, Robert|Jankovic, Joseph|Saint-Hilaire, Marie|Richard, Irene|Shprecher, David|Fernandez, Hubert|Brockmann, Katrina|Rosenthal, Liana|Barone, Paolo|Espay, Alberto|Rowe, Dominic|Marder, Karen|Santiago, Anthony|Bressman, Susan|Hu, Shu-Ching|Isaacson, Stuart|Corvol, Jean-Christophe|Martinez, Javiar Ruiz|Tolosa, Eduardo|Tai, Yen|Politis, Marios|Smejdir, Debra|Rees, Linda|Williams, Karen|Kausar, Farah|Williams, Karen|Richardson, Whitney|Willeke, Diana|Peacock, Shawnees|Heim, Beatrice|Mirelman, Anat|Sommerfeld, Barbara|Freed, Alison|Wakeman, Katrina|Blair, Courtney|Guthrie, Stephanie|Harrell, Leigh|Hunter, Christine|Thomas, Cathi-Ann|James, Raymond|Zimmerman, Grace|Brown, Victoria|Mule, Jennifer|Hilt, Ella|Ribb, Kori|Ainscough, Susan|Wethington, Misty|Ranola, Madelaine|Santana, Helen Mejia|Moreno, Juliana|Raymond, Deborah|Speketer, Krista|Carvajal, Lisbeth|Carvalho, Stephanie|Croitoru, Ioana|Garrido, Alicia|Payne, Laura Marie|Viswanth, Veena|Severt, Lawrence|Facheris, Maurizio|Soares, Holly|Mintun, Mark A.|Cedarbaum, Jesse|Taylor, Peggy|Biglan, Kevin|Vandenbroucke, Emily|Sheikh, Zulfiqar Haider|Bingol, Baris|Fischer, Tanya|Sardi, Pablo|Forrat, Remi|Reith, Alastair|Egebjerg, Jan|Hillert, Gabrielle Ahlberg|Saba, Barbara|Min, Chris|Umek, Robert|Mather, Joe|De Santi, Susan|Post, Anke|Boess, Frank|Taylor, Kirsten|Grachev, Igor|Avbersek, Andreja|Muglia, Pierandrea|Merchant, Kaplana|Tauscher, Johannes Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI) Parkinsonism and Related Disorders [13538020]. 62, 2019.
  • Ridgway, Sam H.|Brownson, Robert H.|Van Alstyne, Kaitlin R.|Hauser, Robert A. Higher neuron densities in the cerebral cortex and larger cerebellums may limit dive times of delphinids compared to deep-diving toothed whales PLoS ONE [19326203]. 14(12) , 2019.
  • Hermanowicz, Neal|Jones, Sarah A|Hauser, Robert A Impact of non-motor symptoms in Parkinson’s disease: a PMDAlliance survey Neuropsychiatric Disease and Treatment [11766328]. Volume 15, 2019.
  • Fernandez, Hubert H.|Stamler, David|Davis, Mat D.|Factor, Stewart A.|Hauser, Robert A.|Jimenez-Shahed, Joohi|Ondo, William G.|Jarskog, L. Fredrik|Woods, Scott W.|Bega, Danny|LeDoux, Mark S.|Shprecher, David R.|Anderson, Karen E. Long-term safety and efficacy of deutetrabenazine for the treatment of tardive dyskinesia Journal of Neurology, Neurosurgery and Psychiatry [00223050]. , 2019.
  • Hauser, R.|Rascol, O.|Poewe, W.|Ferreira, J.|Lees, A.|Klepitskaya, O.|Liang, G.|Santos, A.|Magalhaes, D.|Rocha, F.|Soares-da-Silva, P. Opicapone as a levodopa sparing agent: Pooled analysis of BIPARK-I and II double-blind trials Journal of the Neurological Sciences [0022510X]. 405, 2019.
  • Hauser, Robert A.|Isaacson, Stuart H.|Ellenbogen, Aaron|Safirstein, Beth E.|Truong, Daniel D.|Komjathy, Steven F.|Kegler-Ebo, Deena M.|Zhao, Ping|Oh, Charles Orally inhaled levodopa (CVT-301) for early morning OFF periods in Parkinson's disease Parkinsonism and Related Disorders [13538020]. 64, 2019.
  • Hauser, Robert A.|Pahwa, Rajesh|Wargin, William A.|Souza-Prien, Cindy J.|McClure, Natalie|Johnson, Reed|Nguyen, Jack T.|Patni, Rajiv|Went, Gregory T. Pharmacokinetics of ADS-5102 (Amantadine) Extended Release Capsules Administered Once Daily at Bedtime for the Treatment of Dyskinesia Clinical Pharmacokinetics [03125963]. 58(1) , 2019.
  • Hauser, Robert A.|Kremens, Daniel E.|Elmer, Lawrence W.|Kreitzman, David L.|Walsh, Ryan R.|Johnson, Reed|Howard, Robert|Nguyen, Jack T.|Patni, Rajiv Prevalence of Dyskinesia and OFF by 30-Minute Intervals Through the Day and Assessment of Daily Episodes of Dyskinesia and OFF: Novel Analyses of Diary Data from Gocovri Pivotal Trials Journal of Parkinson's Disease [18777171]. 9(3) , 2019.
  • LeWitt, Peter A|Hauser, Robert A|Pahwa, Rajesh|Isaacson, Stuart H|Fernandez, Hubert H|Lew, Mark|Saint-Hilaire, Marie|Pourcher, Emmanuelle|Lopez-Manzanares, Lydia|Waters, Cheryl|Rudzínska, Monika|Sedkov, Alexander|Batycky, Richard|Oh, Charles Safety and efficacy of CVT-301 (levodopa inhalation powder) on motor function during off periods in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled phase 3 trial Lancet Neurology [14744422]. 18(2) , 2019.
  • Hauser, Robert A.|Sutherland, Dean|Madrid, Juan A.|Rol, Maria Angeles|Frucht, Steven|Isaacson, Stuart|Pagan, Fernando|Maddux, Brian N.|Li, George|Tse, Winona|Walter, Benjamin L.|Kumar, Rajeev|Kremens, Daniel|Lew, Mark F.|Ellenbogen, Aaron|Oguh, Odinachi|Vasquez, Alberto|Kinney, William|Lowery, Matt|Resnick, Maria|Huff, Nicole|Posner, Jerry|Ballman, Karla V.|Harvey, Brian E.|Camilleri, Michael|Zasloff, Michael|Barbut, Denise Targeting neurons in the gastrointestinal tract to treat Parkinson's disease Clinical Parkinsonism & Related Disorders [25901125]. 1, 2019.
  • Vollstedt, Eva‐Juliane|Klein, Christine|Kasten, Meike Using global team science to identify genetic Parkinson's disease worldwide Annals of Neurology [03645134]. 86(2) , 2019.
  • Lew MF, Brashear A, Dashtipour K, Isaacson S, Hauser RA, Maisonobe P, Snyder D, Ondo W. A 500 U/2 mL dilution of abobotulinumtoxinA vs. placebo: randomized study in cervical dystonia. Int J Neurosci 2018;128:619-626.. , 2018.
  • Fernandez, Hubert H.|Davis, Mat D.|Factor, Stewart A.|Hauser, Robert A.|Jarskog, L. Fredrik|Jimenez-Shahed, Joohi|Kumar, Rajeev|Ochudlo, Stanislaw|Ondo, William G.|Anderson, Karen E. 134 Improvements in Clinical Global Impression of Change With Deutetrabenazine Treatment in Tardive Dyskinesia From the ARM-TD and AIM-TD Studies CNS Spectrums [10928529]. 23(1) , 2018.
  • Anderson, Karen E.|Davis, Mat D.|Factor, Stewart A.|Hauser, Robert A.|Jarskog, L. Fredrik|Jimenez-Shahed, Joohi|Kumar, Rajeev|FRCPC|Ochudlo, Stanislaw|Ondo, William G.|Fernandez, Hubert H. 149 Deutetrabenazine for the Treatment of Tardive Dyskinesia: Results From an Open-Label, Long-Term Study CNS Spectrums [10928529]. 23(1) , 2018.
  • Anderson, Karen E.|Davis, Mat D.|Factor, Stewart A.|Hauser, Robert A.|Jarskog, L. Fredrik|Jimenez-Shahed, Joohi|Kumar, Rajeev|Ochudlo, Stanislaw|Ondo, William G.|Fernandez, Hubert H. 158 Long-Term Safety of Deutetrabenazine for the Treatment of Tardive Dyskinesia: Results From an Open-Label, Long-Term Study CNS Spectrums [10928529]. 23(1) , 2018.
  • Lew, Mark F.|Brashear, Allison|Dashtipour, Khashayar|Isaacson, Stuart|Hauser, Robert A.|Maisonobe, Pascal|Snyder, Daniel|Ondo, William A 500 U/2 mL dilution of abobotulinumtoxinA vs. placebo: randomized study in cervical dystonia International Journal of Neuroscience [00207454]. 128(7) , 2018.
  • Gracies, Jean-Michel|Delgado, Mauricio R.|Hauser, Robert A.|Grimes, David A.|Picaut, Philippe|Mann, Amandeep|Om, Savary AbobotulinumtoxinA time to retreatment across indications Toxicon [00410101]. 156, 2018.
  • Espay, A.J.|Hauser, R.A.|Isaacson, S.|Pahwa, R.|Truong, D.|Pappert, E.|Agro, A.|Fernandez, H.H. Efficacy of sublingual apomorphine film (APL-130277) for the treatment of OFF episodes in subjects with Parkinson’s disease: preliminary results from the Phase-3 study dose-titration phase Parkinsonism and Related Disorders [13538020]. 46, 2018.
  • Charvin, Delphine|Medori, Rossella|Hauser, Robert A.|Rascol, Olivier Erratum: Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs Nature Reviews Drug Discovery [14741776]. 17(11) , 2018.
  • Hauser, Robert A. Help cure Parkinson’s disease: please don’t waste the Golden Year npj Parkinson's Disease [23738057]. 4(1) , 2018.
  • Hewitt, L. Arthur|Vernino, Steven|Biaggioni, Italo|Hauser, Robert A. Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease Movement Disorders Clinical Practice [23301619]. 5(6) , 2018.
  • Hauser, Robert A|Ellenbogen, Aaron|Khanna, Sarita|Gupta, Suneel|Modi, Nishit B Onset and duration of effect of extended-release carbidopa-levodopa in advanced Parkinson’s disease Neuropsychiatric Disease and Treatment [11766328]. Volume 14, 2018.
  • Fernandez, H.H.|Isaacson, S.|Espay, A.J.|Pahwa, R.|Truong, D.|Pappert, E.|Agro, A.|Hauser, R.A. Safety of sublingual apomorphine film (APL-130277) for the treatment of OFF-episodes in subjects with Parkinson’s disease: preliminary results from the Phase-3 study dose titration phase Parkinsonism and Related Disorders [13538020]. 46, 2018.
  • Portillo, Ivan|Chen, Jack J.|Dashtipour, Khashayar|Han, Yi|Hauser, Robert A.|Tang, Jonathan Standing and Supine Blood Pressure Outcomes Associated With Droxidopa and Midodrine in Patients With Neurogenic Orthostatic Hypotension: A Bayesian Meta-analysis and Mixed Treatment Comparison of Randomized Trials The Annals of Pharmacotherapy [10600280]. 52(12) , 2018.
  • Hauser, Robert A.|Truong, Daniel Tardive dyskinesia: Out of the shadows Journal of the Neurological Sciences [0022510X]. 389, 2018.
  • Frei, Karen|Truong, Daniel D.|Fahn, Stanley|Jankovic, Joseph|Hauser, Robert A. The nosology of tardive syndromes Journal of the Neurological Sciences [0022510X]. 389, 2018.
  • Chahine, Lana M.|Weintraub, Daniel|Siderowf, Andrew|Trojanowski, John Q.|Shaw, Leslie M.|Tosun‐Turgut, Duygu|Tanner, Caroline M.|Schuff, Norbert|Coffey, Christopher S.|Caspell‐Garcia, Chelsea|Marek, Kenneth|Lasch, Shirley|Seibyl, John|Foroud, Tatiana|Jennings, Danna|Mollenhauer, Brit|Simuni, Tanya|Singleton, Andrew|Toga, Arthur W.|Arnedo, Vanessa|Frasier, Mark|Sherer, Todd|Chowdhury, Sohini|Poston, Kathleen|Kieburtz, Karl|Galasko, Doug The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort Annals of Clinical and Translational Neurology [23289503]. 5(12) , 2018.
  • Charvin, Delphine|Medori, Rossella|Hauser, Robert A.|Rascol, Olivier Therapeutic strategies for Parkinson disease: beyond dopaminergic drugs Nature Reviews Drug Discovery [14741776]. 17(11) , 2018.
  • Jankovic, Joseph|Langston, Bill|Lyons, Kelly|Malaty, Irene|Mari, Zoltan|Marras, Connie|Miyasaki, Janis|Nutt, John"Jay"|Hauser, Robert|Pagan, Fernando|Parashos, Sotirios|Quinn, Joe|Salins, Naomi|Santiago, Anthony|Siderowf, Andrew|Simuni, Tanya|Simon, David|Singer, Carlos|Tarsy, Daniel|Bloem, Bastiaan|Brandabur, Melanie|Dahodwala, Nabila|Davis, Thomas|Dhall, Rohit|Gurevich, Tanya|Guttman, Mark|Parashos, Sotirios A.|Bloem, Bastiaan R.|Browner, Nina M.|Giladi, Nir|Gurevich, Tanya|Hausdorff, Jeffrey M.|He, Ying|Lyons, Kelly E.|Mari, Zoltan|Morgan, John C.|Post, Bart|Schmidt, Peter N.|Wielinski, Catherine L.|Wu, Samuel S. What predicts falls in Parkinson disease?: Observations from the Parkinson's Foundation registry Neurology: Clinical Practice [21630402]. 8(3) , 2018.
  • Hauser RA, Li R, Pérez A, Ren X, Weintraub D, Elm J, Goudreau JL, Morgan JC, Fang JY, Aminoff MJ, Christine CW, Dhall R, Umeh CC, Boyd JT, Stover N, Leehey M, Zweig RM, Nicholas AP, Bodis-Wollner I, Willis A, Kieburtz K, Tilley BC. Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson''s Disease: An Analysis of NET-PD LS1. Journal of Parkinson''s disease. 7(1) : 117-127, 2017.
  • Valdés EG, O''Connor ML, Uc EY, Hauser RA, Andel R, Edwards JD. Use, maintenance and dose effects of cognitive speed of processing training in Parkinson''s disease. The International journal of neuroscience. 127(10) : 841-848, 2017.
  • Pahwa R, Tanner CM, Hauser RA, Isaacson SH, Nausieda PA, Truong DD, Agarwal P, Hull KL, Lyons KE, Johnson R, Stempien MJ. ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial. JAMA neurology. 74(8) : 941-949, 2017.
  • Hauser RA, Pahwa R, Tanner CM, Oertel W, Isaacson SH, Johnson R, Felt L, Stempien MJ. ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson''s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study. Journal of Parkinson''s disease. 7(3) : 511-522, 2017.
  • Anderson KE, Stamler D, Davis MD, Factor SA, Hauser RA, Isojärvi J, Jarskog LF, Jimenez-Shahed J, Kumar R, McEvoy JP, Ochudlo S, Ondo WG, Fernandez HH. Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial. The lancet. Psychiatry. 4(8) : 595-604, 2017.
  • Oertel W, Eggert K, Pahwa R, Tanner CM, Hauser RA, Trenkwalder C, Ehret R, Azulay JP, Isaacson S, Felt L, Stempien MJ. Randomized, placebo-controlled trial of ADS-5102 (amantadine) extended-release capsules for levodopa-induced dyskinesia in Parkinson''s disease (EASE LID 3). Movement disorders : official journal of the Movement Disorder Society. , 2017.
  • Seeberger LC, Hauser RA. Valbenazine for the treatment of tardive dyskinesia. Expert opinion on pharmacotherapy. 18(12) : 1279-1287, 2017.
  • Biglan KM, Oakes D, Lang AE, Hauser RA, Hodgeman K, Greco B, Lowell J, Rockhill R, Shoulson I, Venuto C, Young D, Simuni T. A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY-PD III). Annals of clinical and translational neurology. 4(6) : 360-368, 2017.
  • Tilley BC, Mainous AG, Smith DW, McKee MD, Amorrortu RP, Alvidrez J, Diaz V, Ford ME, Fernandez ME, Hauser RA, Singer C, Landa V, Trevino A, DeSantis SM, Zhang Y, Daniels E, Tabor D, Vernon SW. Design of a cluster-randomized minority recruitment trial: RECRUIT. Clinical trials (London, England). 14(3) : 286-298, 2017.
  • Chou KL, Elm JJ, Wielinski CL, Simon DK, Aminoff MJ, Christine CW, Liang GS, Hauser RA, Sudarsky L, Umeh CC, Voss T, Juncos J, Fang JY, Boyd JT, Bodis-Wollner I, Mari Z, Morgan JC, Wills AM, Lee SL, Parashos SA. Factors associated with falling in early, treated Parkinson''s disease: The NET-PD LS1 cohort. Journal of the neurological sciences. 377: 137-143, 2017.
  • Stocchi F, Rascol O, Hauser RA, Huyck S, Tzontcheva A, Capece R, Ho TW, Sklar P, Lines C, Michelson D, Hewitt DJ. Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease. Neurology. 88(23) : 2198-2206, 2017.
  • Goetz CG, Stebbins GT, Chung KA, Nicholas AP, Hauser RA, Merkitch D, Stacy MA. Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson''s disease: A randomized, double-blind, placebo-controlled multicenter study. Movement disorders : official journal of the Movement Disorder Society. , 2017.
  • Olanow CW, Kieburtz K, Leinonen M, Elmer L, Giladi N, Hauser RA, Klepiskaya OS, Kreitzman DL, Lew MF, Russell DS, Kadosh S, Litman P, Friedman H, Linvah N, The P B Study Group F. A randomized trial of a low-dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson''s disease. Movement disorders : official journal of the Movement Disorder Society. 32(5) : 783-789, 2017.
  • Hauser RA, Factor SA, Marder SR, Knesevich MA, Ramirez PM, Jimenez R, Burke J, Liang GS, O''Brien CF. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia. The American journal of psychiatry. 174(5) : 476-484, 2017.
  • Fernandez HH, Factor SA, Hauser RA, Jimenez-Shahed J, Ondo WG, Jarskog LF, Meltzer HY, Woods SW, Bega D, LeDoux MS, Shprecher DR, Davis C, Davis MD, Stamler D, Anderson KE. Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study. Neurology. 88(21) : 2003-2010, 2017.
  • Simon DK, Wu C, Tilley BC, Lohmann K, Klein C, Payami H, Wills AM, Aminoff MJ, Bainbridge J, Dewey R, Hauser RA, Schaake S, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wei P, Wong PS, Yang T. Caffeine, creatine, GRIN2A and Parkinson''s disease progression. Journal of the neurological sciences. 375: 355-359, 2017.
  • White WB, Hauser RA, Rowse GJ, Ziemann A, Hewitt LA. Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension. The American journal of cardiology. 119(7) : 1111-1115, 2017.
  • Schapira AH, Fox SH, Hauser RA, Jankovic J, Jost WH, Kenney C, Kulisevsky J, Pahwa R, Poewe W, Anand R. Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial. JAMA neurology. 74(2) : 216-224, 2017.
  • Tetrud J, Nausieda P, Kreitzman D, Liang GS, Nieves A, Duker AP, Hauser RA, Farbman ES, Ellenbogen A, Hsu A, Kell S, Khanna S, Rubens R, Gupta S. Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson''s disease. Journal of the neurological sciences. 373: 116-123, 2017.
  • Oakes, David|Young, Diony|Lang, Anthony E.|Rockhill, Rebecca|Venuto, Charles|Hodgeman, Karen|Greco, Brittany|Lowell, Jillian|Biglan, Kevin M.|Hauser, Robert A.|Simuni, Tanya|Shoulson, Ira A novel design of a Phase III trial of isradipine in early Parkinson disease (STEADY‐PD III) Annals of Clinical and Translational Neurology [23289503]. 4(6) , 2017.
  • Kreitzman, David L.|Giladi, Nir|Litman, Pninit|Friedman, Hadas|Linvah, Nurit|Hauser, Robert A.|Klepiskaya, Olga S.|Lew, Mark F.|Russell, David S.|Elmer, Lawrence|Kieburtz, Karl|the P2B Study Group, for|Olanow, C. Warren|Leinonen, Mika|Kadosh, Shaul A randomized trial of a low‐dose Rasagiline and Pramipexole combination (P2B001) in early Parkinson's disease Movement Disorders [08853185]. 32(5) , 2017.
  • Pahwa, Rajesh|Hauser, Robert A. ADS-5102 (Amantadine) Extended Release for Levodopa-Induced Dyskinesia Archives of Neurology [00039942]. 74(12) , 2017.
  • Pahwa, Rajesh|Tanner, Caroline M.|Hauser, Robert A.|Isaacson, Stuart H.|Nausieda, Paul A.|Truong, Daniel D.|Agarwal, Pinky|Hull, Keith L.|Lyons, Kelly E.|Johnson, Reed|Stempien, Mary Jean ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson Disease (EASE LID Study): A Randomized Clinical Trial Archives of Neurology [00039942]. 74(8) , 2017.
  • Hauser, Robert A.|Pahwa, Rajesh|Tanner, Caroline M.|Oertel, Wolfgang|Isaacson, Stuart H.|Johnson, Reed|Felt, Larissa|Stempien, Mary Jean ADS-5102 (Amantadine) Extended-Release Capsules for Levodopa-Induced Dyskinesia in Parkinson’s Disease (EASE LID 2 Study): Interim Results of an Open-Label Safety Study Journal of Parkinson's Disease [18777171]. 7(3) , 2017.
  • Schapira, Anthony H. V.|Fox, Susan H.|Hauser, Robert A.|Jankovic, Joseph|Jost, Wolfgang H.|Kenney, Christopher|Kulisevsky, Jaime|Pahwa, Rajesh|Poewe, Werner|Anand, Ravi Assessment of Safety and Efficacy of Safinamide as a Levodopa Adjunct in Patients With Parkinson Disease and Motor Fluctuations: A Randomized Clinical Trial Archives of Neurology [00039942]. 74(2) , 2017.
  • Simon, David K.|Wu, Cai|Tilley, Barbara C.|Lohmann, Katja|Klein, Christine|Payami, Haydeh|Wills, Anne-Marie|Aminoff, Michael J.|Bainbridge, Jacquelyn|Dewey, Richard|Hauser, Robert A.|Schaake, Susen|Schneider, Jay S.|Sharma, Saloni|Singer, Carlos|Tanner, Caroline M.|Truong, Daniel|Wei, Peng|Wong, Pei Shieen|Yang, Tianzhong Caffeine, creatine, GRIN2A and Parkinson's disease progression Journal of the Neurological Sciences [0022510X]. 375, 2017.
  • White, William B.|Hauser, Robert A.|Rowse, Gerald J.|Ziemann, Adam|Hewitt, L. Arthur Cardiovascular Safety of Droxidopa in Patients With Symptomatic Neurogenic Orthostatic Hypotension American Journal of Cardiology [00029149]. 119(7) , 2017.
  • Tetrud, James|Nausieda, Paul|Kreitzman, David|Liang, Grace S.|Nieves, Anette|Duker, Andrew P.|Hauser, Robert A.|Farbman, Eric S.|Ellenbogen, Aaron|Hsu, Ann|Kell, Sherron|Khanna, Sarita|Rubens, Robert|Gupta, Suneel Conversion to carbidopa and levodopa extended-release (IPX066) followed by its extended use in patients previously taking controlled-release carbidopa-levodopa for advanced Parkinson's disease Journal of the Neurological Sciences [0022510X]. 373, 2017.
  • Tilley, Barbara C|Mainous, Arch G|Smith, Daniel W|McKee, M Diane|Amorrortu, Rossybelle P|Alvidrez, Jennifer|Diaz, Vanessa|Ford, Marvella E|Fernandez, Maria E|Hauser, Robert A|Singer, Carlos|Landa, Veronica|Trevino, Aron|DeSantis, Stacia M|Zhang, Yefei|Daniels, Elvan|Tabor, Derrick|Vernon, Sally W Design of a cluster-randomized minority recruitment trial: RECRUIT Clinical Trials [17407745]. 14(3) , 2017.
  • Anderson, Karen E|Stamler, David|Davis, Mat D|Factor, Stewart A|Hauser, Robert A|Isojärvi, Jouko|Jarskog, L Fredrik|Jimenez-Shahed, Joohi|Kumar, Rajeev|McEvoy, Joseph P|Ochudlo, Stanislaw|Ondo, William G|Fernandez, Hubert H Deutetrabenazine for treatment of involuntary movements in patients with tardive dyskinesia (AIM-TD): a double-blind, randomised, placebo-controlled, phase 3 trial The Lancet Psychiatry [22150366]. 4(8) , 2017.
  • Chou, Kelvin L.|Elm, Jordan J.|Wielinski, Catherine L.|Simon, David K.|Aminoff, Michael J.|Christine, Chadwick W.|Liang, Grace S.|Hauser, Robert A.|Sudarsky, Lewis|Umeh, Chizoba C.|Voss, Tiffini|Juncos, Jorge|Fang, John Y.|Boyd, James T.|Bodis-Wollner, Ivan|Mari, Zoltan|Morgan, John C.|Wills, Anne-Marie|Lee, Stephen L.|Parashos, Sotirios A. Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort Journal of the Neurological Sciences [0022510X]. 377, 2017.
  • Hauser, Robert A.|Factor, Stewart A.|Marder, Stephen R.|Knesevich, Mary Ann|Ramirez, Paul M.|Jimenez, Roland|Burke, Joshua|Liang, Grace S.|O’Brien, Christopher F. KINECT 3: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Trial of Valbenazine for Tardive Dyskinesia American Journal of Psychiatry [0002953X]. 174(5) , 2017.
  • Hauser, Robert A.|Li, Ruosha|Pérez, Adriana|Ren, Xuehan|Weintraub, Dan|Elm, Jordan|Goudreau, John L.|Morgan, John C.|Fang, John Y.|Aminoff, Michael J.|Christine, Chadwick W.|Dhall, Rohit|Umeh, Chizoba C.|Boyd, James T.|Stover, Natividad|Leehey, Maureen|Zweig, Richard M.|Nicholas, Anthony P.|Bodis-Wollner, Ivan|Willis, Allison|Kieburtz, Karl|Tilley, Barbara C. Longer Duration of MAO-B Inhibitor Exposure is Associated with Less Clinical Decline in Parkinson’s Disease: An Analysis of NET-PD LS1 Journal of Parkinson's Disease [18777171]. 7(1) , 2017.
  • Fontaine, Deborah|Mari, Zoltan|Gerstenhaber, Melissa|Brooks, David|Malloy, Sophie|Barone, Paolo|Longo, Katia|Comery, Tom|Ravina, Bernard|Grachev, Igor|Gallagher, Kim|Collins, Michelle|Widnell, Katherine L.|Ostrowizki, Suzanne|Fontoura, Paulo|La-Roche, F. Hoffmann|Ho, Tony|Luthman, Johan|van der Brug, Marcel|Reith, Alastair D.|Taylor, Peggy|Standaert, David|Hauser, Robert|Jankovic, Joseph|Stern, Matthew|Chahine, Lana|Leverenz, James|Frank, Samuel|Richard, Irene|Seppi, Klaus|Shill, Holly|Fernandez, Hubert|Berg, Daniela|Wurster, Isabel|Galasko, Douglas|Mari, Zoltan|Brooks, David|Pavese, Nicola|Barone, Paolo|Isaacson, Stuart|Espay, Alberto|Rowe, Dominic|Brandabur, Melanie|Tetrud, James|Liang, Grace|Iranzo, Alex|Tolosa, Eduardo|Leary, Laura|Riordan, Cheryl|Rees, Linda|Portillo, Alicia|Lenahan, Art|Williams, Karen|Guthrie, Stephanie|Rawlins, Ashlee|Harlan, Sherry|Hunter, Christine|Tran, Baochan|Darin, Abigail|Linder, Carly|Baca, Marne|Venkov, Heli|Thomas, Cathi-Ann|James, Raymond|Williams, Karen|Standaert, David|Guthrie, Stephanie|Hauser, Robert|Delgado, Holly|Jankovic, Joseph|Hunter, Christine|Stern, Matthew|Tran, Baochan|Leverenz, Jim|Baca, Marne|Frank, Sam|Thomas, Cathi-Ann|Richard, Irene|Deeley, Cheryl|Rees, Linda|Sprenger, Fabienne|Oertel, Wolfgang|Lang, Elisabeth|Shill, Holly|Obradov, Sanja|Fernandez, Hubert|Winters, Adrienna|Berg, Daniela|Gauss, Katharina|Galasko, Douglas|Deeley, Cheryl|Bishop, Courtney|Fabienne Sprenger|Willeke, Diana|Obradov, Sanja|Mule, Jennifer|Monahan, Nancy|Gauss, Katharina|Fontaine, Deborah|Gigliotti, Christina|McCoy, Arita|Dunlop, Becky|Shah, Bina|Susan, Ainscough|James, Angela|Silverstein, Rebecca|Espay, Kristy|Ranola, Madelaine|Marek, Kenneth|Investigator, Principal|Jennings, Danna|Lasch, Shirley|Siderowf, Andrew|Caroline, Tanner|Simuni, Tanya|Coffey, Chris|Karl Kieburtz|Flagg, Emily|Chowdhury, Sohini|Poewe, Werner|Mollenhauer, Brit|Sherer, Todd|Frasier, Mark|Meunier, Claire|Rudolph, Alice|Casaceli, Cindy|Seibyl, John|Investigator, Principal|Mendick, Susan|Schuff, Norbert|Ying Zhang|Toga, Arthur|Crawford, Karen|Ansbach, Alison|De Blasio, Pas-quale|Piovella, Michele|Trojanowski, John|Shaw, Les|Singleton, Andrew|Hawkins, Keith|PsyDMichael, J|Eberling, Jamie|Brooks, Deborah|Russell, David|Leary, Laura|Factor, Stewart|Sommerfeld, Barbara|Hogarth, Penelope|Pighetti, Emily|Schuff, Norbert|Caspell, Chelsea|Uribe, Liz|Foster, Eric|Gloer, Katherine|Yankey, Jon|Toga, Arthur|Crawford, Karen|Casalin, Paola|Malferrari, Giulia|Mollenhauer, Brit|Galasko, Douglas|Singleton, Andrew|Hawkins, Keith A.|Russell, David|Factor, Stewart|Hogarth, Penelope|Marek, Kenneth|Jennings, Danna|Lasch, Shirley|Tanner, Caroline|Simuni, Tanya|Coffey, Christopher|Kieburtz, Karl|Wilson, Renee|Poewe, Werner|Mollenhauer, Brit|Foroud, Tatiana|Sherer, Todd|Chowdhury, Sohini|Frasier, Mark|Kopil, Catherine|Arnedo, Vanessa|Rudolph, Alice|Casaceli, Cynthia|Seibyl, John|Mendick, Susan|Mollenhauer, Brit|Caspell-Garcia, Chelsea J.|Coffey, Christopher S.|Taylor, Peggy|Shaw, Leslie M.|Trojanowski, John Q.|Singleton, Andy|Frasier, Mark|Marek, Kenneth|Galasko, Douglas Longitudinal CSF biomarkers in patients with early Parkinson disease and healthy controls Neurology [00283878]. 89(19) , 2017.
  • Fernandez, Hubert H.|Factor, Stewart A.|Hauser, Robert A.|Jimenez-Shahed, Joohi|Ondo, William G.|Jarskog, L. Fredrik|Meltzer, Herbert Y.|Woods, Scott W.|Bega, Danny|LeDoux, Mark S.|Shprecher, David R.|Davis, Charles|Davis, Mat D.|Stamler, David|Anderson, Karen E. Randomized controlled trial of deutetrabenazine for tardive dyskinesia: The ARM-TD study Neurology [00283878]. 88(21) , 2017.
  • Stocchi, Fabrizio|Rascol, Olivier|Hauser, Robert A.|Huyck, Susan|Tzontcheva, Anjela|Capece, Rachel|Ho, Tony W.|Sklar, Peter|Lines, Christopher|Michelson, David|Hewitt, David J. Randomized trial of preladenant, given as monotherapy, in patients with early Parkinson disease Neurology [00283878]. 88(23) , 2017.
  • Azulay, Jean Philippe|Tanner, Caroline M.|Pahwa, Rajesh|Hauser, Robert A.|Trenkwalder, Claudia|Felt, Larissa|Stempien, Mary Jean|Oertel, Wolfgang|Eggert, Karla|Ehret, Reinhard|Isaacson, Stuart Randomized, placebo‐controlled trial of ADS‐5102 (amantadine) extended‐release capsules for levodopa‐induced dyskinesia in Parkinson's disease (EASE LID 3) Movement Disorders [08853185]. 32(12) , 2017.
  • Stacy, Mark A.|Chung, Kathryn A.|Goetz, Christopher G.|Stebbins, Glenn T.|Merkitch, Douglas|Nicholas, Anthony P.|Hauser, Robert A. Topiramate as an adjunct to amantadine in the treatment of dyskinesia in parkinson's disease: A randomized, double‐blind, placebo‐controlled multicenter study Movement Disorders [08853185]. 32(9) , 2017.
  • Uc, Ergun Y.|O'Connor, Melissa L.|Hauser, Robert A.|Andel, Ross|Edwards, Jerri D.|Valdés, Elise G. Use, maintenance and dose effects of cognitive speed of processing training in Parkinson's disease International Journal of Neuroscience [00207454]. 127(10) , 2017.
  • Seeberger, Lauren C.|Hauser, Robert A. Valbenazine for the treatment of tardive dyskinesia Expert Opinion on Pharmacotherapy [14656566]. 18(12) , 2017.
  • Wills AA, Elm JJ, Ye R, Chou KL, Parashos SA, Hauser RA, Bodis-Wollner I, Hinson VK, Christine CW, Schneider JS. Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1. Parkinsonism & related disorders. 33: 127-133, 2016.
  • Augustine EF, Dorsey ER, Hauser RA, Elm JJ, Tilley BC, Kieburtz KK. Communicating with participants during the conduct of multi-center clinical trials. Clinical trials (London, England). 13(6) : 592-596, 2016.
  • Hauser RA, Abler V, Eyal E, Eliaz RE. Efficacy of rasagiline in early Parkinson''s disease: a meta-analysis of data from the TEMPO and ADAGIO studies. The International Journal of Neuroscience. 126(10) : 942-6, 2016.
  • Rascol O, Hauser RA, Stocchi F, Fitzer-Attas CJ, Sidi Y, Abler V, Olanow CW. Long-term effects of rasagiline and the natural history of treated Parkinson''s disease. Movement disorders : official journal of the Movement Disorder Society. 31(10) : 1489-1496, 2016.
  • Hauser RA, Heritier S, Rowse GJ, Hewitt LA, Isaacson SH. Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension. Clinical neuropharmacology. 39(5) : 220-6, 2016.
  • Hauser RA, Olanow CW, Dzyngel B, Bilbault T, Shill H, Isaacson S, Dubow J, Agro A. Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson''s disease. Movement disorders : official journal of the Movement Disorder Society. 31(9) : 1366-72, 2016.
  • François C, Rowse GJ, Hewitt LA, Vo P, Hauser RA. Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension. BMC neurology. 16(1) : 143, 2016.
  • Hauser RA, Slawek J, Barone P, Dohin E, Surmann E, Asgharnejad M, Bauer L. Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson''s disease. BMC neurology. 16: 90, 2016.
  • François C, Hauser RA, Aballéa S, Dorey J, Kharitonova E, Hewitt LA. Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data. Journal of Medical Economics. 19(5) : 515-25, 2016.
  • Weintraub D, Hauser RA, Elm JJ, Pagan F, Davis MD, Choudhry A. Rasagiline for mild cognitive impairment in Parkinson''s disease: A placebo-controlled trial. Movement Disorders : Official Journal of the Movement Disorder Society. 31(5) : 709-14, 2016.
  • LeWitt PA, Hauser RA, Grosset DG, Stocchi F, Saint-Hilaire MH, Ellenbogen A, Leinonen M, Hampson NB, DeFeo-Fraulini T, Freed MI, Kieburtz KD. A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson''s disease. Movement Disorders : Official Journal of the Movement Disorder Society. , 2016.
  • , Biglan KM, Shoulson I, Kieburtz K, Oakes D, Kayson E, Shinaman MA, Zhao H, Romer M, Young A, Hersch S, Penney J, Marder K, Paulsen J, Quaid K, Siemers E, Tanner C, Mallonee W, Suter G, Dubinsky R, Gray C, Nance M, Bundlie S, Radtke D, Kostyk S, Baic C, Caress J, Walker F, Hunt V, O''Neill C, Chouinard S, Factor S, Greenamyre T, Wood-Siverio C, Corey-Bloom J, Song D, Peavy G, Moskowitz C, Wesson M, Samii A, Bird T, Lipe H, Blindauer K, Marshall F, Zimmerman C, Goldstein J, Rosas D, Novak P, Caviness J, Adler C, Duffy A, Wheelock V, Tempkin T, Richman D, Seeberger L, Albin R, Chou KL, Racette B, Perlmutter JS, Perlman S, Bordelon Y, Martin W, Wieler M, Leavitt B, Raymond L, Decolongon J, Clarke L, Jankovic J, Hunter C, Hauser RA, Sanchez-Ramos J, Furtado S, Suchowersky O, Klimek ML, Guttman M, Sethna R, Feigin A, Cox M, Shannon B, Percy A, Dure L, Harrison M, Johnson W, Higgins D, Molho E, Nickerson C, Evans S, Hobson D, Singer C, Galvez-Jimenez N, Shannon K, Comella C, Ross C, Saint-Hilaire MH, Testa C, Rosenblatt A, Hogarth P, Weiner W, Como P, Kumar R, Cotto C, Stout J, Brocht A, Watts A, Eberly S, Weaver C, Foroud T, Gusella J, MacDonald M, Myers R, Fahn S, Shults C. Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials. JAMA Neurology. 73(1) : 102-10, 2016.
  • Han, Yi|Stevens, Andrea L.|Dashtipour, Khashayar|Hauser, Robert A.|Mari, Zoltan A mixed treatment comparison to compare the efficacy and safety of botulinum toxin treatments for cervical dystonia Journal of Neurology [03405354]. 263(4) , 2016.
  • LeWitt, Peter A.|Hauser, Robert A.|Grosset, Donald G.|Stocchi, Fabrizio|Saint-Hilaire, Marie-Helene|Ellenbogen, Aaron|Leinonen, Mika|Hampson, Neil B.|DeFeo-Fraulini, Tia|Freed, Martin I.|Kieburtz, Karl D. A randomized trial of inhaled levodopa (CVT-301) for motor fluctuations in Parkinson's disease: Inhaled Levodopa (CVT-301) for Fluctuating PD Movement Disorders [08853185]. 31(9) , 2016.
  • François, Clément|Rowse, Gerald J.|Hewitt, L. Arthur|Vo, Pamela|Hauser, Robert A. Analysis of number needed to treat for droxidopa in patients with symptomatic neurogenic orthostatic hypotension BMC Neurology [14712377]. 16(1) , 2016.
  • Biglan, Kevin Michael|Shoulson, Ira|Kieburtz, Karl|Oakes, David|Kayson, Elise|Shinaman, M. Aileen|Zhao, Hongwei|Romer, Megan|Young, Anne|Hersch, Steven|Penney, Jack|Marder, Karen|Paulsen, Jane|Quaid, Kimberly|Siemers, Eric|Tanner, Caroline|Mallonee, William|Suter, Greg|Dubinsky, Richard|Gray, Carolyn|Nance, Martha|Bundlie, Scott|Radtke, Dawn|Kostyk, Sandra|Baic, Corrine|Caress, James|Walker, Francis|Hunt, Victoria|O’Neill, Christine|Chouinard, Sylvain|Factor, Stewart|Greenamyre, Timothy|Wood-Siverio, Cathy|Corey-Bloom, Jody|Song, David|Peavy, Guerry|Moskowitz, Carol|Wesson, Melissa|Samii, Ali|Bird, Thomas|Lipe, Hillary|Blindauer, Karen|Marshall, Frederick|Zimmerman, Carol|Goldstein, Jody|Rosas, Diana|Novak, Peter|Caviness, John|Adler, Charles|Duffy, Amy|Wheelock, Vicki|Tempkin, Teresa|Richman, David|Seeberger, Lauren|Albin, Roger|Chou, Kelvin L.|Racette, Brad|Perlmutter, Joel S.|Perlman, Susan|Bordelon, Yvette|Martin, Wayne|Wieler, Marguerite|Leavitt, Blair|Raymond, Lynn|Decolongon, Joji|Clarke, Lorne|Jankovic, Joseph|Hunter, Christine|Hauser, Robert A.|Sanchez-Ramos, Juan|Furtado, Sarah|Suchowersky, Oksana|Klimek, Mary Lou|Guttman, Mark|Sethna, Rustom|Feigin, Andrew|Cox, Marie|Shannon, Barbara|Percy, Alan|Dure, Leon|Harrison, Madaline|Johnson, William|Higgins, Donald|Molho, Eric|Nickerson, Constance|Evans, Sharon|Hobson, Douglas|Singer, Carlos|Galvez-Jimenez, Nestor|Shannon, Kathleen|Comella, Cynthia|Ross, Christopher|Saint-Hilaire, Marie H.|Testa, Claudia|Rosenblatt, Adam|Hogarth, Penelope|Weiner, William|Como, Peter|Kumar, Rajeev|Cotto, Candace|Stout, Julie|Brocht, Alicia|Watts, Arthur|Eberly, Shirley|Weaver, Christine|Foroud, Tatiana|Gusella, James|MacDonald, Marcy|Myers, Richard|Fahn, Stanley|Shults, Clifford Clinical-Genetic Associations in the Prospective Huntington at Risk Observational Study (PHAROS): Implications for Clinical Trials Archives of Neurology [00039942]. 73(1) , 2016.
  • Wills, Anne-Marie A.|Elm, Jordan J.|Ye, Rong|Chou, Kelvin L.|Parashos, Sotirios A.|Hauser, Robert A.|Bodis-Wollner, Ivan|Hinson, Vanessa K.|Christine, Chadwick W.|Schneider, Jay S. Cognitive function in 1736 participants in NINDS Exploratory Trials in PD Long-term Study-1 Parkinsonism and Related Disorders [13538020]. 33, 2016.
  • Augustine, Erika F|Dorsey, E Ray|Hauser, Robert A|Elm, Jordan J|Tilley, Barbara C|Kieburtz, Karl K Communicating with participants during the conduct of multi-center clinical trials Clinical Trials [17407745]. 13(6) , 2016.
  • François, Clément|Hauser, Robert A.|Aballéa, Samuel|Dorey, Julie|Kharitonova, Elizaveta|Hewitt, L. Arthur Cost-effectiveness of droxidopa in patients with neurogenic orthostatic hypotension: post-hoc economic analysis of Phase 3 clinical trial data Journal of Outcomes Research [13696998]. 19(5) , 2016.
  • Hauser, Robert A.|Heritier, Stephane|Rowse, Gerald J.|Hewitt, L. Arthur|Isaacson, Stuart H. Droxidopa and Reduced Falls in a Trial of Parkinson Disease Patients With Neurogenic Orthostatic Hypotension Clinical Neuropharmacology [03625664]. 39(5) , 2016.
  • Hauser, Robert A.|Abler, Victor|Eyal, Eli|Eliaz, Rom E. Efficacy of rasagiline in early Parkinson's disease: a meta-analysis of data from the TEMPO and ADAGIO studies International Journal of Neuroscience [00207454]. 126(10) , 2016.
  • Weintraub, Daniel|Hauser, Robert A.|Davis, Matthew|Choudhry, Azhar Efficacy of rasagiline in PD patients with mild cognitive impairment Parkinsonism and Related Disorders [13538020]. 22, 2016.
  • Agro, Albert|Dubow, Jordan|Dzyngel, Bruce|Bilbault, Thierry|Giovinazzo, Anthony|Shill, Holly|Hauser, Robert Efficacy of sublingual apomorphine (APL-130277) for the treatment of OFF episodes in patients with Parkinson's disease Parkinsonism and Related Disorders [13538020]. 22, 2016.
  • Agro, Albert|Dubow, Jordan|Dzyngel, Bruce|Bilbault, Thierry|Giovinazzo, Anthony|Shill, Holly|Hauser, Robert Efficacy of sublingual apomorphine (APL-130277) for the treatment of off episodes in patients with Parkinson's disease Parkinsonism and Related Disorders [13538020]. 22, 2016.
  • Hauser, Robert A|Slawek, Jaroslaw|Barone, Paolo|Dohin, Elisabeth|Surmann, Erwin|Asgharnejad, Mahnaz|Bauer, Lars Evaluation of rotigotine transdermal patch for the treatment of apathy and motor symptoms in Parkinson’s disease BMC Neurology [14712377]. 16(1) , 2016.
  • Hauser, Robert A.|Olanow, C. Warren|Abler, Victor|Fitzer‐Attas, Cheryl J.|Stocchi, Fabrizio|Rascol, Olivier|Sidi, Yulia Long‐term effects of rasagiline and the natural history of treated Parkinson's disease Movement Disorders [08853185]. 31(10) , 2016.
  • Kumar, Rajeev|Hauser, Robert A.|Mostillo, Joseph|Dronamraju, Nalina|Graf, Ana|Merschhemke, Martin|Kenney, Christopher Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson's disease patients International Journal of Neuroscience [00207454]. 126(1) , 2016.
  • Espay, Alberto J|LeWitt, Peter A|Hauser, Robert A|Merola, Aristide|Masellis, Mario|Lang, Anthony E Neurogenic orthostatic hypotension and supine hypertension in Parkinson's disease and related synucleinopathies: prioritisation of treatment targets Lancet Neurology [14744422]. 15(9) , 2016.
  • Weintraub, Daniel|Elm, Jordan J.|Pagan, Fernando|Hauser, Robert A.|Davis, Matthew D.|Choudhry, Azhar Rasagiline for mild cognitive impairment in Parkinson's disease: A placebo‐controlled trial Movement Disorders [08853185]. 31(5) , 2016.
  • Hauser, Robert A.|Olanow, C. Warren|Dzyngel, Bruce|Bilbault, Thierry|Shill, Holly|Isaacson, Stuart|Dubow, Jordan|Agro, Albert Sublingual apomorphine (APL-130277) for the acute conversion of OFF to ON in Parkinson's disease: Sublingual Apomorphine Film Strip in PD Movement Disorders [08853185]. 31(9) , 2016.
  • Hauser, Robert A.|Eliaz, Rom|Eyal, Eli|Abler, Victor|Schilling, Traci Symptomatic efficacy of rasagiline in early PD: A meta-analysis Parkinsonism and Related Disorders [13538020]. 22, 2016.
  • Seeberger LC, Hauser RA. Carbidopa levodopa enteral suspension. Expert Opinion on Pharmacotherapy. 16(18) : 2807-17, 2015.
  • Hauser RA, Stocchi F, Rascol O, Huyck SB, Capece R, Ho TW, Sklar P, Lines C, Michelson D, Hewitt D. Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned. JAMA Neurology. 72(12) : 1491-500, 2015.
  • O''Brien CF, Jimenez R, Hauser RA, Factor SA, Burke J, Mandri D, Castro-Gayol JC. NBI-98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double-blind, placebo-controlled study. Movement Disorders : Official Journal of the Movement Disorder Society. 30(12) : 1681-7, 2015.
  • Simon DK, Wu C, Tilley BC, Wills AM, Aminoff MJ, Bainbridge J, Hauser RA, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wong PS. Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine. Clinical Neuropharmacology. 38(5) : 163-9, 2015.
  • Hauser RA. α-Synuclein in Parkinson''s disease: getting to the core of the matter. The Lancet. Neurology. 14(8) : 785-6, 2015.
  • Pahwa R, Tanner CM, Hauser RA, Sethi K, Isaacson S, Truong D, Struck L, Ruby AE, McClure NL, Went GT, Stempien MJ. Amantadine extended release for levodopa-induced dyskinesia in Parkinson''s disease (EASED Study). Movement Disorders : Official Journal of the Movement Disorder Society. 30(6) : 788-95, 2015.
  • Hauser RA, Isaacson S, Lisk JP, Hewitt LA, Rowse G. Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson''s disease (nOH306B). Movement Disorders : Official Journal of the Movement Disorder Society. 30(5) : 646-54, 2015.
  • Poewe W, Hauser RA, Lang A. Effects of rasagiline on the progression of nonmotor scores of the MDS-UPDRS. Movement Disorders : Official Journal of the Movement Disorder Society. 30(4) : 589-92, 2015.
  • Fernandez HH, Standaert DG, Hauser RA, Lang AE, Fung VS, Klostermann F, Lew MF, Odin P, Steiger M, Yakupov EZ, Chouinard S, Suchowersky O, Dubow J, Hall CM, Chatamra K, Robieson WZ, Benesh JA, Espay AJ. Levodopa-carbidopa intestinal gel in advanced Parkinson''s disease: final 12-month, open-label results. Movement Disorders : Official Journal of the Movement Disorder Society. 30(4) : 500-9, 2015.
  • Hauser RA. Initial choice of medication has little effect on short-term or long-term outcome for most patients with Parkinson''s disease. Evidence-based Medicine. 20(1) : 17, 2015.
  • Wechsler R, Hauser RA, French J. Who is helping whom? Manuscript support and transfer of value. Annals of Neurology. 77(2) : 353-5, 2015.
  • Ruby, April E.|McClure, Natalie L.|Went, Gregory T.|Stempien, Mary Jean|Pahwa, Rajesh|Hauser, Robert A.|Struck, Lynn|Sethi, Kapil|Tanner, Caroline M.|Isaacson, Stuart|Truong, Daniel Amantadine extended release for levodopa‐induced dyskinesia in Parkinson's disease (EASED Study) Movement Disorders [08853185]. 30(6) , 2015.
  • Simon, David K.|Wu, Cai|Tilley, Barbara C.|Wills, Anne-Marie|Aminoff, Michael J.|Bainbridge, Jacquelyn|Hauser, Robert A.|Schneider, Jay S.|Sharma, Saloni|Singer, Carlos|Tanner, Caroline M.|Truong, Daniel|Wong, Pei Shieen Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine Clinical Neuropharmacology [03625664]. 38(5) , 2015.
  • Seeberger, Lauren C|Hauser, Robert A Carbidopa levodopa enteral suspension Expert Opinion on Pharmacotherapy [14656566]. 16(18) , 2015.
  • Hauser, Robert A.|Hewitt, L. Arthur|Rowse, Gerry|Isaacson, Stuart|Lisk, Jerome P. Droxidopa for the S hort‐ T erm T reatment of S ymptomatic N eurogenic O rthostatic H ypotension in P arkinson's D isease (n OH 306 B ) Movement Disorders [08853185]. 30(5) , 2015.
  • Kieburtz, Karl|Tilley, Barbara C.|Elm, Jordan J.|Babcock, Debra|Hauser, Robert|Ross, G. Webster|Augustine, Alicia H.|Augustine, Erika U.|Aminoff, Michael J.|Bodis-Wollner, Ivan G.|Boyd, James|Cambi, Franca|Chou, Kelvin|Christine, Chadwick W.|Cines, Michelle|Dahodwala, Nabila|Derwent, Lorelei|Dewey, Richard B.|Hawthorne, Katherine|Houghton, David J.|Kamp, Cornelia|Leehey, Maureen|Lew, Mark F.|Liang, Grace S. Lin|Luo, Sheng T.|Mari, Zoltan|Morgan, John C.|Parashos, Sotirios|Pérez, Adriana|Petrovitch, Helen|Rajan, Suja|Reichwein, Sue|Roth, Jessie Tatsuno|Schneider, Jay S.|Shannon, Kathleen M.|Simon, David K.|Simuni, Tanya|Singer, Carlos|Sudarsky, Lewis|Tanner, Caroline M.|Umeh, Chizoba C.|Williams, Karen|Wills, Anne-Marie Effect of Creatine Monohydrate on Clinical Progression in Patients With Parkinson Disease: A Randomized Clinical Trial Journal of the American Medical Association [00987484]. 313(6) , 2015.
  • Lang, Anthony|Poewe, Werner|Hauser, Robert A. Effects of rasagiline on the progression of nonmotor scores of the MDS‐UPDRS Movement Disorders [08853185]. 30(4) , 2015.
  • Hauser, R.A.|Abler, V.|Eliaz, R.E.|Eyal, E.|Choudhry, A. Efficacy of rasagiline in early Parkinson’s disease (PD): a meta-analysis of data from the tempo and adagio studies Journal of the Neurological Sciences [0022510X]. 357, 2015.
  • Weintraub, D.|Hauser, R.A.|Davis, M.|Choudhry, A. Efficacy of rasagiline in patients with Parkinson’s disease and mild cognitive impairment: results from moderato, a 24-week randomized, double-blind, placebo-controlled trial Journal of the Neurological Sciences [0022510X]. 357, 2015.
  • Stegemöller, Elizabeth L.|Schmidt, Peter|Hass, Chris|Malaty, Irene|Okun, Michael S.|Bransabur, Melanie|Bloem, Bastiaan|Cho, Catherine|Santiago, Anthony|Gurevich, Tanya|Guttman, Mark|Hauser, Robert|Jankovic, Jospeoh|Lyons, Kelly|Mari, Zoltan|Morgan, John|Nutt, John|Parashos, Sotirios|Siderowf, Andrew|Simuni, Tanya|Tarsy, Daniel|Davis, Thomas|Miyasaki, Janis|Cheng, Eric|Giraldi, Nir|Marsh, Laura|Nelson, Eugene|Zamundio, Jorge How Should Pushing Off or the Use of Assistive Devices Be Incorporated in the Timed Up and Go for Persons With Parkinson Disease? Archives of Physical Medicine and Rehabilitation [00039993]. 96(9) , 2015.
  • Hauser, Robert A Initial choice of medication has little effect on short-term or long-term outcome for most patients with Parkinson's disease Evidence-Based Medicine [13565524]. 20(1) , 2015.
  • Fung, Victor S.C.|Odin, Per|Espay, Alberto J.|Steiger, Malcolm|Suchowersky, Oksana|Lang, Anthony E.|Chouinard, Sylvain|Lew, Mark F.|Yakupov, Eduard Z.|Standaert, David G.|Klostermann, Fabian|Fernandez, Hubert H.|Dubow, Jordan|Hall, Coleen M.|Chatamra, Krai|Robieson, Weining Z.|Benesh, Janet A.|Hauser, Robert A. Levodopa‐carbidopa intestinal gel in advanced Parkinson's disease: Final 12‐month, open‐label results Movement Disorders [08853185]. 30(4) , 2015.
  • Factor, Stewart A.|Mandri, Daniel|Castro‐Gayol, Julio C.|O'Brien, Christopher F.|Jimenez, Roland|Burke, Joshua|Hauser, Robert A. NBI‐98854, a selective monoamine transport inhibitor for the treatment of tardive dyskinesia: A randomized, double‐blind, placebo‐controlled study Movement Disorders [08853185]. 30(12) , 2015.
  • Bega, Danny|Kim, Soeun|Zhang, Yunxi|Elm, Jordan|Schneider, Jay|Hauser, Robert|Fraser, Andy|Simuni, Tanya Predictors of Functional Decline in Early Parkinson’s Disease: NET-PD LS1 Cohort Journal of Parkinson's Disease [18777171]. 5(4) , 2015.
  • Hauser, Robert A.|Stocchi, Fabrizio|Rascol, Olivier|Huyck, Susan B.|Capece, Rachel|Ho, Tony W.|Sklar, Peter|Lines, Christopher|Michelson, David|Hewitt, David Preladenant as an Adjunctive Therapy With Levodopa in Parkinson Disease: Two Randomized Clinical Trials and Lessons Learned Archives of Neurology [00039942]. 72(12) , 2015.
  • Wechsler, Robert|Hauser, Robert A.|French, Jacqueline Who is helping whom? Manuscript support and transfer of value Annals of Neurology [03645134]. 77(2) , 2015.
  • Hauser, Robert A α-Synuclein in Parkinson's disease: getting to the core of the matter Lancet Neurology [14744422]. 14(8) , 2015.
  • Bajaj N, Hauser RA, Seibyl J, Kupsch A, Plotkin M, Chen C, Grachev ID. Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCAN™) in subjects with clinically uncertain parkinsonian syndromes. Alzheimer''s Research & Therapy. 6: 67, 2014.
  • Hauser RA, Isaacson S, Clinch T. Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection. Parkinsonism & Related Disorders. 20(11) : 1171-6, 2014.
  • Seibyl JP, Kupsch A, Booij J, Grosset DG, Costa DC, Hauser RA, Darcourt J, Bajaj N, Walker Z, Marek K, McKeith I, O''Brien JT, Tatsch K, Tolosa E, Dierckx RA, Grachev ID. Individual-reader diagnostic performance and between-reader agreement in assessment of subjects with Parkinsonian syndrome or dementia using 123I-ioflupane injection (DaTscan) imaging. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 55(8) : 1288-96, 2014.
  • Goldman SM, Kamel F, Ross GW, Jewell SA, Marras C, Hoppin JA, Umbach DM, Bhudhikanok GS, Meng C, Korell M, Comyns K, Hauser RA, Jankovic J, Factor SA,. Peptidoglycan recognition protein genes and risk of Parkinson''s disease. Mov Disord. 29(9) : 1171-80, 2014.
  • Hauser RA, Olanow CW, Kieburtz KD, Pourcher E, Docu-Axelerad A, Lew M, Kozyolkin O, Neale A, Resburg C, Meya U, Kenney C, Bandak S. Tozadenant (SYN115) in patients with Parkinson''s disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial. The Lancet. Neurology. 13(8) : 767-76, 2014.
  • Cicchetti F, Lacroix S, Cisbani G, Vallières N, Saint-Pierre M, St-Amour I, Tolouei R, Skepper J, Hauser R, Mantovani D, Barker R, Freeman T. Mutant huntingtin is present in neuronal grafts in Huntington''s disease patients. Ann Neurol. 76(1) : 31-42, 2014.
  • Hauser RA, Silver D, Choudhry A, Eyal E, Isaacson S, for the ANDANTE study investigators. Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson’s disease Mov Disord. 29(8) : 1028-34, 2014.
  • Hauser RA, Silver D, Choudhry A, Eyal E, Isaacson S. Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson''s disease. Movement Disorders : Official Journal of the Movement Disorder Society. 29(8) : 1028-34, 2014.
  • The Parkinson Study Group QE3 Investigators (including Hauser RA). A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit. JAMA Neurol. 71(5) : 543-52, 2014.
  • Hauser RA, Gordon MF, Mizuno Y, Poewe W, Barone P, Schapira AH, Rascol O, Debieuvre C, Fräßdorf M. Minimal clinically important difference in Parkinson''s disease as assessed in pivotal trials of pramipexole extended release. Parkinson''s Disease. 2014: 467131, 2014.
  • Hauser RA, Schapira AH, Barone P, Mizuno Y, Rascol O, Busse M, Debieuvre C, Fraessdorf M, Poewe W. Pramipexole ER Studies Group.Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson''s disease. Eur J Neurol. 21(5) : 736-43, 2014.
  • Low PA, Robertson D, Gilman S, Kaufmann H, Singer W, Biaggioni I, Freeman R, Perlman S, Hauser RA, Cheshire W, Lessig S, Vernino S, Mandrekar J,. Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial. Lancet Neurol. 13(3) : 268-75, 2014.
  • Hauser RA, Gordon MF, Mizuno Y, Poewe W, Barone P, Schapira AH, Rascol O, Debieuvre C, Fräßdorf M. Minimal clinically important difference in Parkinson''s disease as assessed in pivotal trials of pramipexole extended release. Parkinsons Dis. , 2014.
  • Pahwa R, Lyons KE, Hauser RA, Fahn S, Jankovic J, Pourcher E, Hsu A, O''Connell M, Kell S, Gupta S. Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson''s disease. Parkinsonism & Related Disorders. 20(2) : 142-8, 2014.
  • Kremens D, Hauser RA, Dorsey ER. An update on Parkinson''s disease: improving patient outcomes. The American Journal of Medicine. 127(1) : S3, 2014.
  • Han, Y.|Stevens, A.|Dashtipour, K.|Hauser, R.|Mari, Z. A Mixed Treatment Comparison (Mtc) To Compare The Efficacy Of Botulinum Toxin Type A Treatments For Cervical Dystonia Value in Health [10983015]. 17(3) , 2014.
  • Beal, M. Flint|Oakes, David|Shoulson, Ira|Henchcliffe, Claire|Galpern, Wendy R.|Haas, Richard|Juncos, Jorge L.|Nutt, John G.|Voss, Tiffini Smith|Ravina, Bernard|Shults, Clifford M.|Helles, Karen|Snively, Victoria|Lew, Mark F.|Griebner, Brian|Watts, Arthur|Gao, Shan|Pourcher, Emmanuelle|Bond, Louisette|Kompoliti, Katie|Agarwal, Pinky|Sia, Cherissa|Jog, Mandar|Cole, Linda|Sultana, Munira|Kurlan, Roger|Richard, Irene|Deeley, Cheryl|Waters, Cheryl H.|Figueroa, Angel|Arkun, Ani|Brodsky, Matthew|Ondo, William G.|Hunter, Christine B.|Jimenez-Shahed, Joohi|Palao, Alicia|Miyasaki, Janis M.|So, Julie|Tetrud, James|Reys, Liza|Smith, Katharine|Singer, Carlos|Blenke, Anita|Russell, David S.|Cotto, Candace|Friedman, Joseph H.|Lannon, Margaret|Zhang, Lin|Drasby, Edward|Kumar, Rajeev|Subramanian, Thyagarajan|Ford, Donna Stuppy|Grimes, David A.|Cote, Diane|Conway, Jennifer|Siderowf, Andrew D.|Evatt, Marian Leslie|Sommerfeld, Barbara|Lieberman, Abraham N.|Okun, Michael S.|Rodriguez, Ramon L.|Merritt, Stacy|Swartz, Camille Louise|Martin, W. R. Wayne|King, Pamela|Stover, Natividad|Guthrie, Stephanie|Watts, Ray L.|Ahmed, Anwar|Fernandez, Hubert H.|Winters, Adrienna|Mari, Zoltan|Dawson, Ted M.|Dunlop, Becky|Feigin, Andrew S.|Shannon, Barbara|Nirenberg, Melissa Jill|Ogg, Mattson|Ellias, Samuel A.|Thomas, Cathi-Ann|Frei, Karen|Bodis-Wollner, Ivan|Glazman, Sofya|Mayer, Thomas|Hauser, Robert A.|Pahwa, Rajesh|Langhammer, April|Ranawaya, Ranjit|Derwent, Lorelei|Sethi, Kapil D.|Farrow, Buff|Prakash, Rajan|Litvan, Irene|Robinson, Annette|Sahay, Alok|Gartner, Maureen|Hinson, Vanessa K.|Markind, Samuel|Pelikan, Melisa|Perlmutter, Joel S.|Hartlein, Johanna|Molho, Eric|Evans, Sharon|Adler, Charles H.|Duffy, Amy|Lind, Marlene|Elmer, Lawrence|Davis, Kathy|Spears, Julia|Wilson, Stephanie|Leehey, Maureen A.|Hermanowicz, Neal|Niswonger, Shari|Shill, Holly A.|Obradov, Sanja|Rajput, Alex|Cowper, Marilyn|Lessig, Stephanie|Song, David|Fontaine, Deborah|Zadikoff, Cindy|Williams, Karen|Blindauer, Karen A.|Bergholte, Jo|Propsom, Clara Schindler|Stacy, Mark A.|Field, Joanne|Mihaila, Dragos|Chilton, Mark|Uc, Ergun Y.|Sieren, Jeri|Simon, David K.|Kraics, Lauren|Silver, Althea|Boyd, James T.|Hamill, Robert W.|Ingvoldstad, Christopher|Young, Jennifer|Thomas, Karen|Kostyk, Sandra K.|Wojcieszek, Joanne|Pfeiffer, Ronald F.|Panisset, Michel|Beland, Monica|Reich, Stephen G.|Cines, Michelle|Zappala, Nancy|Rivest, Jean|Zweig, Richard|Lumina, L. Pepper|Hilliard, Colette Lynn|Grill, Stephen|Kellermann, Marye|Tuite, Paul|Rolandelli, Susan|Kang, Un Jung|Young, Joan|Rao, Jayaraman|Cook, Maureen M.|Severt, Lawrence|Boyar, Karyn A Randomized Clinical Trial of High-Dosage Coenzyme Q10 in Early Parkinson Disease: No Evidence of Benefit Archives of Neurology [00039942]. 71(5) , 2014.
  • Kremens, Daniel|Hauser, Robert A.|Dorsey, E. Ray An Update on Parkinson's Disease: Improving Patient Outcomes The American Journal of Medicine Supplements [00029343]. 127(1) , 2014.
  • Bajaj, Nin|Hauser, Robert A|Seibyl, John|Kupsch, Andreas|Plotkin, Michail|Chen, Chris|Grachev, Igor D Association between Hoehn and Yahr, Mini-Mental State Examination, age, and clinical syndrome predominance and diagnostic effectiveness of ioflupane I 123 injection (DaTSCANTM) in subjects with clinically uncertain parkinsonian syndromes Alzheimer's Research and Therapy [17589193]. 6(5-8) , 2014.
  • LeWitt, Peter A.|Chen, Dan|Lissin, Dmitri|Zomorodi, Katie|Cundy, Kenneth C.|Huff, F. Jacob|Hauser, Robert A. Double‐blind study of the actively transported levodopa prodrug XP21279 in Parkinson's disease Movement Disorders [08853185]. 29(1) , 2014.
  • Hauser, Robert A.|Hewitt, L. Arthur|Isaacson, Stuart Droxidopa in Patients with Neurogenic Orthostatic Hypotension Associated with Parkinson's Disease (NOH306A) Journal of Parkinson's Disease [18777171]. 4(1) , 2014.
  • Low, Phillip A|Robertson, David|Gilman, Sid|Kaufmann, Horacio|Singer, Wolfgang|Biaggioni, Italo|Freeman, Roy|Perlman, Susan|Hauser, Robert A|Cheshire, William|Lessig, Stephanie|Vernino, Steven|Mandrekar, Jay|Dupont, William D|Chelimsky, Thomas|Galpern, Wendy R Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial Lancet Neurology [14744422]. 13(3) , 2014.
  • Seibyl, John P.|Kupsch, Andreas|Booij, Jan|Grosset, Donald G.|Costa, Durval C.|Hauser, Robert A.|Darcourt, Jacques|Bajaj, Nin|Walker, Zuzana|Marek, Kenneth|McKeith, Ian|O’Brien, John T.|Tatsch, Klaus|Tolosa, Eduardo|Dierckx, Rudi A.|Grachev, Igor D. Individual-Reader Diagnostic Performance and Between-Reader Agreement in Assessment of Subjects with Parkinsonian Syndrome or Dementia Using 123 I-Ioflupane Injection (DaTscan) Imaging Journal of Nuclear Medicine [01615505]. 55(8) , 2014.
  • Hauser, R. A.|Schapira, A. H. V.|Barone, P.|Mizuno, Y.|Rascol, O.|Busse, M.|Debieuvre, C.|Fraessdorf, M.|Poewe, W. Long‐term safety and sustained efficacy of extended‐release pramipexole in early and advanced P arkinson's disease European Journal of Neurology [13515101]. 21(5) , 2014.
  • Hauser, Robert A.|Gordon, Mark Forrest|Mizuno, Yoshikuni|Poewe, Werner|Barone, Paolo|Schapira, Anthony H.|Rascol, Olivier|Debieuvre, Catherine|Fräßdorf, Mandy Minimal Clinically Important Difference in Parkinson’s Disease as Assessed in Pivotal Trials of Pramipexole Extended Release Parkinson's Disease [20908083]. 2014, 2014.
  • Nutt, J.G.|Siderowf, A.D.|Guttman, M.|Schmidt, P.N.|Zamudio, J.I.|Wu, S.S.|Okun, M.S.|Simuni, T.|Parashos, S.A.|Dahodwala, N.A.|Davis, T.L.|Giladi, N.|Gurevich, T.|Hauser, R.A.|Jankovic, J.|Lyons, K.E.|Marsh, L.|Miyasaki, J.M.|Morgan, J.C.|Santiago, A.J.|Tarsy, D.|Mari, Z.|Malaty, I.A.|Nelson, E.C. Mobility, mood and site of care impact health related quality of life in Parkinson's disease Parkinsonism and Related Disorders [13538020]. 20(3) , 2014.
  • Hauser, Robert A.|Barker, Roger A.|Tolouei, Ranna|Mantovani, Diego|Cisbani, Giulia|Vallières, Nicolas|Saint‐Pierre, Martine|St‐Amour, Isabelle|Cicchetti, Francesca|Lacroix, Steve|Freeman, Thomas B.|Skepper, Jeremy N. Mutant huntingtin is present in neuronal grafts in huntington disease patients Annals of Neurology [03645134]. 76(1) , 2014.
  • Hoppin, Jane A.|Tanner, Caroline M.|Jewell, Sarah A.|Factor, Stewart A.|Kamel, Freya|Sandler, Dale P.|Hauser, Robert A.|Bhudhikanok, Grace S.|Meng, Cheryl|Korell, Monica|Comyns, Kathleen|Langston, J. William|Lyons, Kelly E.|Marras, Connie|Goldman, Samuel M.|Umbach, David M.|Jankovic, Joseph|Bressman, Susan|Ross, G. Webster Peptidoglycan recognition protein genes and risk of Parkinson's disease Movement Disorders [08853185]. 29(9) , 2014.
  • Mari, Zoltan|Dashtipour, Khashayar|Han, Yi|Stevens, Andrea|Lomax, Kathleen G.|Hauser, Robert Poster 350 A Random Effect Mixed Treatment Comparison (MTC) to Compare the Efficacy of Botulinum Toxin Type A Treatments for Cervical Dystonia PM&R [19341482]. 6(9S) , 2014.
  • Pahwa, Rajesh|Lyons, Kelly E.|Hauser, Robert A.|Fahn, Stanley|Jankovic, Joseph|Pourcher, Emmanuelle|Hsu, Ann|O'Connell, Martin|Kell, Sherron|Gupta, Suneel Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease Parkinsonism and Related Disorders [13538020]. 20(2) , 2014.
  • Silver, Dee|Hauser, Robert A.|Eyal, Eli|Choudhry, Azhar|Isaacson, Stuart Randomized, controlled trial of rasagiline as an add‐on to dopamine agonists in Parkinson's disease Movement Disorders [08853185]. 29(8) , 2014.
  • Hauser, Robert A.|Isaacson, Stuart|Clinch, Thomas Randomized, placebo-controlled trial of trimethobenzamide to control nausea and vomiting during initiation and continued treatment with subcutaneous apomorphine injection Parkinsonism and Related Disorders [13538020]. 20(11) , 2014.
  • Hauser, Robert A|Olanow, C Warren|Kieburtz, Karl D|Pourcher, Emmanuelle|Docu-Axelerad, Any|Lew, Mark|Kozyolkin, Olexandr|Neale, Ann|Resburg, Chris|Meya, Uwe|Kenney, Christopher|Bandak, Stephen Tozadenant (SYN115) in patients with Parkinson's disease who have motor fluctuations on levodopa: a phase 2b, double-blind, randomised trial Lancet Neurology [14744422]. 13(8) , 2014.
  • Lewitt PA, Huff FJ, Hauser RA, Chen D, Lissin D, Zomorodi K, Cundy KC. Double-blind study of the actively transported levodopa prodrug XP21279 in Parkinson''s disease. Movement Disorders : Official Journal of the Movement Disorder Society. , 2013.
  • Hauser RA, Hewitt LA, Isaacson S. Droxidopa in Patients with Neurogenic Orthostatic Hypotension Associated with Parkinson''s Disease (NOH306A). Journal of Parkinson''s disease. : 57-65, 2013.
  • Stocchi F, Rascol O, Destee A, Hattori N, Hauser RA, Lang AE, Poewe W, Stacy M, Tolosa E, Gao H, Nagel J, Merschhemke M, Graf A, Kenney C, Trenkwalder C. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. Movement Disorders : Official Journal of the Movement Disorder Society. 28(13) : 1838-46, 2013.
  • Bajaj N, Hauser RA, Grachev ID. Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with (123I) ioflupane in diagnosis of parkinsonian syndromes. Journal of Neurology, Neurosurgery, and psychiatry. 84(11) : 1288-95, 2013.
  • The Parkinson Study Group (including Hauser RA). Phase II safety, tolerability, and dose selection study of isradipine as a potential disease-modifying intervention in early Parkinson''s disease (STEADY-PD) Mov Disord. 28(13) : 1823-31, 2013.
  • Nutt JG, Siderowf AD, Guttman M, Schmidt PN, Zamudio JI, Wu SS, Okun MS, Simuni T, Parashos SA, Dahodwala NA, Davis TL, Giladi N, Gurevich T, Hauser RA, Jankovic J, Lyons KE, Marsh L, Miyasaki JM, Morgan JC, Santiago AJ, Tarsy D, Mari Z, Malaty IA, Nelson EC. Mobility, mood and site of care impact health related quality of life in Parkinson''s disease. Parkinsonism & Related Disorders. , 2013.
  • Edwards JD, Hauser RA, O''Connor ML, Valdés EG, Zesiewicz TA, Uc EY. Randomized trial of cognitive speed of processing training in Parkinson disease. Neurology. 81(15) : 1284-90, 2013.
  • Kumar R, Hauser RA, Mostillo J, Dronamraju N, Graf A, Merschhemke M, Kenney C. Mavoglurant (AFQ056) in combination with increased levodopa dosages in Parkinson''s disease patients. The International Journal of Neuroscience. , 2013.
  • Hauser RA. PROUD stands tall: delayed-start studies in Parkinson''s disease. Lancet Neurology. 12(8) : 728-9, 2013.
  • Factor SA, Wolski K, Togasaki DM, Huyck S, Cantillon M, Ho TW, Hauser RA, Pourcher E. Long-term safety and efficacy of preladenant in subjects with fluctuating Parkinson''s disease. Movement Disorders : Official Journal of the Movement Disorder Society. 28(6) : 817-20, 2013.
  • Hauser RA, Hsu A, Kell S, Espay AJ, Sethi K, Stacy M, Ondo W, O''Connell M, Gupta S. Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson''s disease and motor fluctuations: a phase 3 randomised, double-blind trial. Lancet neurology. 12(4) : 346-56, 2013.
  • Fernandez HH, Vanagunas A, Odin P, Espay AJ, Hauser RA, Standaert DG, Chatamra K, Benesh J, Pritchett Y, Hass SL, Lenz RA. Levodopa-carbidopa intestinal gel in advanced Parkinson''s disease open-label study: interim results. Parkinsonism & related disorders. 19(3) : 339-45, 2013.
  • Goetz CG, Stebbins GT, Chung KA, Hauser RA, Miyasaki JM, Nicholas AP, Poewe W, Seppi K, Rascol O, Stacy MA, Nutt JG, Tanner CM, Urkowitz A, Jaglin JA, Ge S. Which dyskinesia scale best detects treatment response? Movement disorders : official journal of the Movement Disorder Society. 28(3) : 341-6, 2013.
  • Hauser RA, Truong D, Hubble J, Coleman C, Beffy JL, Chang S, Picaut P. AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies. Journal of neural transmission (Vienna, Austria : 1996). 120(2) : 299-307, 2013.
  • Cisbani G, Freeman TB, Soulet D, Saint-Pierre M, Gagnon D, Parent M, Hauser RA, Barker RA, Cicchetti F. Striatal allografts in patients with Huntington''s disease: impact of diminished astrocytes and vascularization on graft viability. Brain : A Journal of Neurology. 136(2) : 433-43, 2013.
  • HORIZON Investigators of the Huntington Study Group and European Huntington''s Disease Network. A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease JAMA Neurol. 70(1) : 25-33, 2013.
  • Schapira AH, Barone P, Hauser RA, Mizuno Y, Rascol O, Busse M, Debieuvre C, Fraessdorf M, Poewe W. Patient-reported convenience of once-daily versus three-times-daily dosing during long-term studies of pramipexole in early and advanced Parkinson''s disease. European journal of neurology : the official journal of the European Federation of Neurological Societies. 20(1) : 50-6, 2013.
  • Schapira AH, Barone P, Hauser RA, Mizuno Y, Rascol O, Busse M, Debieuvre C, Fraessdorf M, Poewe W. Success rate, efficacy, and safety/tolerability of overnight switching from immediate- to extended-release pramipexole in advanced Parkinson''s disease. European journal of neurology : the official journal of the European Federation of Neurological Societies. 20(1) : 180-7, 2013.
  • Standaert, D.G.|Fernandez, H.H.|Odin, P.|Hauser, R.A.|Espay, A.J.|Steiger, M.|Chouinard, S.|Suchowersky, O.|Yakupov, E.|Merikle, E.P.|Robieson, W.Z.|Chatamra, K.|Benesh, J. A long-term, open-label study of levodopa–/INS;carbidopa intestinal gel in advanced Parkinson's disease patients: Functional and health-related quality-of-life endpoints Journal of the Neurological Sciences [0022510X]. 333, 2013.
  • Espay, A.J.|Odin, P.|Fernandez, H.H.|Hauser, R.A.|Standaert, D.G.|Lang, A.E.|Fung, V.S.|Klostermann, F.|Robieson, W.Z.|Chatamra, K.|Benesh, J. A long-term, open-label study of levodopa–/INS;carbidopa intestinal gel in advanced Parkinson's disease patients: safety and motor-symptom endpoints Journal of the Neurological Sciences [0022510X]. 333, 2013.
  • Hauser, R.A.|Olanow, C.W.|Kieburtz, K.D.|Neale, A.|Resburg, C.|Meya, U.|Bankak, S.I. A phase 2, placebo-controlled, randomized, double-blind trial of tozadenant (Syn-115) in patients with Parkinson's disease with wearing-off fluctuations on levodopa Journal of the Neurological Sciences [0022510X]. 333, 2013.
  • Hubble, J.|Hauser, R.|Coleman, C.|Yair, J.|Beffy, J.|Picaut, P. Abobotulinumtoxin A dosing in cervical dystonia: An analysis of two large open-label extension studies Toxicon [00410101]. 68, 2013.
  • Hauser, Robert A.|Truong, Daniel|Hubble, Jean|Coleman, Chandra|Beffy, Jean-Luc|Chang, Stephen|Picaut, Philippe AbobotulinumtoxinA (Dysport) dosing in cervical dystonia: an exploratory analysis of two large open-label extension studies Journal of Neural Transmission [03009564]. 120(2) , 2013.
  • Stocchi, Fabrizio|Trenkwalder, Claudia|Nagel, Jennifer|Merschhemke, Martin|Graf, Ana|Destee, Alain|Gao, Haitao|Kenney, Christopher|Lang, Anthony E.|Rascol, Olivier|Tolosa, Eduardo|Stacy, Mark|Poewe, Werner|Hattori, Nobutaka|Hauser, Robert A. AFQ056 in Parkinson patients with levodopa‐induced dyskinesia: 13‐week, randomized, dose‐finding study Movement Disorders [08853185]. 28(13) , 2013.
  • Bajaj, Nin|Hauser, Robert A|Grachev, Igor D Clinical utility of dopamine transporter single photon emission CT (DaT-SPECT) with ( 123 I) ioflupane in diagnosis of parkinsonian syndromes Journal of Neurology, Neurosurgery and Psychiatry [00223050]. 84(11) , 2013.
  • Grachev, I.|Sherwin, P.|Lane, D.|Moreno, E.|Freid, J.|Bajaj, N.|Hauser, R.A.|Seibyl, J.|Grosset, D.G.|Marek, K. DaTSCAN™ (ioflupane I 123 injection), a radiopharmaceutical indicated for visualization of the striatal dopamine transporter using SPECT: Safety profile review Journal of the Neurological Sciences [0022510X]. 333, 2013.
  • Isaacson, S.|Silver, D.|Choudhry, A.|Hauser, R.A. Efficacy, safety and tolerability of rasagiline as an add-on therapy to dopamine agonists in early Parkinson's disease: The ANDANTE study Journal of the Neurological Sciences [0022510X]. 333, 2013.
  • Hauser, Robert A|Hsu, Ann|Kell, Sherron|Espay, Alberto J|Sethi, Kapil|Stacy, Mark|Ondo, William|O'Connell, Martin|Gupta, Suneel Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial Lancet Neurology [14744422]. 12(4) , 2013.
  • Fernandez, Hubert H.|Vanagunas, Arvydas|Odin, Per|Espay, Alberto J.|Hauser, Robert A.|Standaert, David G.|Chatamra, Krai|Benesh, Janet|Pritchett, Yili|Hass, Steven L.|Lenz, Robert A. Levodopa–carbidopa intestinal gel in advanced Parkinson's disease open-label study: Interim results Parkinsonism and Related Disorders [13538020]. 19(3) , 2013.
  • Pourcher, Emmanuelle|Factor, Stewart A.|Togasaki, Daniel M.|Hauser, Robert A.|Wolski, Kenneth|Huyck, Susan|Cantillon, Marc|Ho, T.W. Long‐term safety and efficacy of preladenant in subjects with fluctuating Parkinson's disease Movement Disorders [08853185]. 28(6) , 2013.
  • Schapira, A. H. V.|Barone, P.|Hauser, R. A.|Mizuno, Y.|Rascol, O.|Busse, M.|Debieuvre, C.|Fraessdorf, M.|Poewe, W. Patient‐reported convenience of once‐daily versus three‐times‐daily dosing during long‐term studies of pramipexole in early and advanced Parkinson’s disease European Journal of Neurology [13515101]. 20(1) , 2013.
  • Hauser, Robert A PROUD stands tall: delayed-start studies in Parkinson's disease Lancet Neurology [14744422]. 12(8) , 2013.
  • Edwards, Jerri D.|Hauser, Robert A.|O'Connor, Melissa L.|Valdés, Elise G.|Zesiewicz, Theresa A.|Uc, Ergun Y. Randomized trial of cognitive speed of processing training in Parkinson disease Neurology [00283878]. 81(15) , 2013.
  • Bajaj, N.|Grachev, I.D.|Seibyl, J.|Marek, K.|Kupsch, A.|Plotkin, M.|Hauser, R.A. Sensitivity, specificity, positive and negative predictive values and accuracy of datscan™/INS; for prediction of clinical diagnosis of early parkinsonian syndromes Journal of the Neurological Sciences [0022510X]. 333, 2013.
  • Cisbani, Giulia|Freeman, Thomas B.|Soulet, Denis|Saint-Pierre, Martine|Gagnon, Dave|Parent, Martin|Hauser, Robert A.|Barker, Roger A.|Cicchetti, Francesca Striatal allografts in patients with Huntington’s disease: impact of diminished astrocytes and vascularization on graft viability Brain [00068950]. 136(2) , 2013.
  • Poewe, W.|Hauser, R. A.|Barone, P.|Mizuno, Y.|Debieuvre, C.|Busse, M.|Fraessdorf, M.|Rascol, O.|Schapira, A. H. V. Success rate, efficacy, and safety/tolerability of overnight switching from immediate‐ to extended‐release pramipexole in advanced Parkinson's disease European Journal of Neurology [13515101]. 20(1) , 2013.
  • Rascol, Olivier|Nicholas, Anthony P.|Jaglin, Jean A.|Ge, Song|Goetz, Christopher G.|Stebbins, Glenn T.|Stacy, Mark A.|Chung, Kathryn A.|Nutt, John G.|Seppi, Klaus|Poewe, Werner|Tanner, Caroline M.|Urkowitz, Alison|Miyasaki, Janis M.|Hauser, Robert A. Which dyskinesia scale best detects treatment response? Movement Disorders [08853185]. 28(3) , 2013.
  • Hauser RA, Grosset DG. [123I]FP-CIT (DaTscan) SPECT brain imaging in patients with suspected parkinsonian syndromes. Journal of neuroimaging : official journal of the American Society of Neuroimaging. 22(3) : 225-30, 2012.
  • Lewitt PA, Hauser RA, Lu M, Nicholas AP, Weiner W, Coppard N, Leinonen M, Savola JM. Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study). Neurology. 79(2) : 163-9, 2012.
  • Hauser RA, Lyons KE, Pahwa R. The UPDRS-8: a brief clinical assessment scale for Parkinson''s disease. The International journal of neuroscience. 122(7) : 333-7, 2012.
  • Rascol O, Bronzova J, Hauser RA, Lang AE, Sampaio C, Theeuwes A, van de Witte SV. Pardoprunox as adjunct therapy to levodopa in patients with Parkinson''s disease experiencing motor fluctuations: results of a double-blind, randomized, placebo-controlled, trial. Parkinsonism & related disorders. 18(4) : 370-6, 2012.
  • Hauser RA. IPX066: a novel carbidopa-levodopa extended-release formulation. Expert review of neurotherapeutics. 12(2) : 133-40, 2012.
  • Goldman SM, Kamel F, Ross GW, Jewell SA, Bhudhikanok GS, Umbach D, Marras C, Hauser RA, Jankovic J, Factor SA, Bressman S, Lyons KE, Meng C, Korell M, Roucoux DF, Hoppin JA, Sandler DP, Langston JW, Tanner CM. Head injury, α-synuclein Rep1, and Parkinson''s disease. Annals of neurology. 71(1) : 40-8, 2012.
  • Hauser, Robert A.|Grosset, Donald G. [ 123 I]FP‐CIT (DaTscan) SPECT Brain Imaging in Patients with Suspected Parkinsonian Syndromes Journal of Neuroimaging [10512284]. 22(3) , 2012.
  • Schapira, A.|Barone, P.|Hauser, R.|Mizuno, Y.|Rascol, O.|Busse, M.|Debieuvre, C.|Fraessdorf, M.|Poewe, W. 2.263 PATIENT-REPORTED CONVENIENCE OF ONCE-DAILY VS TID DOSING DURING LONG-TERM STUDIES OF PRAMIPEXOLE IN EARLY AND ADVANCED PARKINSON'S DISEASE Parkinsonism and Related Disorders [13538020]. 18, 2012.
  • Poewe, W.|Barone, P.|Hauser, R.|Mizuno, Y.|Rascol, O.|Busse, M.|Debieuvre, C.|Fraessdorf, M.|Schapira, A. 2.265 LONG-TERM SAFETY AND SUSTAINED EFFICACY OF EXTENDED-RELEASE PRAMIPEXOLE IN EARLY AND ADVANCED PARKINSON'S DISEASE Parkinsonism and Related Disorders [13538020]. 18, 2012.
  • Morelli, Micaela|Blandini, Fabio|Simola, Nicola|Hauser, Robert A. A 2A Receptor Antagonism and Dyskinesia in Parkinson’s Disease Parkinson's Disease [20908083]. 2012, 2012.
  • Morelli M, Blandini F, Simola N, Hauser RA. A(2A) Receptor Antagonism and Dyskinesia in Parkinson''s Disease. Parkinson''s disease. 2012: 489853, 2012.
  • Jung Kang, Un|Auinger, Peggy|Marek, Kenneth|Seibyl, John|Russell, David S.|Jennings, Danna|Fussell, Barbara|Shinaman, Aileen|Shoulson, Ira|Kieburtz, Karl|Ramos, Serrano|Simuni, Tanya|Siderowf, Andrew|Colcher, Amy|Lloyd, Mary|Trugman, Joel|Wooten, G. Frederick|Rost-Ruffner, Elke|Waters, Cheryl|Lew, Mark|Welsh, Mickie|Kawai, Connie|Kurlan, Roger|Richard, Irene|Pearson, Nancy|Zhao, Hongwei|Oakes, David|Schifitto, Giovanni|Suchowersky, Oksana|Ranawaya, Ranjit|Wood, Susan|Pantella, Carol|Pahwa, Rajesh|Dubinsky, Richard M.|Martin, Wayne|Roberts, Ted|King, Pamela|Weiner, William|Shulman, Lisa|Koller, William|Lyons, Kelly|Albin, Roger|Frey, Kirk|Wernette, Kristine|Rudolph, Alice|Hauser, Robert|Zesiewicz, Theresa|Gauger, Lisa|Mark, Margery H.|Sage, Jacob I.|Caputo, Debbie|Perlmutter, Joel|Racette, Brad A.|O'Brien, Christopher|Kumar, Rajeev|Seeberger, Lauren|Judd, Deborah|Samanta, Johan|Stacy, Mark|Williamson, Kelli|Harrigan, Mary|Feldman, Robert G.|Brown, Diane|Jankovic, Joseph|Ondo, William|Atassi, Farah|Hunter, Christine|Factor, Stewart A.|Molho, Eric|Evans, Sharon|Juncos, Jorge|Watts, Ray|Partlow, Anna|Olanow, C. Warren|Brin, Mitchell|Danisi, Fabio|Benabou, Reina|Gould, Harry|Rao, Jayaraman|McKendrick, Ann|Caviness, John N.|Adler, Charles|Lind, Marlene|Dawson, Ted|Reich, Stephen|Dunlop, Rebecca|Wszolek, Zbigniew|Uitti, Ryan|Turk, Margaret|Standaert, David|Schwarzschild, Michael A.|Growdon, John H.|Tennis, Marsha|Panisset, Michel|Hall, Jean|Gauthier, Serge|Gancher, Stephen|Hammerstad, John P.|Stone, Claudia|Alexander-Brown, Barbara|Hubble, Jean|Paulson, George W.|Reider, Carson|Truong, Daniel D.|Pathak, Mayank|Tuite, Paul|Rottenberg, David|Hansen, Joy|Barclay, C. Lynn|Grimes, David A.|Sutherland, Laura|Mendis, Tilak|Reyes, Lydia|Greene, Paul|Ford, Blair|Moskowitz, Carol|Fahn, Stanley|Jacques, Carol|Friedman, Joseph H.|Lannon, Margaret|Saint-Hilaire, Marie H.|Ellias, Samuel|Thomas, Cathi-Ann|Clark, Jeffrey|Manyam, Bala|Simpson, Patricia|Wulbrecht, Brian|Whetteckey, Jacqueline|Comella, Cynthia L.|Goetz, Christopher|Blasucci, Lucia M.|Tanner, Caroline|Tetrud, James|Togasaki, Daniel M.|Stewart, Tracy|Lang, Anthony|Birnbaum, Alex|Miyasaki, Janis|Johnston, Lisa|So, Julie Activity enhances dopaminergic long-duration response in Parkinson disease Neurology [00283878]. 78(15) , 2012.
  • Elm JJ; The NINDS NET-PD Investigators. Design innovations and baseline findings in a long-term Parkinson’s trial: The national institute of neurological disorders and stroke exploratory trials in Parkinson’s Disease Long-Term Study-1 Mov Disord. 12(27) : 1513-1521, 2012.
  • Mizuno, Yoshikuni|Yamamoto, Mitsutoshi|Kuno, Sadako|Hasegawa, Kazuko|Hattori, Nobutaka|Kagimura, Tatsuro|Sarashina, Akiko|Rascol, Olivier|Schapira, Anthony H.V.|Barone, Paolo|Hauser, Robert A.|Poewe, Werner Efficacy and Safety of Extended- Versus Immediate-Release Pramipexole in Japanese Patients With Advanced and L-dopa–Undertreated Parkinson Disease: A Double-Blind, Randomized Trial Clinical Neuropharmacology [03625664]. 35(4) , 2012.
  • Mizuno Y, Yamamoto M, Kuno S, Hasegawa K, Hattori N, Kagimura T, Sarashina A, Rascol O, Schapira AH, Barone P, Hauser RA, Poewe W. Efficacy and safety of extended- versus immediate-release pramipexole in Japanese patients with advanced and L-dopa-undertreated Parkinson disease: a double-blind, randomized trial. Clinical neuropharmacology. 35(4) : 174-81, 2012.
  • Charles, David|Brashear, Allison|Hauser, Robert A.|Li, Hung-Ir|Boo, Lee-Ming|Brin, Mitchell F. Efficacy, Tolerability, and Immunogenicity of OnabotulinumtoxinA in a Randomized, Double-Blind, Placebo-Controlled Trial for Cervical Dystonia Clinical Neuropharmacology [03625664]. 35(5) , 2012.
  • Charles D, Brashear A, Hauser RA, Li HI, Boo LM, Brin MF. Efficacy, tolerability, and immunogenicity of onabotulinumtoxina in a randomized, double-blind, placebo-controlled trial for cervical dystonia. Clinical Neuropharmacology. 35(5) : 208-14, 2012.
  • Goldman, Samuel M.|Kamel, Freya|Ross, G. Webster|Jewell, Sarah A.|Bhudhikanok, Grace S.|Umbach, David|Marras, Connie|Hauser, Robert A.|Jankovic, Joseph|Factor, Stewart A.|Bressman, Susan|Lyons, Kelly E.|Meng, Cheryl|Korell, Monica|Roucoux, Diana F.|Hoppin, Jane A.|Sandler, Dale P.|Langston, J. William|Tanner, Caroline M. Head injury, alpha‐synuclein Rep1, and Parkinson's disease Annals of Neurology. 71(1) , 2012.
  • Hauser, Robert A IPX066: a novel carbidopa–levodopa extended-release formulation Expert Review of Neurotherapeutics. 12(2) , 2012.
  • Rascol, O.|Bronzova, J.|Hauser, R.A.|Lang, A.E.|Sampaio, C.|Theeuwes, A.|van de Witte, S.V. Pardoprunox as adjunct therapy to levodopa in patients with Parkinson’s disease experiencing motor fluctuations: Results of a double-blind, randomized, placebo-controlled, trial Parkinsonism and Related Disorders [13538020]. 18(4) , 2012.
  • LeWitt, Peter A.|Hauser, Robert A.|Lu, Mei|Nicholas, Anthony P.|Weiner, William|Coppard, Nicholas|Leinonen, Mika|Savola, Juha-Matti Randomized clinical trial of fipamezole for dyskinesia in Parkinson disease (FJORD study) Neurology [00283878]. 79(2) , 2012.
  • Hauser, R.|Nausieda, P.|Surmann, E.|Moran, K.|Barone, P. Rotigotine Transdermal System Improves Neuropsychiatric Features (Apathy, Anhedonia, Anxiety, and Depression) and Fatigue in Patients with Parkinson's Disease: A Post-Hoc Analysis of Five Double-Blind Placebo-Controlled Studies (P06.088) Neurology [00283878]. 78(Meeting Abstract) , 2012.
  • Hauser, Robert A.|Lyons, Kelly E.|Pahwa, Rajesh The UPDRS-8: A Brief Clinical Assessment Scale for Parkinson's Disease International Journal of Neuroscience. 122(7) , 2012.
  • Schapira AH, Barone P, Hauser RA, Mizuno Y, Rascol O, Busse M, Salin L, Juhel N, Poewe W. Extended-release pramipexole in advanced Parkinson disease: a randomized controlled trial. Neurology. 77(8) : 767-74, 2011.
  • Hauser RA, Cantillon M, Pourcher E, Micheli F, Mok V, Onofrj M, Huyck S, Wolski K. Preladenant in patients with Parkinson''s disease and motor fluctuations: a phase 2, double-blind, randomised trial. Lancet neurology. 10(3) : 221-9, 2011.
  • Rascol, Olivier|Fitzer-Attas, Cheryl J|Hauser, Robert|Jankovic, Joseph|Lang, Anthony|Langston, J William|Melamed, Eldad|Poewe, Werner|Stocchi, Fabrizio|Tolosa, Eduardo|Eyal, Eli|Weiss, Yoni M|Olanow, C Warren A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes Lancet Neurology [14744422]. 10(5) , 2011.
  • Rascol, O., Fitzer-Attas, C.J., Hauser, R., Jankovic, J., Lang, A., Langston, J. W., …& Olanow, C. W. A double-blind, delayed-start trial of rasgiline in Parkinson’s disease (the ADAGIO study) : prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes. The Lancet Neurology. 5(10) : 415-423, 2011.
  • Friedman JH, Agarwal P, Alcalay R, Black KJ, Chou KL, Cote L, Dayalu P, Frank S, Hartlein J, Hauser RA, Lang AE, Marsh L, Marshall F, Moskowitz C, Ravina B, Riley D, Sanchez-Ramos J, Simon DK, Simuni T, Sutton J, Tuite P, Weintraub D, Zesiewicz T. Clinical vignettes in Parkinson''s disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behaviours. Int J Neurosci.. 8(121) : 767-74, 2011.
  • Hsu, Ann|O'Connell, Martin J.|Modi, Nishit B.|Yao, Hsuan‐Ming|Kell, Sherron H.|Gupta, Suneel K.|Hauser, Robert A.|Ellenbogen, Aaron L.|Metman, Leo Verhagen Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson's disease Movement Disorders. 26(12) , 2011.
  • Hauser RA, Ellenbogen AL, Metman LV, Hsu A, O''Connell MJ, Modi NB, Yao HM, Kell SH, Gupta SK. Crossover comparison of IPX066 and a standard levodopa formulation in advanced Parkinson''s disease Mov Disord. 12(26) : 2246-52, 2011.
  • Hauser, Robert A.|Auinger, Peggy Determination of minimal clinically important change in early and advanced Parkinson's disease Movement Disorders. 26(5) , 2011.
  • Hauser RA, Auinger P, Parkinson Study Group. Determination of Minimal Clinically Important Change in Early and Advanced Parkinson''s Disease. Mov Disord. 5(26) : 813-8., 2011.
  • Schapira, A.H.V.|Barone, P.|Hauser, R.A.|Mizuno, Y.|Rascol, O.|Busse, M.|Salin, L.|Juhel, N.|Poewe, W. Extended-release pramipexole in advanced Parkinson disease: A randomized controlled trial Neurology. 77(8) , 2011.
  • Poewe, W.|Rascol, O.|Barone, P.|Hauser, R.A.|Mizuno, Y.|Haaksma, M.|Salin, L.|Juhel, N.|Schapira, A.H.V. Extended-release pramipexole in early Parkinson disease: A 33-week randomized controlled trial Neurology. 77(8) : 759-66, 2011.
  • Hauser RA. Future treatments for Parkinson’s disease: surfing the PD pipeline Int J Neurosci.. 2(121) : 53-62, 2011.
  • Hauser, Robert A. Future Treatments for Parkinson's Disease: Surfing the PD Pipeline International Journal of Neuroscience. 121(sup2) , 2011.
  • Gross RE, Watts RL, Hauser RA, Bakay RA, Reichmann H, von Kummer R, Ondo WG, Reissig E, Eisner W, Steiner-Schulze H, Siedentop H, Fichte K, Hong W, Cornfeldt M, Beebe K, Sandbrink R; the Spheramine Investigational Group. Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson''s disease: a double-blind, randomised, controlled trial Lancet Neurol. 6(10) : 509-519, 2011.
  • Gross, Robert E|Watts, Raymond L|Hauser, Robert A|Bakay, Roy AE|Reichmann, Heinz|von Kummer, Rüdiger|Ondo, William G|Reissig, Elke|Eisner, Wilhelm|Steiner-Schulze, Heike|Siedentop, Harald|Fichte, Klaus|Hong, Walter|Cornfeldt, Michael|Beebe, Katherine|Sandbrink, Rupert Intrastriatal transplantation of microcarrier-bound human retinal pigment epithelial cells versus sham surgery in patients with advanced Parkinson's disease: a double-blind, randomised, controlled trial Lancet Neurology [14744422]. 10(6) , 2011.
  • Hauser, Robert A.|Reichmann, Heinz|Lew, Mark|Asgharian, Afsaneh|Makumi, Clare|Shulman, Kenneth J. Long-term, Open-label Study of Once-daily Ropinirole Prolonged Release in Early Parkinson's Disease International Journal of Neuroscience. 121(5) , 2011.
  • Hauser RA, Reichmann H, Lew M, Asgharian A, Makumi C, Shulman KJ. Long-term, Open-label Study of Once-daily Ropinirole Prolonged Release in Early Parkinson''s Disease. Int J Neurosci. 5(121) : 246-53, 2011.
  • Sampaio, Cristina|Bronzova, Juliana|Hauser, Robert A.|Lang, Anthony E.|Rascol, Olivier|van de Witte, Serge V.|Theeuwes, and Ad Pardoprunox in early Parkinson's disease: Results from 2 large, randomized double‐blind trials Movement Disorders. 26(8) , 2011.
  • Sampaio C, Bronzova J, Hauser RA, Lang AE, Rascol O, van de Witte SV, Theeuwes AA; for the Rembrandt/Vermeer Study Groups. Pardoprunox in early Parkinson''s disease: Results from 2 large, randomized double-blind trials. Mov Disord. 8(26) : 1464-76, 2011.
  • Hauser, Robert A|Cantillon, Marc|Pourcher, Emmanuelle|Micheli, Federico|Mok, Vincent|Onofrj, Marco|Huyck, Susan|Wolski, Kenneth Preladenant in patients with Parkinson's disease and motor fluctuations: a phase 2, double-blind, randomised trial Lancet Neurology. 10(3) , 2011.
  • Elmer, Lawrence|Hauser, Robert A Strategies for Parkinson’s disease care: prevention and management of motor fluctuations Neurodegenerative Disease Management [17582024]. 1(5) , 2011.
  • Marek, Kenneth|Jennings, Danna|Lasch, Shirley|Siderowf, Andrew|Tanner, Caroline|Simuni, Tanya|Coffey, Chris|Kieburtz, Karl|Flagg, Emily|Chowdhury, Sohini|Poewe, Werner|Mollenhauer, Brit|Klinik, Paracelsus-Elena|Sherer, Todd|Frasier, Mark|Meunier, Claire|Rudolph, Alice|Casaceli, Cindy|Seibyl, John|Mendick, Susan|Schuff, Norbert|Zhang, Ying|Toga, Arthur|Crawford, Karen|Ansbach, Alison|De Blasio, Pasquale|Piovella, Michele|Trojanowski, John|Shaw, Les|Singleton, Andrew|Hawkins, Keith|Eberling, Jamie|Brooks, Deborah|Russell, David|Leary, Laura|Factor, Stewart|Sommerfeld, Barbara|Hogarth, Penelope|Pighetti, Emily|Williams, Karen|Standaert, David|Guthrie, Stephanie|Hauser, Robert|Delgado, Holly|Jankovic, Joseph|Hunter, Christine|Stern, Matthew|Tran, Baochan|Leverenz, Jim|Baca, Marne|Frank, Sam|Thomas, Cathi-Ann|Richard, Irene|Deeley, Cheryl|Rees, Linda|Sprenger, Fabienne|Lang, Elisabeth|Shill, Holly|Obradov, Sanja|Fernandez, Hubert|Winters, Adrienna|Berg, Daniela|Gauss, Katharina|Galasko, Douglas|Fontaine, Deborah|Mari, Zoltan|Gerstenhaber, Melissa|Brooks, David|Malloy, Sophie|Barone, Paolo|Longo, Katia|Comery, Tom|Ravina, Bernard|Grachev, Igor|Gallagher, Kim|Collins, Michelle|Widnell, Katherine L.|Ostrowizki, Suzanne|Fontoura, Paulo|Ho, Tony|Luthman, Johan|Brug, Marcel van der|Reith, Alastair D.|Taylor, Peggy The Parkinson Progression Marker Initiative (PPMI) Progress in Neurobiology [03010082]. 95(4) , 2011.
  • Antonini, Angelo|Martinez‐Martin, Pablo|Chaudhuri, Ray K.|Merello, Marcelo|Hauser, Robert|Katzenschlager, Regina|Odin, Per|Stacy, Mark|Stocchi, Fabrizio|Poewe, Werner|Rascol, Oliver|Sampaio, Cristina|Schrag, Anette|Stebbins, Glenn T.|Goetz, Christopher G. Wearing‐off scales in Parkinson's disease: Critique and recommendations Movement Disorders. 26(12) , 2011.
  • Hauser RA, Schapira AH, Rascol O, Barone P, Mizuno Y, Salin L, Haaksma M, Juhel N, Poewe W. Randomized, double-blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson''s disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25(15) : 2542-9, 2010.
  • Rascol O, Barone P, Hauser RA, Mizuno Y, Poewe W, Schapira AH, Salin L, Sohr M, Debieuvre C. Efficacy, safety, and tolerability of overnight switching from immediate- to once daily extended-release pramipexole in early Parkinson''s disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25(14) : 2326-32, 2010.
  • Colosimo C, Martínez-Martín P, Fabbrini G, Hauser RA, Merello M, Miyasaki J, Poewe W, Sampaio C, Rascol O, Stebbins GT, Schrag A, Goetz CG. Task force report on scales to assess dyskinesia in Parkinson''s disease: critique and recommendations. Movement Disorders : Official Journal of the Movement Disorder Society. 25(9) : 1131-42, 2010.
  • Lew MF, Hauser RA, Hurtig HI, Ondo WG, Wojcieszek J, Goren T, Fitzer-Attas CJ. Long-term efficacy of rasagiline in early Parkinson''s disease. The International Journal of neuroscience. 120(6) : 404-8, 2010.
  • Hersh BP, Earl NL, Hauser RA, Stacy M. Early treatment benefits of ropinirole prolonged release in Parkinson''s disease patients with motor fluctuations. Movement Disorders : Official Journal of the Movement Disorder Society. 25(7) : 927-31, 2010.
  • Watts RL, Lyons KE, Pahwa R, Sethi K, Stern M, Hauser RA, Olanow W, Gray AM, Adams B, Earl NL. Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson''s disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25(7) : 858-66, 2010.
  • Bronzova J, Sampaio C, Hauser RA, Lang AE, Rascol O, Theeuwes A, van de Witte SV, van Scharrenburg G. Double-blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson''s disease. Movement Disorders : Official Journal of the Movement Disorder Society. 25(6) : 730-8, 2010.
  • Hauser RA. Early pharmacologic treatment in Parkinson''s disease. The American Journal of Managed Care. 16: S100-7, 2010.
  • Bronzova, Juliana|Sampaio, Cristina|Hauser, Robert A.|Lang, Anthony E.|Rascol, Olivier|Theeuwes, Ad|van de Witte, Serge V.|van Scharrenburg, Guus Double‐blind study of pardoprunox, a new partial dopamine agonist, in early Parkinson's disease Movement Disorders. 25(6) , 2010.
  • Hersh, Bonnie P.|Earl, Nancy L.|Hauser, Robert A.|Stacy, Mark Early treatment benefits of ropinirole prolonged release in Parkinson's disease patients with motor fluctuations Movement Disorders. 25(7) , 2010.
  • Rascol, Olivier|Barone, Paolo|Hauser, Robert A.|Mizuno, Yoshikuni|Poewe, Werner|Schapira, Anthony H.V.|Salin, Laurence|Sohr, Mandy|Debieuvre, Catherine Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease Movement Disorders. 25(14) , 2010.
  • Lew, Mark F.|Hauser, Robert A.|Hurtig, Howard I.|Ondo, William G.|Wojcieszek, Joanne|Goren, Tamar|Fitzer-Attas, Cheryl J. Long-Term Efficacy of Rasagiline in Early Parkinson's Disease International Journal of Neuroscience. 120(6) , 2010.
  • Watts, Ray L.|Lyons, Kelly E.|Pahwa, Rajesh|Sethi, Kapil|Stern, Matthew|Hauser, Robert A.|Olanow, Warren|Gray, Alex M.|Adams, Bryan|Earl, Nancy L. Onset of dyskinesia with adjunct ropinirole prolonged-release or additional levodopa in early Parkinson's disease Movement Disorders. 25(7) , 2010.
  • Lyons, Kelly E.|Friedman, Joseph H.|Hermanowicz, Neal|Isaacson, Stuart H.|Hauser, Robert A.|Hersh, Bonnie P.|Silver, Dee E.|Tetrud, James W.|Elmer, Lawrence W.|Parashos, Sotirios A.|Struck, Lynn K.|Lew, Mark F.|Pahwa, Rajesh Orally Disintegrating Selegiline in Parkinson Patients With Dopamine Agonist-Related Adverse Effects Clinical Neuropharmacology. 33(1) , 2010.
  • Lyons KE, Friedman JH, Hermanowicz N, Isaacson SH, Hauser RA, Hersh BP, Silver DE, Tetrud JW, Elmer LW, Parashos SA, Struck LK, Lew MF, Pahwa R. Orally disintegrating selegiline in Parkinson patients with dopamine agonist-related adverse effects. Clinical Neuropharmacology. 33(1) : 5-10, 2010.
  • Hauser, Robert A.|Schapira, Anthony H.V.|Rascol, Olivier|Barone, Paolo|Mizuno, Yoshikuni|Salin, Laurence|Haaksma, Monika|Juhel, Nolwenn|Poewe, Werner Randomized, double‐blind, multicenter evaluation of pramipexole extended release once daily in early Parkinson's disease Movement Disorders. 25(15) , 2010.
  • Hauser, Robert A.|Lyons, Kelly E. Reply: Intravenous glutathione in Parkinson's disease Movement Disorders. 25(7) , 2010.
  • Colosimo, Carlo|Martínez‐Martín, Pablo|Fabbrini, Giovanni|Hauser, Robert A.|Merello, Marcelo|Miyasaki, Janis|Poewe, Werner|Sampaio, Cristina|Rascol, Olivier|Stebbins, Glenn T.|Schrag, Anette|Goetz, Christopher G. Task force report on scales to assess dyskinesia in Parkinson's disease: Critique and recommendations Movement Disorders. 25(9) , 2010.
  • Butterfield, London C.|Cimino, Cynthia R.|Oelke, Lynn E.|Hauser, Robert A.|Sanchez-Ramos, Juan The independent influence of apathy and depression on cognitive functioning in Parkinson's disease. Neuropsychology. 24(6) , 2010.
  • Butterfield LC, Cimino CR, Oelke LE, Hauser RA, Sanchez-Ramos J. The independent influence of apathy and depression on cognitive functioning in Parkinson''s disease. Neuropsychology. 6(24) : 721-30, 2010.
  • Hauser RA, Auinger P, Oakes D. Levodopa response in early Parkinson''s disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24(16) : 2328-36, 2009.
  • Hauser RA. New considerations in the medical management of early Parkinson''s disease: impact of recent clinical trials on treatment strategy. Parkinsonism & Related Disorders. 15: S17-21, 2009.
  • Isaacson SH, Hauser RA. Improving symptom control in early Parkinson''s disease. Therapeutic advances in neurological disorders. 2(6) : 29-41, 2009.
  • Tanner CM, Ross GW, Jewell SA, Hauser RA, Jankovic J, Factor SA, Bressman S, Deligtisch A, Marras C, Lyons KE, Bhudhikanok GS, Roucoux DF, Meng C, Abbott RD, Langston JW. Occupation and risk of parkinsonism: a multicenter case-control study. Archives of Neurology. 66(9) : 1106-13, 2009.
  • Seeberger LC, Hauser RA. Levodopa/carbidopa/entacapone in Parkinson''s disease. Expert Review of Neurotherapeutics. 9(7) : 929-40, 2009.
  • Cicchetti F, Saporta S, Hauser RA, Parent M, Saint-Pierre M, Sanberg PR, Li XJ, Parker JR, Chu Y, Mufson EJ, Kordower JH, Freeman TB. Neural transplants in patients with Huntington''s disease undergo disease-like neuronal degeneration. Proceedings of the National Academy of Sciences of the United States of America. 106(30) : 12483-8, 2009.
  • Connors JJ, Sacks D, Furlan AJ, Selman WR, Russell EJ, Stieg PE, Hadley MN, Wojak JC, Koroshetz WJ, Heros RC, Strother CM, Duckwiler GR, Durham JD, Tom-sick TO, Rosenwasser RH, McDougall CG, Haughton VM, Derdeyn CP, Wechsler LR, Hudgins PA, Alberts MJ, Raabe RD, Gomez CR, Cawley CM, Krol KL, Futrell N, Hauser RA, Frank JI. Training, competency, and credentialing standards for diagnostic cervicocerebral angiography, carotid stenting, and cerebrovascular intervention: a joint statement from the American Academy of Neurology, the American Association of Neurological Surgeons, the American Society of Interventional and Therapeutic Neuroradiology, the American Society of Neuroradiology, the Congress of Neurological Surgeons, the AANS/CNS Cerebrovascular Section, and the Society of Interventional Radiology. Journal of vascular and interventional radiology : JVIR. 20(7 Suppl) : S292-301, 2009.
  • Hauser RA, Lyons KE, McClain T, Carter S, Perlmutter D. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson''s disease. Movement disorders : official journal of the Movement Disorder Society. 24(7) : 979-83, 2009.
  • Hauser RA, Panisset M, Abbruzzese G, Mancione L, Dronamraju N, Kakarieka A. Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson''s disease. Movement Disorders : Official Journal of the Movement Disorder Society. 24(4) : 541-50, 2009.
  • Hauser RA, Lew MF, Hurtig HI, Ondo WG, Wojcieszek J, Fitzer-Attas CJ. Long-term outcome of early versus delayed rasagiline treatment in early Parkinson''s disease. Movement disorders : official journal of the Movement Disorder Society. 24(4) : 564-73, 2009.
  • Olanow, C. Warren|Rascol, Olivier|Hauser, Robert|Feigin, Paul D.|Jankovic, Joseph|Lang, Anthony|Langston, William|Melamed, Eldad|Poewe, Werner|Stocchi, Fabrizio|Tolosa, Eduardo A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease New England Journal of Medicine. 361(13) , 2009.
  • Snyder, Evan Y.|Acosta, S. A.|Jernberg, J.|Cole, M.|Schlunk, A.|Shytle, R. D.|Tan, J.|Sanberg, C.|Sanberg, P.|Gemma, G.|Bickford, P. C.|Airavaara, M.|Harvey, B.|Chiocco, M.|Howard, D.|Peränen, J.|Saarma, M.|Wang, Y.|Hoffer, B.|Andres, R. H.|Pendharkar, A. V.|Guzman, R.|De, A.|Bliss, T. M.|McMillan, E.|Svendsen, C. N.|Gambhir, S. S.|Widmer, H. R.|Wallimann, T.|Steinberg, G. K.|Bachstetter, A. D.|Jernberg, J.|Schlunk, A.|Hudson, C. E.|Bickford, P. C.|Gemma, C.|Baek, S.-H.|Kim, E.-K.|Lee, H.|Park, S. K.|Lookingland, K. J.|Goudreau, J. L.|Kim, S. W.|Yu, and S.-W.|Behrouz, B.|Lookingland, K.|Goudreau, J.|Berk, M. A.|Salli, U.|Ramachandra, R.|Venkiteswaran, K.|Subramanian, and T.|Bernal, G. M.|Peterson, D. A.|Bjugstad, K. B.|Lampe, K.|Kern, D. S.|Mahoney, M.|Bobek, V.|Kolostova, K.|Pinterova, D.|Boubelik, M.|Raska, O.|Rokyta, R.|Jirkovska, M.|Boger, H. A.|Middaugh, L. D.|Granholm, A.-Ch.|Chermenina, M.|Nevalainen, N.|Marschinke, F.|Rehnmark, A.|Berglöf, E.|Strömberg, I.|Cicchetti, F.|Saporta, S.|Hauser, R. A.|Parent, M.|Saint-Pierre, M.|Sanberg, P. R.|Li, X. J.|Parker, J. R.|Chu, Y.|Mufson, E. J.|Kordower, J. H.|Freeman, T. B.|Collado, L. M.|Collado, M. E.|Hama, A.|Gajavelli, S.|Sagen, J.|Daadi, M. M.|Arac, A.|Li, Z.|Sun, G.|Wu, J. C.|Steinberg, G. K.|Dodiya, H. B.|Kirik, D.|Mandel, R.|Stansell, III, J.|Björklund, A.|Kordower, J. H.|Emborg, E. M.|Johnson, J.|Swanson, C.|Dobbert, M.|Joers, V.|Brunner, K.|Kemnitz, J.|Ziegler, T.|Eve, D. J.|Musso, III, J.|Park, D.-H.|Bui, V.|Smith, A.|Cameron, D.|Oliveira, C.|Pollock, K.|Hope, A.|Baradez, M.-O.|Sinden, J. D.|Sanberg, P. R.|Federici, T.|Raore, B.|Taub, J.|Johe, K.|Boulis, N.|Fortress, A. M.|Helke, K. L.|Granholm, L.|Freeman, L.|Granholm, A.-Ch.|Garbuzova-Davis, S.|Xie, Y.|Zayko, O.|Sanberg, and P. R.|Ghosh, M.|Tuesta, L. M.|Puentes, R.|Monaco, B.|El Maarouf, A.|Rutishauser, U.|Pearse, D. D.|Golshani, R.|Savant-Bhonsale, S.|Tuesta, L. M.|Louro, J.|Wilson, T.|Patel, S.|Pearse, D. D.|Gombash, S. E.|Cole-Strauss, A.|Lipton, J. W.|Collier, T. J.|Steece-Collier, K.|Terpstra, B. T.|Spieles-Engemann, A. L.|Daley, B. F.|Wohlgenant, S. L.|Thompson, V. B.|Mandel, R. J.|Manfredsson, F.|Sortwell, C. E.|Gorenkova, N.|Franco, C.|Hassani, Z.|Price, J.|West, J.|Modo, M.|Granholm, A.-Ch.|Fortress, A.|Lockrow, J.|Moore, A.|Williams, B.|Helke, K.|Buhusil, M.|Hallett, P. J.|Vinuela, A.|Licznerski, P.|Sotnikova, T. D.|Caron, M. G.|Gainetdinov, R. R.|Isacson, O.|Harvey, B. K.|Chou, J.|Shen, H.|Chiang, Y. H.|Hoffer, B. J.|Wang, Y.|Hayashi, T.|Kaneko, Y.|Yu, S. J.|Parolini, O.|Borlongan, C. V.|Hess, D. C.|Deans, R. J.|Mays, R. W.|Jain, A.|Henao, H.|Puentes, R.|Bleicher, D.|Maggio, D.|Pearse, and D. D.|Jensen, P.|Meyer, M.|Ducray, A. D.|Widmer, H. R.|Jergova, S.|Collado, L.|Collado, M.|Varghese, M.|Furmanski, O.|Hama, A.|Gajavelli, S.|Sagen, J.|Jinwal, U. K.|Miyata, Y.|Koren, III, J.|Jones, J. R.|Trotter, J. H.|Chang, L.|O'Leary, L.|Morgan, D.|Lee, D. C.|Shults, C. L.|Rousaki, A.|Weeber, E. J.|Zuiderweg, E. R. P.|Gestwicki, J. E.|Dickey, C. A.|Johansson, S.|Vernon, A. C.|Price, J.|Modo, M.|Kelly, L.|Newman, M.|Smith, A.|Bakay, R.|Khaing, Z. Z.|Seidlits, S. K.|Rosenberger, R. R.|Vanscoy, J. E.|Schmidt, C. E.|Khaing, Z. Z.|Vanscoy, J. E.|Seidlits, S. K.|Grill, R. J.|Schmidt, C. E.|Kuruba, R.|Hattiangady, B.|Shuai, B.|Shetty, A. K.|Lee, C.-T.|Chen, J.|Errico, S.|Worden, L. T.|Amable, R.|Freed, W. J.|Lee, D. C.|Lebson, L.|Rizer, J.|Ruiz, C.|Rojiani, R.|Gordon, M. N.|Morgan, D.|Lieu, C. A.|Marupudi, N. I.|Berk, M. A.|Ramachandra, R.|Subramanian, T.|Li, Q.|Gordon, M. N.|Chackerian, B.|Alamed, J.|Ugen, K. E.|Morgan, D.|Luo, Y.|Kuo, C.-C.|Shen, H.|Chou, J.|Greig, N. H.|Hoffer, B. J.|Wang, Y.|Ma, B.-F.|Xue, Y.-Q.|Zhao, L.-R.|Duan, W.-M.|Macklis, J. D.|Madhavan, L.|Daley, B. F.|Paumier, K. L.|Collier, T. J.|Maksoud, Y. A.|Manfredsson, F. P.|Rising, A.|Burger, C.|Hasona, K.|Muzyczka, N.|Mandel, R. J.|Manfredsson, F. P.|Tumer, N.|Erdos, B.|Landa, T.|Broxson, C. S.|Sullivan, L. F.|Rising, A. C.|Foust, K. D.|Zhang, Y.|Muzyczka, N.|Gorbatyuk, O. S.|Scarpace, P. J.|Mandel, R. J.|Marschinke, F.|Oldenborg, P.-A.|Strömberg, I.|Marupudi, N. I.|Lieu, C.|Tombran-Tink, J.|Ramachandra, R.|Subramanian, T.|Mervis, R. F.|Kotick, J.|Shah, M.|Winkler, A.|Kasimos, K.|Joshi, S.|Scheff, S.|Mufson, E. J.|Miller, C.|Sanberg, P. R.|Kuzmin-Nichols, N.|Sanberg, C. D.|Garbuzova-Davis, S.|Monahan, A. J.|Ling, Z.|Carvey, P. M.|Moradian, S.|Pick, C. G.|Rubovitch, V.|Kaminsky, J.|Mervis, R. F.|Musso, III, J.|Eve, D. J.|Park, D.-H.|Oliveria, C.|Pollick, K.|Hope, A.|Baradez, M.-O.|Sinden, J. D.|Sanberg, P. R.|Neckel, N. D.|Nevalainen, N.|af Bjerkén, S.|Gerhardt, G.|Strömberg, I.|Newman, M. B.|Smith, A. P.|Kelly, L. P.|Bakay, R. A. E.|Nguyen, T.|Hupalo, N.|Jimenez, J.|Morgan, D.|Alcantar, N.|Nikas, J. B.|Low, W. C.|Pabn, M. M.|Hudson, C. E.|Jernberg, J.|Bachstetter, A.|Acosta, S. A.|Gemma, C.|Klein, R.|Bickford, P. C.|Parihar, V. K.|Shuai, B.|Hattiangady, B.|Kuruba, R.|Shetty, A. K.|Park, D.-H.|Eve, D. J.|Musso, III, J.|Gemma, C.|Bachstetter, A. D.|Wolfson, A.|Schlunk, A.|Baradez, M.-O.|Sinden, J. D.|Sanberg, P. R.|Pendharkar, A. V.|De, A.|Wang, H.|Gaeta, X.|Wang, N.|Andres, R. H.|Chen, X.|Gambhir, S. S.|Guzman, R.|Piao, C.-S.|Zhao, L.-R.|Priest, C.|Davies, A.|Wirth, E.|Conta, A.|Polonskaya, Y.|Polonskowski, J.|Rachubinski, A.|Cornelius, S. K.|Maclean, K. N.|Bjugstad, K. B.|Rehnmark, A.|Bickford, P. C.|Strömberg, I.|Ross, J. M.|Brené, S.|berg, J.|Sitnikov, R.|Pernold, K.|Terzioglu, M.|Trifunovic, A.|Kehr, J.|Larsson, N.-G.|Hoffer, B. J.|Olson, L.|Rossignol, J.|Boyer, C.|Lévque, X.|Dunbar, G. L.|Lescaudron, L.|Sanchez-Ramos, J.|Song, S.|Mori, T.|Patel, N.|Cao, C.|Arendash, G.|Selenica, M.-L. B.|Dickey, C.|Gordon, M.|Morgan, D.|Shahaduzzaman, S. D.|Golden, J. E.|Green, S. M.|Womble, T.|Sanberg, P. R.|Pennypacker, K. R.|Willing, A. E.|Sinden, J.|Singec, I.|Snyder, E. Y.|Sladek, Jr., J. R.|Elsworth, J. D.|Roth, R. H.|Leranth, C.|Collier, T. J.|Bjugstad, K. B.|Blanchard, B. C.|Samulski, R. J.|Aebischer, P.|Redmond, Jr., D. E.|Smith, A. J.|Shytle, R. D.|Tan, J.|Bickford, P. C.|Rezai-zadeh, K.|Hou, L.|Zeng, J.|Sanberg, P. R.|Sanberg, C. D.|Roschek, Jr., B.|Fink, R. C.|Albert, R. S.|Spieles-Engemann, A. L.|Behbehani, M. M.|Collier, T. J.|Steece-Collier, K.|Wohlgenant, S. L.|Thompson, V. B.|Lipton, J. W.|Sortwell, C. E.|Spieles-Engemann, A. M.|Behbehani, M. M.|Collier, T. J.|Wohlgenant, S. L.|Mandybur, G. T.|Lipton, J. W.|Terpstra, B. T.|Sortwell, C. E.|Steece-Collier, K.|Soderstrom, K.|O'Malley, J.|Stancati, J.|Levine, N.|Sortwell, C.|Lipton, J.|Collier, T.|Stoner, S.|Sanberg, P. R.|Garbuzova-Davis, S.|Strömberg, I.|Marscinke, F.|Nevalainen, N.|Chermenina, M.|Rehnmark, A.|Berglöf, E.|af Bjerkén, S.|Teng, Y. D.|Yu, D.|Benedict, D. E.|Wilhelmsson, U.|Pekny, and M.|Thompson, V. B.|Sortwell, C. E.|Collier, T. J.|Steece-Collier, K.|Lipton, J. W.|Timmer, M.|Winkler, C.|Klein, A.|Sauter, J.|Oertel, W.|Nikkhah, G.|Vazin, T.|Becker, K. G.|Chen, J.|Zhang, Y.|Worden, L.|Freed, W. J.|Vorobyeva, T. M.|Berchenko, O. G.|Gejko, V. V.|Storchak, E. O.|Titkova, A. M.|Kolyadko, S. P.|Wakeman, D. R.|Redmond, Jr., D. E.|Sladek, Jr., J. R.|Snyder, E. Y.|Walczak, P.|Gorelik, M.|Levy, M.|Rumpal, N.|Rifkin, R.|Muja, N.|Kim, H.|Kerr, D. A.|Bulte, J. W. M.|Wang, L.|Shi, J.|van Ginkel, F. W.|Lan, L.|Niemeyer, G.|Martin, D. R.|Snyder, E. Y.|Cox, N. R.|Womble, T. A.|Green, S. M.|Nelson, A. P.|Shahaduzzaman, M. D.|Golden, J. E.|Sanberg, P. R.|Pennypacker, K. R.|Willing, A. E.|Woods, III, R. L.|Louis, M. K.|Zesiewicz, T.|Xie, Y.|Sullivan, K. L.|Miller, A. M.|Kuzmin-Nichols, N.|Sanberg, P. R.|Garbuzova-Davis, S.|Worden, L. T.|Lee, C.-T.|Freed, W. J.|Yu, S.|Hayashi, T.|Kaneko, Y.|Bae, E.|Stahl, C. E.|Wang, Y.|Borlongan, C. V.|Zhu, Y.|Oregon, D.|Hou, H.|Luo, D.|Mori, T.|Giunta, B.|Zhao, Y.|Town, T.|Tan, J. Abstracts for the 16th Annual Meeting of the American Society for Neural Therapy and Repair Cell Transplantation [09636897]. 18(2) , 2009.
  • Jenner, P.|Mori, A.|Hauser, R.|Morelli, M.|Fredholm, B.B.|Chen, J.F. Adenosine, adenosine A2A antagonists, and Parkinson's disease Parkinsonism and Related Disorders. 15(6) , 2009.
  • Hauser, Robert A.|Panisset, Michel|Abbruzzese, Giovanni|Mancione, Linda|Dronamraju, Nalina|Kakarieka, Algirdas Double‐blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease Movement Disorders. 24(4) , 2009.
  • Zesiewicz, Theresa A.|Hauser, Robert A.|Freeman, Alan|Sullivan, Kelly L.|Miller, Amber M.|Halim, Tariq Fentanyl-Induced Bradykinesia and Rigidity After Deep Brain Stimulation in a Patient With Parkinson Disease Clinical Neuropharmacology. 32(1) , 2009.
  • Zesiewicz TA, Hauser RA, Freeman A, Sullivan KL, Miller AM, Halim T. Fentanyl-induced bradykinesia and rigidity after deep brain stimulation in a patient with Parkinson disease. Clinical neuropharmacology. 32(1) : 48-50, 2009.
  • Cobb, Stephanie A.|Wider, Christian|Ross, Owen A.|Mata, Ignacio F.|Adler, Charles H.|Rajput, Alex|Rajput, Ali H.|Wu, Ruey-Meei|Hauser, Robert|Josephs, Keith A.|Carr, Jonathan|Gwinn, Katrina|Heckman, Michael G.|Aasly, Jan O.|Lynch, Timothy|Uitti, Ryan J.|Wszolek, Zbigniew K.|Kapatos, Gregory|Farrer, Matthew J. GCH1 in early‐onset Parkinson's disease Movement Disorders. 24(14) , 2009.
  • Hauser, Robert A.|Auinger, Peggy|Oakes, David Levodopa response in early Parkinson's disease Movement Disorders. 24(16) , 2009.
  • Sethi KD, Hauser RA, Isaacson SH, McClain T. Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo 200) in the treatment of Parkinson''s disease: a case series. Cases Journal. 2: 7134, 2009.
  • Sethi, Kapil D|Hauser, Robert A|Isaacson, Stuart H|McClain, Terry Levodopa/carbidopa/entacapone 200/50/200 mg (Stalevo® 200) in the treatment of Parkinson's disease: a case series Cases Journal [17571626]. 2(1) , 2009.
  • Seeberger, Lauren C|Hauser, Robert A Levodopa/carbidopa/entacapone in Parkinson’s disease Expert Review of Neurotherapeutics. 9(7) , 2009.
  • Hauser RA. Levodopa: past, present, and future. European neurology. 62(1) : 1-8, 2009.
  • Hauser, Robert A.|Lew, Mark F.|Hurtig, Howard I.|Ondo, William G.|Wojcieszek, Joanne|Fitzer‐Attas, Cheryl J. Long‐term outcome of early versus delayed rasagiline treatment in early Parkinson's disease Movement Disorders. 24(4) , 2009.
  • Saint-Pierre, M.|Cicchetti, F.|Sanberg, P. R.|Freeman, T. B.|Parker, J. R.|Saporta, S.|Parent, M.|Mufson, E. J.|Kordower, J. H.|Chu, Y.|Li, X. J.|Hauser, R. A. Neural transplants in patients with Huntington's disease undergo disease-like neuronal degeneration Proceedings of the National Academy of Sciences of the United States of America. 106(30) , 2009.
  • Hauser, Robert A. New considerations in the medical management of early Parkinson's disease: Impact of recent clinical trials on treatment strategy Parkinsonism and Related Disorders. 15, 2009.
  • Hauser, R. O.076 Medical management of early Parkinson's disease Parkinsonism and Related Disorders. 15, 2009.
  • Tanner, Caroline M.|Ross, G. Webster|Jewell, Sarah A.|Hauser, Robert A.|Jankovic, Joseph|Factor, Stewart A.|Bressman, Susan|Deligtisch, Amanda|Marras, Connie|Lyons, Kelly E.|Bhudhikanok, Grace S.|Roucoux, Diana F.|Meng, Cheryl|Abbott, Robert D.|Langston, J. William Occupation and Risk of Parkinsonism: A Multicenter Case-Control Study Archives of Neurology [00039942]. 66(9) , 2009.
  • Cicchetti, F.|Saporta, S.|Hauser, R.|Parent, M.|Saint-Pierre, M.|Sanberg, P.|Li, X.-J.|Parker, J.|Chu, Y.|Mufson, E.|Kordower, J.|Freeman, T. P1.016 Neural transplants in patients with Huntington's disease undergo disease-speciflc neuronal degeneration Parkinsonism and Related Disorders. 15, 2009.
  • Hauser, R.A.|Pourcher, E.|Micheli, F.|Mok, V.|Onofrj, M.|Huyck, S.B.|Wolski, K.P.|Cantillon, M. P2.101 Efflcacy and safety of preladenant, a novel A2A receptor antagonist, as a levodopa adjunct in patients with moderate-to-severe Parkinson's disease Parkinsonism and Related Disorders. 15, 2009.
  • Hauser, R.A.|Gertner, J.M.|Okamoto, M.|Reed, R.F.|Sage, J.I. P2.109 Piclozotan reduces dyskinesia and OFF time in Parkinson's disease (PD) patients with L-dopa induced motor complications Parkinsonism and Related Disorders. 15, 2009.
  • Hauser, R.A.|Hunter, B.|Rolfe, K.|Giorgi, L. P2.132 Long-term safety and patient preference for dose frequency in patients receiving ropinirole prolonged release in early or advanced Parkinson's disease Parkinsonism and Related Disorders. 15, 2009.
  • Ellenbogen, A.|Hauser, R.|Omidvar, O.|Hsu, A.|O'Connell, M.|Kell, S.|Gupta, S. P2.136 Comparative efflcacy and safety of a novel carbidopa–levodopa product (IPX066) and Sinemet in advanced Parkinson's disease Parkinsonism and Related Disorders. 15, 2009.
  • Poewe, W.|Barone, P.|Hauser, R.|Mizuno, Y.|Rascol, O.|Schapira, A.|Haaksma, M.|Juhel, N.|Salin, L. P2.153 Once-daily pramipexole extended-release (ER) demonstrated non-inferiority compared to immediate release (IR) tid dosing in early Parkinson's disease Parkinsonism and Related Disorders. 15, 2009.
  • Rascol, O.|Barone, P.|Hauser, R.|Mizuno, Y.|Poewe, W.|Schapira, A.|Debieuvre, C.|Sohr, M.|Salin, L. P2.155 Simple overnight switching from immediate- to extended-release pramipexole in early Parkinson's disease at the same daily dosage Parkinsonism and Related Disorders. 15, 2009.
  • Schapira, A.|Barone, P.|Hauser, R.|Mizuno, Y.|Poewe, W.|Rascol, O.|Busse, M.|Juhel, N.|Salin, L. P2.159 Efflcacy and safety of once-daily (qd) pramipexole extended-release for advanced Parkinson's disease Parkinsonism and Related Disorders. 15, 2009.
  • Stocchi, F.|Hunter, B.|Giorgi, L.|Hauser, R.A. P2.165 Dose-related decrease in “off” time with ropinirole prolonged release in patients with advanced Parkinson's disease Parkinsonism and Related Disorders. 15, 2009.
  • Hauser, Robert A.|Lyons, Kelly E.|McClain, Terry|Carter, Summer|Perlmutter, David Randomized, double‐blind, pilot evaluation of intravenous glutathione in Parkinson's disease Movement Disorders. 24(7) , 2009.
  • Isaacson, Stuart H.|Hauser, Robert A. Review: Improving symptom control in early Parkinson’s disease Therapeutic Advances in Neurological Disorders. 2(6) , 2009.
  • Hauser, R.A.|Bronzova, J.|Sampaio, C.|Lang, A.E.|Rascol, O.|Theeuwes, A.|van de Witte, S.V. Safety and Tolerability of Pardoprunox, a New Partial Dopamine Agonist, in a Randomized, Controlled Study of Patients with Advanced Parkinson’s Disease European Neurology. 62(1) , 2009.
  • Hauser RA, Bronzova J, Sampaio C, Lang AE, Rascol O, Theeuwes A, van de Witte SV. Safety and tolerability of pardoprunox, a new partial dopamine agonist, in a randomized, controlled study of patients with advanced Parkinson''s disease. European neurology. 62(1) : 40-8, 2009.
  • Jahan I, Hauser RA, Sullivan KL, Miller A, Zesiewicz TA. Sleep disorders in Parkinson''s disease. Neuropsychiatric Disease and treatment. 5: 535-40, 2009.
  • Simuni, Tanya|Lyons, Kelly E.|Pahwa, Rajesh|Hauser, Robert A.|Comella, Cynthia|Elmer, Lawrence|Weintraub, Daniel Treatment of Early Parkinson’s Disease European Neurology. 61(4) , 2009.
  • Simuni T, Lyons KE, Pahwa R, Hauser RA, Comella C, Elmer L, Weintraub D. Treatment of early Parkinson''s disease. Part 1. European neurology. 61(4) : 193-205, 2009.
  • Simuni T, Lyons KE, Pahwa R, Hauser RA, Comella C, Elmer L, Weintraub D. Treatment of early Parkinson''s disease. Part 2. European neurology. 61(4) : 206-15, 2009.
  • Kordower JH, Chu Y, Hauser RA, Olanow CW, Freeman TB. Transplanted dopaminergic neurons develop PD pathologic changes: a second case report. Movement disorders : official journal of the Movement Disorder Society. 23(16) : 2303-6, 2008.
  • Olanow CW, Hauser RA, Jankovic J, Langston W, Lang A, Poewe W, Tolosa E, Stocchi F, Melamed E, Eyal E, Rascol O. A randomized, double-blind, placebo-controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson''s disease (the ADAGIO study): rationale, design, and baseline characteristics. Movement disorders : official journal of the Movement Disorder Society. 23(15) : 2194-201, 2008.
  • Hauser RA, Shulman LM, Trugman JM, Roberts JW, Mori A, Ballerini R, Sussman NM. Study of istradefylline in patients with Parkinson''s disease on levodopa with motor fluctuations. Movement disorders : official journal of the Movement Disorder Society. 23(15) : 2177-85, 2008.
  • Kordower JH, Chu Y, Hauser RA, Freeman TB, Olanow CW. Lewy body-like pathology in long-term embryonic nigral transplants in Parkinson''s disease. Nature medicine. 14(5) : 504-6, 2008.
  • Zesiewicz TA, Shimberg WR, Hauser RA, Robinson W, Wilson MC, Sullivan KL. Chorea as a side effect of gabapentin (Neurontin) in a patient with complex regional pain syndrome Type 1. Clinical rheumatology. 27(3) : 389-90, 2008.
  • Goetz CG, Wuu J, McDermott MP, Adler CH, Fahn S, Freed CR, Hauser RA, Olanow WC, Shoulson I, Tandon PK, Leurgans S. Placebo response in Parkinson''s disease: comparisons among 11 trials covering medical and surgical interventions. Movement disorders : official journal of the Movement Disorder Society. 23(5) : 690-9, 2008.
  • Olanow, C. Warren|Hauser, Robert A.|Jankovic, Joseph|Langston, William|Lang, Anthony|Poewe, Werner|Tolosa, Eduardo|Stocchi, Fabrizio|Melamed, Eldad|Eyal, Eli|Rascol, Olivier A randomized, double‐blind, placebo‐controlled, delayed start study to assess rasagiline as a disease modifying therapy in Parkinson's disease (the ADAGIO study): Rationale, design, and baseline characteristics Movement Disorders. 23(15) , 2008.
  • Simon, David K.|Swearingen, Christopher J.|Hauser, Robert A.|Trugman, Joel M.|Aminoff, Michael J.|Singer, Carlos|Truong, Daniel|Tilley, Barbara C. Caffeine and Progression of Parkinson Disease Clinical Neuropharmacology. 31(4) , 2008.
  • Simon DK, Swearingen CJ, Hauser RA, Trugman JM, Aminoff MJ, Singer C, Truong D, Tilley BC. Caffeine and progression of Parkinson disease. Clinical neuropharmacology. 31(4) : 189-96, 2008.
  • Zesiewicz, Theresa A.|Shimberg, W. Reed|Hauser, Robert A.|Robinson, Wendy|Wilson, Maria-Carmen|Sullivan, Kelly L. Chorea as a side effect of gabapentin (Neurontin®) in a patient with complex regional pain syndrome Type 1 Clinical Rheumatology [07703198]. 27(3) , 2008.
  • Zesiewicz, Theresa A.|Sullivan, Kelly L.|Hoffmann, Michael|Benes, Lourdes M.|Smith, Donald A.|Ward, Christopher L.|Hauser, Robert A. Delayed Thalamic Intracranial Hemorrhage in an Essential Tremor Patient following Deep Brain Stimulation European Neurology [00143022]. 59(3-4) , 2008.
  • Zesiewicz TA, Sullivan KL, Hoffmann M, Benes LM, Smith DA, Ward CL, Hauser RA. Delayed thalamic intracranial hemorrhage in an essential tremor patient following deep brain stimulation. European neurology. 59(3-4) : 187-9, 2008.
  • Shimberg, W. Reed|Patel, Neha B.|Sullivan, Kelly L.|Hauser, Robert A.|Zesiewicz, Theresa A. Levetiracetam for Stiff-Person Syndrome: Report of 2 Patients Clinical Neuropharmacology [03625664]. 31(5) , 2008.
  • Shimberg WR, Patel NB, Sullivan KL, Hauser RA, Zesiewicz TA. Levetiracetam for stiff-person syndrome: report of 2 patients. Clinical neuropharmacology. 31(5) : 301-2, 2008.
  • Hauser, Robert A. Levodopa: Past, Present, and Future European Neurology. 62(1) , 2008.
  • Encarnacion, Elmyra V.|Hauser, Robert A. Levodopa-Induced Dyskinesias in Parkinson’s Disease: Etiology, Impact on Quality of Life, and Treatments European Neurology. 60(2) , 2008.
  • Encarnacion EV, Hauser RA. Levodopa-induced dyskinesias in Parkinson''s disease: etiology, impact on quality of life, and treatments. European neurology. 60(2) : 57-66, 2008.
  • Kordower, Jeffrey H|Chu, Yaping|Hauser, Robert A|Freeman, Thomas B|Olanow, C Warren Lewy body–like pathology in long-term embryonic nigral transplants in Parkinson's disease Nature Medicine. 14(5) , 2008.
  • Freeman, Thomas B.|Chu, Yaping|Hauser, Robert|Olanow, Warren|Kordower, Jeffrey H. Parkinson's Disease Pathology in Nigral Grafts 14 Years after Transplantation: 865 Neurosurgery [0148396X]. 62(6) , 2008.
  • Goetz, Christopher G.|Wuu, Joanne|McDermott, Michael P.|Adler, Charles H.|Fahn, Stanley|Freed, Curt R.|Hauser, Robert A.|Olanow, Warren C.|Shoulson, Ira|Tandon, P.K.|Leurgans, Sue Placebo response in Parkinson's disease: Comparisons among 11 trials covering medical and surgical interventions Movement Disorders. 23(5) , 2008.
  • Hauser, Robert A.|Shulman, Lisa M.|Trugman, Joel M.|Roberts, John W.|Mori, Akihisa|Ballerini, Rocco|Sussman, Neil M. Study of istradefylline in patients with Parkinson's disease on levodopa with motor fluctuations Movement Disorders. 23(15) , 2008.
  • Kordower, Jeffrey H.|Chu, Yaping|Hauser, Robert A.|Olanow, C.Warren|Freeman, Thomas B. Transplanted dopaminergic neurons develop PD pathologic changes: A second case report Movement Disorders. 23(16) , 2008.
  • Seeberger LC, Hauser RA. Optimizing bioavailability in the treatment of Parkinson''s disease. Neuropharmacology. 53(7) : 791-800, 2007.
  • Sullivan KL, Ward CL, Hauser RA, Zesiewicz TA. Prevalence and treatment of non-motor symptoms in Parkinson''s disease. Parkinsonism & related disorders. 13(8) : 545, 2007.
  • Zesiewicz TA, Patel-Larson A, Hauser RA, Sullivan KL. Social Security Disability Insurance (SSDI) in Parkinson''s disease. Disability and rehabilitation. 29(24) : 1934-6, 2007.
  • Hauser RA, Rascol O, Korczyn AD, Jon Stoessl A, Watts RL, Poewe W, De Deyn PP, Lang AE. Ten-year follow-up of Parkinson''s disease patients randomized to initial therapy with ropinirole or levodopa. Movement disorders : official journal of the Movement Disorder Society. 22(16) : 2409-17, 2007.
  • Simonson W, Hauser RA, Schapira AH. Role of the pharmacist in the effective management of wearing-off in Parkinson''s disease. The Annals of pharmacotherapy. 41(11) : 1842-9, 2007.
  • Zesiewicz TA, Sullivan KL, Ward CL, Hauser RA. Tiagabine and exacerbation of essential tremor. Movement disorders : official journal of the Movement Disorder Society. 22(14) : 2132-3, 2007.
  • Zesiewicz TA, Ward CL, Hauser RA, Salemi JL, Siraj S, Wilson MC, Sullivan KL. A pilot, double-blind, placebo-controlled trial of pregabalin (Lyrica) in the treatment of essential tremor. Movement disorders : official journal of the Movement Disorder Society. 22(11) : 1660-3, 2007.
  • Zesiewicz TA, Sullivan KL, Hauser RA. Levodopa-induced dyskinesia in Parkinson''s disease: epidemiology, etiology, and treatment. Current neurology and neuroscience reports. 7(4) : 302-10, 2007.
  • Hauser RA, Zesiewicz TA. Advances in the pharmacologic management of early Parkinson disease. The neurologist. 13(3) : 126-32, 2007.
  • Samanta J, Hauser RA. Duodenal levodopa infusion for the treatment of Parkinson''s disease. Expert opinion on pharmacotherapy. 8(5) : 657-64, 2007.
  • Hauser RA, Salin L, Juhel N, Konyago VL. Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson''s disease. Movement disorders : official journal of the Movement Disorder Society. 22(3) : 359-65, 2007.
  • Zesiewicz TA, Ward CL, Hauser RA, Sanchez-Ramos J, Staffetti JF, Sullivan KL. A double-blind placebo-controlled trial of zonisamide (zonegran) in the treatment of essential tremor. Movement disorders : official journal of the Movement Disorder Society. 22(2) : 279-82, 2007.
  • Zesiewicz TA, Ward CL, Hauser RA, Pease Campbell JA, Sullivan KL. Pregabalin (Lyrica) in the treatment of essential tremor. Movement disorders : official journal of the Movement Disorder Society. 22(1) : 139-41, 2007.
  • Zesiewicz, Theresa A.|Ward, Christopher L.|Hauser, Robert A.|Sanchez‐Ramos, Juan|Staffetti, Joseph F.|Sullivan, Kelly L. A double‐blind placebo‐controlled trial of zonisamide (zonegran) in the treatment of essential tremor Movement Disorders. 22(2) , 2007.
  • Zesiewicz, Theresa A.|Ward, Christopher L.|Hauser, Robert A.|Salemi, Jason L.|Siraj, Shaila|Wilson, Maria‐Carmen|Sullivan, Kelly L. A pilot, double‐blind, placebo‐controlled trial of pregabalin (Lyrica) in the treatment of essential tremor Movement Disorders. 22(11) , 2007.
  • Hauser, Robert A.|Zesiewicz, Theresa A. Advances in the Pharmacologic Management of Early Parkinson Disease Neurologist. 13(3) , 2007.
  • Stacy, M.|Hauser, R. Development of a Patient Questionnaire to facilitate recognition of motor and non-motor wearing-off in Parkinson’s disease Journal of Neural Transmission [03009564]. 114(2) , 2007.
  • Samanta, Johan|Hauser, Robert A Duodenal levodopa infusion for the treatment of Parkinson’s disease Expert Opinion on Pharmacotherapy. 8(5) , 2007.
  • Taylor, Julie P.|Hulihan, Mary M.|Kachergus, Jennifer M.|Melrose, Heather L.|Lincoln, Sarah J.|Hinkle, Kelly M.|Stone, Jeremy T.|Ross, Owen A.|Hauser, Robert|Aasly, Jan|Gasser, Thomas|Payami, Haydeh|Wszolek, Zbigniew K.|Farrer, Matthew J. Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson’s disease Neurogenetics. 8(2) , 2007.
  • Zesiewicz, Theresa A.|Sullivan, Kelly L.|Hauser, Robert A. Levodopa-induced Dyskinesia in Parkinson’s disease: Epidemiology, etiology, and treatment Current Neurology and Neuroscience Reports. 7(4) , 2007.
  • Zesiewicz, Theresa A.|Hauser, Robert A. MEDICAL TREATMENT OF MOTOR AND NONMOTOR FEATURES OF PARKINSON'S DISEASE CONTINUUM: Lifelong Learning in Neurology [10802371]. 13, 2007.
  • Seeberger, Lauren C.|Hauser, Robert A. Optimizing bioavailability in the treatment of Parkinson's disease Neuropharmacology [00283908]. 53(7) , 2007.
  • Langbehn, Douglas R.|Paulsen, Jane S. Predictors of diagnosis in Huntington disease Neurology. 68(20) , 2007.
  • Zesiewicz, Theresa A.|Ward, Christopher L.|Hauser, Robert A.|Pease Campbell, Jessica A.|Sullivan, Kelly L. Pregabalin (Lyrica) in the treatment of essential tremor Movement Disorders. 22(1) , 2007.
  • Sullivan, Kelly L.|Ward, Christopher L.|Hauser, Robert A.|Zesiewicz, Theresa A. Prevalence and treatment of non-motor symptoms in Parkinson's disease Parkinsonism and Related Disorders. 13(8) , 2007.
  • Hauser, Robert A.|Salin, Laurence|Juhel, Nolwenn|Konyago, Victor L. Randomized trial of the triple monoamine reuptake inhibitor NS 2330 (tesofensine) in early Parkinson's disease Movement Disorders. 22(3) , 2007.
  • Simonson, W.|Hauser, R. A|Schapira, A. H. Role of the Pharmacist in the Effective Management of Wearing-Off in Parkinson's Disease The Annals of Pharmacotherapy. 41(11) , 2007.
  • Zesiewicz, T. A.|Patel-Larson, A.|Hauser, R. A.|Sullivan, K. L. Social Security Disability Insurance (SSDI) in Parkinson's disease Disability and Rehabilitation [09638288]. 29(24) , 2007.
  • Hauser, Robert A.|Rascol, Olivier|Korczyn, Amos D.|Jon Stoessl, A.|Watts, Ray L.|Poewe, Werner|De Deyn, Peter P.|Lang, Anthony E. Ten‐year follow‐up of Parkinson's disease patients randomized to initial therapy with ropinirole or levodopa Movement Disorders. 22(16) , 2007.
  • Zesiewicz, Theresa A.|Sullivan, Kelly L.|Ward, Christopher L.|Hauser, Robert A. Tiagabine and exacerbation of essential tremor Movement Disorders [08853185]. 22(14) , 2007.
  • Zesiewicz, Theresa A.|Sullivan, Kelly L.|Hauser, Robert A. Chorea Induced by Lamotrigine Journal of Child Neurology [08830738]. 21(4) , 2006.
  • Hauser, Robert A.|Zesiewicz, Theresa A. Clinical trials aimed at detecting neuroprotection in Parkinson’s disease Neurology [00283878]. 66(10_suppl_4) , 2006.
  • Graff-Radford, John|Foote, Kelly D.|Rodriguez, Ramon L.|Fernandez, Hubert H.|Hauser, Robert A.|Sudhyadhom, Atchar|Rosado, Christian A.|Sanchez, Justin C.|Okun, Michael S. Deep Brain Stimulation of the Internal Segment of the Globus Pallidus in Delayed Runaway Dyskinesia Archives of Neurology. 63(8) , 2006.
  • Stacy, Mark|Hauser, Robert|Oertel, Wolfgang|Schapira, Anthony|Sethi, Kapil|Stocchi, Fabrizio|Tolosa, Eduardo End-of-dose Wearing Off in Parkinson Disease: A 9-Question Survey Assessment Clinical Neuropharmacology. 29(6) , 2006.
  • Hauser, Robert A. Factors Associated With the Development of Motor Fluctuations and Dyskinesias in Parkinson Disease Archives of Neurology. 63(12) , 2006.
  • Samanta, Johan|Hauser, Robert A Levodopa/Carbidopa/Entacapone for the Treatment of Parkinson’s Disease Aging Health. 2(2) , 2006.
  • Pahwa, Rajesh|Lyons, Kelly E.|Wilkinson, Steven B.|Simpson, Richard K.|Ondo, William G.|Tarsy, Daniel|Norregaard, Thorkild|Hubble, Jean P.|Smith, Donald A.|Hauser, Robert A.|Jankovic, Joseph Long-term evaluation of deep brain stimulation of the thalamus Journal of Neurosurgery Pediatrics [00223085]. 104(4) , 2006.
  • Zesiewicz, Theresa A|Sullivan, Kelly L|Hauser, Robert A Nonmotor symptoms of Parkinson’s disease Expert Review of Neurotherapeutics. 6(12) , 2006.
  • Zesiewicz, Theresa A.|Sullivan, Kelly L.|Hauser, Robert A.|Sanchez-Ramos, Juan Open‐label pilot study of levetiracetam (Keppra) for the treatment of chorea in Huntington's disease Movement Disorders. 21(11) , 2006.
  • Hauser, Robert A.|Russ, Hermann|Haeger, Doris-Anita|Bruguiere-Fontenille, Michel|Müller, Thomas|Wenning, Gregor K. Patient Evaluation of a Home Diary to Assess Duration and Severity of Dyskinesia in Parkinson Disease Clinical Neuropharmacology. 29(6) , 2006.
  • Sullivan, Kelly L.|Staffetti, Joseph F.|Hauser, Robert A.|Dunne, Peter B.|Zesiewicz, Theresa A. Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease Movement Disorders. 21(1) , 2006.
  • Zesiewicz, Theresa A.|Wecker, Lynn|Sullivan, Kelly L.|Merlin, Lisa R.|Hauser, Robert A. The Controversy Concerning Plasma Homocysteine in Parkinson Disease Patients Treated with Levodopa Alone or with Entacapone: Effects of Vitamin Status Clinical Neuropharmacology. 29(3) , 2006.
  • Zesiewicz, Theresa A.|Tullidge, Archer|Tidwell, Jonathan|Sullivan, Kelly L.|Hauser, Robert A. Topiramate-induced Psychosis in Patients with Essential Tremor: Report of 2 Cases Clinical Neuropharmacology [03625664]. 29(3) , 2006.
  • Zesiewicz, Theresa A.|Pathak, Amit|Sullivan, Kelly L.|Shamayev, Mikhail|Hauser, Robert A. Treatment of chorea with levetiracetam European Journal of Clinical Pharmacology. 62(1) , 2006.
  • Wolfrath, Summer C.|Borenstein, Amy R.|Schwartz, Skai|Hauser, Robert A.|Sullivan, Kelly L.|Zesiewicz, Theresa A. Use of nutritional supplements in Parkinson's disease patients Movement Disorders. 21(8) , 2006.
  • Zesiewicz, Theresa A.|Sullivan, Kelly L.|Hauser, Robert A. Vascular hemichorea/hemiballismus and topiramate Movement Disorders. 21(4) , 2006.
  • Hauser, Robert A|Schwarzschild, Michael A Adenosine A2A Receptor Antagonists for Parkinson???s Disease: Rationale, Therapeutic Potential and Clinical Experience Drugs and Aging. 22(6) , 2005.
  • Recio, Maria V.|Hauser, Robert A.|Louis, Elan D.|Radhashakar, Harsha|Sullivan, Kelly L.|Zesiewicz, Theresa A. Chorea in a patient with cerebral palsy: Treatment with levetiracetam Movement Disorders. 20(6) , 2005.
  • Truong, Daniel|Duane, Drake D.|Jankovic, Joseph|Singer, Carlos|Seeberger, Lauren C.|Comella, Cynthia L.|Lew, Mark F.|Rodnitzky, Robert L.|Danisi, Fabio O.|Sutton, James P.|Charles, P. David|Hauser, Robert A.|Sheean, Geoffrey L. Efficacy and safety of botulinum type A toxin (Dysport) in cervical dystonia: Results of the first US randomized, double‐blind, placebo‐controlled study Movement Disorders. 20(7) , 2005.
  • Stacy, Mark|Bowron, Annette|Guttman, Mark|Hauser, Robert|Hughes, Kim|Larsen, Jan Petter|LeWitt, Peter|Oertel, Wolfgang|Quinn, Niall|Sethi, Kapil|Stocchi, Fabrizio Identification of motor and nonmotor wearing‐off in Parkinson's disease: Comparison of a patient questionnaire versus a clinician assessment Movement Disorders. 20(6) , 2005.
  • Hogarth, Penelope|Kayson, Elise|Kieburtz, Karl|Marder, Karen|Oakes, David|Rosas, Diana|Shoulson, Ira|Wexler, Nancy S.|Young, Anne B.|Zhao, Hongwei Interrater agreement in the assessment of motor manifestations of Huntington's disease Movement Disorders. 20(3) , 2005.
  • Sullivan, Kelly L.|Hauser, Robert A.|Zesiewicz, Theresa A. Levetiracetam for the treatment of essential tremor Movement Disorders. 20(5) , 2005.
  • Sullivan, Kelly L.|Hauser, Robert A.|Louis, Elan D.|Chari, Ganesh|Zesiewicz, Theresa A. Levetiracetam for the treatment of generalized dystonia Parkinsonism and Related Disorders. 11(7) , 2005.
  • Zesiewicz, Theresa A|Sanchez-Ramos, Juan|Sullivan, Kelly L|Hauser, Robert A Levetiracetam-Induced Parkinsonism in a Huntington Disease Patient Clinical Neuropharmacology. 28(4) , 2005.
  • Zesiewicz, Theresa A.|Sullivan, Kelly L.|Maldonado, John L.|Tatum, William O.|Hauser, Robert A. Open‐label pilot study of levetiracetam (Keppra) for the treatment of levodopa‐induced dyskinesias in Parkinson's disease Movement Disorders. 20(9) , 2005.
  • Furtado, Sarah|Sossi, Vesna|Hauser, Roberta A.|Samii, Ali|Schulzer, Michael|Murphy, Colleen B.|Freeman, Thomas B.|Stoessl, A. Jon Positron emission tomography after fetal transplantation in Huntington's disease Annals of Neurology. 58(2) , 2005.
  • Zesiewicz, T. A.|Elble, R.|Louis, E. D.|Hauser, R. A.|Sullivan, K. L.|Dewey, R. B.|Ondo, W. G.|Gronseth, G. S.|Weiner, W. J. Practice Parameter: Therapies for essential tremor [RETIRED]: Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology. 64(12) , 2005.
  • Zesiewicz, Theresa A|Stamey, William|Sullivan, Kelly L|Hauser, Robert A Botulinum toxin A for the treatment of cervical dystonia Expert Opinion on Pharmacotherapy. 5(9) , 2004.
  • Hauser, Robert A.|Pahwa, Rajesh Current treatment challenges and emerging therapies in Parkinson's disease Neurologic Clinics. 22(3) , 2004.
  • Stern, Matthew B.|Marek, Kenneth L.|Friedman, Joseph|Hauser, Robert A.|LeWitt, Peter A.|Tarsy, Daniel|Olanow, C. Warren Double‐blind, randomized, controlled trial of rasagiline as monotherapy in early Parkinson's disease patients Movement Disorders. 19(8) , 2004.
  • Sullivan, Kelly L.|Hauser, Robert A.|Zesiewicz, Theresa A. Essential Tremor: Epidemiology, Diagnosis, and Treatment Neurologist. 10(5) , 2004.
  • Hauser, Robert A.|Lyons, Kelly E. Future therapies for Parkinson's disease Neurologic Clinics. 22(3) , 2004.
  • Zesiewicz, T.A.|Strom, J.A.|Borenstein, A.R.|Hauser, R.A.|Cimino, C.R.|Fontanet, H.L.|Cintron, G.B.|Staffetti, J.F.|Dunne, P.B.|Sullivan, K.L. Heart failure in Parkinson's disease: analysis of the United States medicare current beneficiary survey Parkinsonism and Related Disorders. 10(7) , 2004.
  • Hauser, Robert A. Levodopa/carbidopa/entacapone (Stalevo) Neurology [00283878]. 62(1_suppl_1) , 2004.
  • Hauser, Robert A.|Deckers, Frieda|Lehert, Philippe Parkinson's disease home diary: Further validation and implications for clinical trials Movement Disorders. 19(12) , 2004.
  • Adler, C. H.|Hauser, R. A.|Sethi, K.|Caviness, J. N.|Marlor, L.|Anderson, W. M.|Hentz, J. G. Ropinirole for restless legs syndrome: A placebo-controlled crossover trial Neurology [00283878]. 62(8) , 2004.
  • Pahwa, Rajesh|Lyons, Kelly E|Hauser, Robert A Ropinirole therapy for Parkinson’s disease Expert Review of Neurotherapeutics. 4(4) , 2004.
  • Zesiewicz, Theresa A.|Louis, Elan D.|Sullivan, Kelly L.|Menkin, Martin|Dunne, Peter B.|Hauser, Robert A. Substantial improvement in a Meige's syndrome patient with levetiracetam treatment Movement Disorders. 19(12) , 2004.
  • Waters, Cheryl H.|Sethi, Kapil D.|Hauser, Robert A.|Molho, Eric|Bertoni, John M. Zydis selegiline reduces off time in Parkinson's disease patients with motor fluctuations: A 3‐month, randomized, placebo‐controlled study Movement Disorders. 19(4) , 2004.
  • Kordower, Jeffrey H.|Freeman, Thomas B.|Chen, Er‐Yun|Mufson, Elliott J.|Sanberg, Paul R.|Hauser, Robert A.|Snow, Barry|Warren Olanow, C. Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease Movement Disorders. 13(3) , 1998.